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Abstract 
 
Bacteria, plants, fungi, and apicomplexan parasites require the functionality of the 
shikimate pathway for biosynthesis of essential aromatic compounds. Animals lack 
the enzymes that constitute the shikimate pathway, making these attractive 
antimicrobial targets.  
Glyphosate (the active ingredient in Roundup herbicide) inhibits the shikimate 
pathway enzyme 5-enolpyruvyl-shikimate-3-phosphate synthase (EPSPS), but has 
limited antimicrobial activity. Several EPSPS point-substitutions can induce 
glyphosate tolerance, and some species possess EPSPS with intrinsic glyphosate 
insensitivity.  
To aid development of second-generation EPSPS inhibitors, I probed the inhibition of 
glyphosate-tolerant EPSPS. I examined the effects of mutations at Pro101 and Thr97 
on the structure, function, and glyphosate sensitivity of E. coli EPSPS; I kinetically 
characterized the glyphosate-tolerant Staphylococcus aureus EPSPS and 
Agrobacterium sp. strain CP4 EPSPS and determined the three-dimensional structure 
of the CP4 enzyme; I studied the interaction of EPSPS with analogs of the substrate 
and the tetrahedral intermediate; and I conducted high throughput screening to 
identify novel EPSPS inhibitors. 
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Chpt. 1: Introduction and Background 
 
The 20th century was marked by the introduction of the first synthetic antibiotics, the 
sulfa drugs, and the first chemical herbicide, 2,4-D (2,4-Dichlorophenoxyacetic acid).  
The subsequent chemical revolution provided effective strategies to combat human 
disease and to control agricultural pests. These achievements are threatened by the 
evolution of drug-resistance in the target organisms, necessitating efforts to combat 
the development of resistance and strategies toward the discovery of novel 
chemotherapeutic agents. 
Selectivity with respect to bioactivity is the crucial difference between a drug and a 
poison. To achieve this selectivity, non-conserved biosynthetic pathways are often 
targeted – for example, β-lactam antibiotics interfere with the crosslinking of 
peptidoglycan, essential for bacteria but non-existent in mammals. One of the most 
promising targets for the development of novel non-toxic herbicides and 
antimicrobial agents is the shikimate pathway.  
The shikimate pathway is ancient and highly conserved, found in plants, fungi, and 
microorganisms, but never in animals (Fig. 1.1)2, 3. This seven-step biosynthetic 
pathway is responsible for the synthesis of chorismate, an essential precursor to the 
aromatic amino acids and many secondary metabolites. Representatives of each 
enzyme in the pathway have been purified from both prokaryotic and eukaryotic 
sources, and representative structures are available for each enzyme (Fig. 1.2). This 
pathway occurs in the cytosol of bacteria and in the plastids of plants, consistent with  
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Fig. 1.1: Simplified six-kingdom tree of life4 – Red coloring indicates the presence 
of the shikimate pathway. This biosynthetic pathway apparently originated in the 
common ancestor and was only lost in Animalia (which ingest the necessary 
compounds)5-8 
  
 
 
 
 
Common
Ancestor
Eubacteria
Archaebacteria
Protista
Plantae
Fungi
Animalia
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the concept that the eukaryotic shikimate pathway is the product of endosymbiosis. 
The shikimate pathway has been most extensively studied in bacteria, and the gene 
names listed in Fig. 1.2 correspond to Escherichia coli nomenclature. Substantial 
amino acid sequence divergence, along with structural and functional dissimilarities, 
are observed in shikimate pathway orthologs, and some species have various 
isozymes, but the synthetic steps of this pathway are consistent and conserved. The 
enzyme catalyzing the sixth step of the shikimate pathway, 5-enolpyruvyl shikimate-
3-phosphate synthase (EPSPS; EC 2.5.1.19), has attracted particular attention as the 
molecular target of the broad-spectrum herbicide, glyphosate9, 10 (N-
phosphonomethylglycine; trade name, Roundup).  
The reaction catalyzed by EPSPS (Fig. 1.3) results in the transfer of the enolpyruvyl 
moiety of phosphoenolpyruvate (PEP) to the 5’-hydroxyl of shikimate-3-phosphate 
(S3P), forming 5-enolpyruvyl shikimate-3-phosphate (EPSP) and inorganic phosphate 
(Pi). Glyphosate is a reversible inhibitor of this reaction, and shows competitive 
inhibition with respect to PEP11. While no structures of EPSPS from plants have been 
reported, the structure of E. coli EPSPS has been utilized as a model of EPSPS 
enzymes from plants and from other bacterial species. 
A variety of evidence suggests that EPSPS and other shikimate pathway enzymes are 
attractive drug targets. The product of the shikimate pathway, chorismate, serves as a 
starting material for the biosynthesis of essential compounds including the aromatic 
amino acids and cofactors such as ubiquinone, vitamin K, and folate in plants, fungi,  
 16 
Fig. 1.3: The reaction catalyzed by EPSPS. 
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and microorganisms, while mammals instead obtain the necessary aromatic 
compounds from their diets12-14. The deletion of the gene encoding EPSPS has been 
shown to result in attenuated virulence in Staphylococcus aureus, Streptococcus 
pneumoniae, and Bordetella bronchiseptica15-17. Many organisms, including 
Mycobacterium tuberculosis, Pseudamonas aeruginosa, Vibrio cholerae, and 
Yersinia pestis, require the production of chorismate-derived siderophores for 
pathogenicity18, 19. Further, the EPSPS inhibitor, glyphosate, has been shown to 
inhibit the in vitro growth of apicomplexan parasites including Toxoplasma gondii, 
Plasmodium falciparum, and Cryptosporidium parvum20.  
EPSPS in plants and bacteria is a 44-48 kDa enzyme composed of two globular 
domains connected by a short “hinge” region (Fig. 1.4). Binding of the first substrate, 
S3P, induces a global conformational change, with the N-terminal and C-terminal 
globular domains approaching each other to form the active site at the interdomain 
cleft. Several orthologs of EPSPS have known structures (Fig. 1.5); these include the 
EPSPS enzyme from E. coli, as mentioned, and also EPSPS enzymes from bacterial 
pathogens Streptococcus pneumoniae21 and, recently, Mycobacterium tuberculosis 
(unpublished). The global structures and folding pattern are quite similar, with each 
globular domain composed of a three repeats of a βαβαββ-unit; each of these 
enzymes also exhibit the global induced fit as shown in E. coli EPSPS. The structure 
of the EPSPS active site, depicted in Fig. 1.6a, shows the inhibitor, glyphosate, bound 
adjacent to the substrate S3P, where PEP has been observed in other structures.  
 18 
 
Fig. 1.4: Global conformational change: “open” to “closed” conformational change 
of EPSPS is induced by S3P binding22. 
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Fig. 1.5: Known structures of EPSPS. All show similar folding pattern and global 
induced-fit mechanism. 
 
 
E. coli EPSPS 
Open-form: Stallings et al. (1991) PDB ID 1eps23 
Closed-form : Schönbrunn et al. (2001) PDB ID 
1g6s22  
 
 
 
 
 
 
 
 
 
 
S. pneumoniae EPSPS  
Open- and Closed-forms: Park et al. (2004) Respective 
PDB IDs are 1rf4 and 1rf621 
 
 
 
 
 
 
 
 
 
 
M. tuberculosis EPSPS  
Open-form: Bourenkov et al. (2006) PDB ID 2bjb 
Closed-form: Kachalova et al. (2008) PDB ID 2o0e 
(Unpublished; structures deposited to the PDB) 
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Fig. 1.6b: Hydrogen bonding interactions in E. coli EPSPS (E•S•I ternary 
complex1). Exploded active-site diagram shows hydrogen bonding to S3P and 
glyphosate (black dotted lines). Glyphosate occupies the binding site of the substrate, 
PEP (structure shown on right). 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Fig. 1.6a: Structure of E. 
coli EPSPS active-site 
(E•S•I ternary complex; 
PDB ID 1g6s1). Glyphosate 
(green) binds in the active 
site adjacent to S3P 
(yellow). White dotted lines 
indicate hydrogen bonding 
interactions; water 
molecules and Tyr-200 are 
omitted for simplicity. 
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The hydrogen bonding interactions and active site architecture of EPSPS enzymes is 
highly conserved, even in enzymes with divergent amino acid sequences. Fig. 1.6b 
shows an exploded view of the active site hydrogen bonding interactions as found in 
the E.coli EPSPS•S3P•glyphosate active site; the PEP oxacarbenium ion is shown in 
the inset, next to the bound glyphosate molecule, to emphasize the structural 
similarities. The catalytic mechanism of the enzyme-catalyzed enolpyruvyl transfer is 
not completely understood. The mutation of active-site residue Asp313 (E. coli 
EPSPS D313A mutant) allowed trapping of the tetrahedral reaction intermediate (TI) 
bound to the enzyme24. This result, supported by the results obtained by chemical 
synthesis of the TI25, demonstrated that the addition-elimination reaction proceeds 
through an (S)-configured tetrahedral intermediate (Fig. 1.7a). The possible 
mechanisms of this reaction are described and shown in more detail in Fig. 1.7b; the 
base responsible for the initial nucleophilic attack leading to the addition reaction is 
unknown, while the crystallographic results demonstrated that Asp313 proton-
extraction results in the elimination reaction. 
The structural information obtained has thus far not lead to the development of novel 
EPSPS inhibitors. The confined, highly charged nature of the active site limits the 
binding of many molecules, and the global induced-fit mechanism and flexibility of 
this enzyme have frustrated molecular modeling experiments. In fact, all potent 
inhibitors of this reaction are ground-state, product, or TI analogs, and the most 
potent known inhibitors are select TI analogs26-28. Extensive efforts to modify the 
 22 
  
Fig. 1.7a: The enolpyruvyl transfer catalyzed by EPSPS is an addition/elimination 
reaction, proceeding through an S-configured tetrahedral intermediate24 
 
 
 
 
 
 
 
Fig. 1.7b: Proposed catalytic mechanism: Addition mechanism is not well known, 
elimination proceeds via proton abstraction by Asp31324 
 
 
 
 
(Left)  Two conceivable mechanisms 
for the elimination reaction of 
enolpyruvyl transfer. 
A: Asp313 abstracts a proton from 
the PEP C-3 methyl group of the 
intermediate structure directly. 
B: Asp313 abstracts a proton from 
the 4-OH of S3P; the resulting 
oxyanion then abstracts a proton 
from the C-3 of the PEP moiety.  
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structure of glyphosate showed that essentially any modification of this molecule 
resulted in decreased activity against EPSPS29. Glyphosate has excellent herbicidal 
properties and very low human and environmental toxicity30, 31. These attributes, 
together with the existence and widespread adoption of commercial varieties of 
glyphosate-tolerant crops (52% of corn, 70% of cotton, and 91% of soybeans planted 
in the United States in 2007 were glyphosate-resistant varieties32), have made 
glyphosate the most-used pesticide in the world.  
While the success of glyphosate as a herbicide demonstrates proof-of-concept for the 
targeting of the shikimate pathway, glyphosate itself has poor antimicrobial 
properties, and a number of bacteria have intrinsically glyphosate-insensitive EPSPS 
synthases33-37. On the basis of their catalytic efficiency in the presence of glyphosate, 
EPSPS enzymes from bacteria including Staphylococcus aureus, Agrobacterium sp. 
strain CP4, and Pseudomonas sp. strain PG2982, have been termed “class II” EPSPS 
enzymes. The sequence of aroA genes isolated from plants or bacterial species such 
as E. coli, Klebsiella pneumonia, or Salmonella typhimurium are quite similar; based 
on their sensitivity to inhibition by glyphosate, these “plant-like” enzymes are termed 
“class I” EPSPS.  
Richards et al. (2006) examined the phylogenetic relationship of shikimate pathway 
genes from a variety of organisms5.  The phylogeny of aroA genes (Fig. 1.8) suggests 
a genetic basis for some of the observed functional differences. The genes encoding 
plant EPSPS enzymes are clustered in the upper branch of this phylogenetic tree, 
 24 
 
Fig. 1.8:  Phylogenetic tree of aroA genes (taken from ref 5). The length of the 
horizontal connecting lines represents the degree of sequence divergence observed 
(longer line = more substitutions). 
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together with aroA genes from proteobacterial species, including E. coli. The genes 
encoding EPSPS enzymes from Fungi, Mycobacterium spp., and apicomplexan 
parasites seem to form a clade and appear to be related to the class I EPSPS enzymes. 
Substantial sequence diversity is observed within class II EPSPS enzymes, and while 
these glyphosate-tolerant enzymes cannot be easily defined or distinguished by amino 
acid sequence, it appears likely that organisms with Class II EPSPS genes comprise a 
subset of the largest and most diverse clade (the lower branch of this phylogenetic 
tree). To confirm this would require examination of the glyphosate-sensitivity of each 
organism’s EPSPS enzyme.  Overall, phylogenetic analysis indicates that the aroA 
genes encoding class I and class II EPSPS enzymes diverged long ago and have 
undergone substantial sequence differentiation. The diversity of Class I EPSPS 
enzymes is very limited compared to the overall diversity of EPSPS enzymes, and 
few pathogenic species have Class I enzymes. Some organisms knows to possess 
class II EPSPS enzymes are human pathogens, but essentially no data are available 
concerning the structure, activity, or inhibition of the class II EPSPS enzymes. Such 
data are desired, along with detailed structure-function studies, in order to facilitate 
the development of broad-spectrum antimicrobial compounds.  
The effectiveness of antibiotic drugs characteristically deteriorates due to the 
emergence of drug-resistant bacterial strains. A great deal of genetic variation exists 
between bacterial species; in combination with the massive number of individual 
bacteria, this represents an enormous reservoir of genetic diversity. Utilization of 
antibacterial agents effectively screens this genetic reservoir, selecting for drug-
 26 
resistant organisms. The short generation time of bacteria, coupled with horizontal 
gene-transfer mechanisms, facilitates the relatively rapid emergence of drug-resistant 
bacterial strains. L.C. McDonald (2006) examined the emergence of penicillin-
resistant and methicillin-resistant strains of S. aureus (Fig. 1.9)38. Drug-resistant S. 
aureus strains emerge first in hospital settings, then in the general population. In each 
case, the percentage of antibiotic-resistant S. aureus isolates increased at an 
exponential rate, quickly diminishing the utility of the antibiotic agent and 
demonstrating the need for novel drugs. The maintenance of effective therapies to 
combat bacterial infections thus requires on-going research into potential drug targets 
and the continual development of novel antimicrobial agents. 
The development of resistance is also observed in plants. From the introduction of 
glyphosate-based herbicides in 1974 until 1996, no evolved glyphosate-resistant weed 
species were described. R.F. Service (2007) plotted the evolution of glyphosate-
resistant plants (Fig. 1.10)39. These data show that since 1996, the number of plant 
species with evolved glyphosate-resistance has increased at an exponential rate. The 
scale of modern chemical agriculture is such that the question is not whether 
pesticides will be used, but which pesticides will be used. In light of glyphosate’s 
broad-spectrum phytoxicity, minimal environmental persistence, and lack of animal 
toxicity, coupled with the increasing utilization of glyphosate-dependent soil 
conservation practices (such as no-till farming), and the efficiency and market 
dominance of glyphosate-tolerant (Roundup Ready) crops varieties, the widespread  
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Fig. 1.9: Evolution of antimicrobial resistance in S. aureus (taken from ref 38). 
Grey lines indicate percentage of resistant bacteria isolated from healthcare settings, 
black lines indicate percentage of resistant bacteria in the general population. The 
left-side plots show occurrence of penicillin-resistant isolates, while the right-side 
plots show the occurrence of methicillin-resistant isolates. 
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Fig. 1.10: Evolution of glyphosate-resistant weed species (taken from ref 39). The 
first field-evolved glyphosate-resistant weed species was described in 1996; the 
number of such species appears to be increasing at an exponential rate. 
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emergence of glyphosate-resistant weeds constitutes a significant threat to agriculture 
and the environment39-42.   
We believe that the targeting of shikimate pathway enzymes is an efficient strategy 
toward the development of the required novel antimicrobial and herbicidal agents. 
Here, we describe our progress in understanding the inhibition of EPSPS and our 
efforts toward development of second-generation EPSPS inhibitors. 
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List of Abbreviations 
 
2,4-D 2,4-Dichlorophenoxyacetic acid 
2F-TI (R)-difluoromethyl TI analog 
Abs Absorbance 
Ala, A Alanine 
Amp Ampicillin 
ANS 1-anilino-8-naphthalene sulfonate 
Arg, R Arginine 
APS Ammonium persulfate 
a.u. Arbitrary units 
AUC Area-under-the-curve 
BSA Bovine serum albumin 
CP4 Agrobacterium sp. strain CP4 EPSPS 
CV Column volume 
Cys, C Cysteine 
DMSO Dimethysulfoxide 
DNA Deoxyribonucleic acid 
DTT Dithiothreitol 
E. coli Escherichia coli 
EDTA Ethylenediaminetetraacetic acid 
EPS 5-enolpyruvylshikimate 
EPSP 5-enolpyruvylshikimate-3-phosphate  
EPSPS 5-enolpyruvylshikimate-3-phosphate synthase 
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EtOH Ethanol 
Fc Calculated structure factors 
FL Fluorescence intensity observed in presence of ligand 
Fo Observed structure factors 
FO Original fluorescence intensity observed 
FPLC Fast protein liquid chromatography 
Glp Glyphosate 
Glu, E Glutamic acid 
HCl Hydrochloric acid 
HEPES N-[2-Hydroxyethyl] piperazine-N'-[2-ethanesulfonic acid] 
HPLC High pressure liquid chromatography 
HTS High throughput screening 
IC50 50% inhibitory concentration 
ID Identification number 
Ile, I Isoleucine 
IPTG Isopropyl-β-D-thiogalactoside 
Kb Kilobase 
kcat Catalytic rate constant 
Kd Dissociation constant 
Ki Inhibition constant 
Km Michaelis constant 
kDa Kilodalton 
LB Luria-Bertani 
Leu, L Leucine 
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M. jannaschii Methanococcus jannaschii 
M. tuberculosis Mycobacterium tuberculosis 
MES 2-[N-Morpholino] ethanesulfonic acid 
NAD+ Nicotinamide adenine dinucleotide 
NADPH Nicotinamide adenosine dinucleotide phosphate 
OD Optical density 
PEP Phosphoenolpyruvate 
PDB Protein data bank 
Phe, F Phenylalanine 
Pi Inorganic phosphate 
Q-seph Q-sepharose 
r.m.s.d. Root mean squared deviation 
rpm Revolutions per min 
RP-TI (R)-phosphonate TI analog 
S3P Shikimate-3-phosphate 
S. aureus Staphylococcus aureus 
S. pneumoniae Streptomyces pneumoniae 
Ser, S Serine 
SDS Sodium dodecyl sulfate  
SDS-PAGE Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SK Shikimate Kinase 
SP-TI (S)-phosphonate TI analog 
TAE Tris, Acetic acid and EDTA buffer 
TEAB Triethylammonium bicarbonate 
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TEMED N,N,N',N'-Tetra-methylethylenediamine 
TI Tetrahedral reaction intermediate 
Tris Tris hydroxymethyl aminomethane 
U/mg micromoles product formed per minute, per milligram of enzyme 
UV Ultraviolet 
(v/v) Volume/volume 
(w/v) Weight/volume 
WT Wild-type enzyme  
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General Protocols 
 
All chemicals and equipment were purchased from Sigma (St. Louis, MO) or Fisher 
(Springfield, NJ) unless otherwise noted. A Labconco Water Pure Plus System was 
used to purify all ddH2O used for research. Deviations from the standard procedures, 
as well as additional specific procedures, are noted in the Experimental procedures 
section of each research chapter. 
Media- All media was autoclaved and stored at 4 ˚C.  Antibiotic stocks were added to 
the media just prior to use.  
LB Media: 
10 g tryptone 
7.5 g yeast extract 
5 g NaCl 
Fill to 1 L with H2O  
LB Agar: 
20 g granulated agar 
Fill to 1 L with LB media 
LB agar was autoclaved and allowed to cool to 30 °C before addition of appropriate 
antibiotic stocks, then was poured into Petri dishes and stored at 4 °C. 
Antibiotics- Ampicillin stocks at 100 mg/ml in H2O or Kanamycin stocks at 30 
mg/ml were sterile filtered with a 0.45 µm filter and stored at -20 ˚C.  Amp and Kan 
 36 
stocks were diluted 1:1000 for all purposes (final [Amp] = 100 µg/ml; final [Kan] = 
30 µg/ml).  
DNA Electrophoresis- One-percent (w/v) agarose gels were utilized to separate DNA 
on the basis of size; 500 mg of agarose was heated in 50 ml of 1X TAE until 
dissolved, 1 µl of ethidium bromide (5 mg/ml) was added to the solution and the gel 
was cast using a DNA mini-submarine gel electrophoresis unit (GE Healthcare, 
Piscataway, NJ). DNA samples were prepared by addition of 1 µl of 10X Bluejuice 
and 1-9 µl of DNA to 0-8 µl of H2O, for total sample volume = 10 µl. Electrophoresis 
of gels was typically performed at 120 mV for 45 min. A 50X concentrated solution 
of TAE was stored at room temperature and diluted to 1X prior to use. 
50X TAE: 
242 g Tris (pH 8.5) 
57.1 ml glacial acetic acid 
100 ml 0.5 M EDTA (pH 8.0) 
Fill to 1 L with H2O 
Following electrophoresis, the ethidium bromide-intercalated DNA was visualized 
with UV light and compared to a molecular ladder containing 10, 7, 5, 4, 3, 2.5, 2, 1.5 
and 1 Kb markers, prepared by adding 5 µl Low-Range DNA marker (Cambrex Bio 
Science, Rockland, ME) and 2 µl 10X Bluejuice (Invitrogen) to 3 µl H2O.  
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SDS-PAGE- Protein samples for SDS-PAGE were denatured by addition of 5x SDS-
PAGE loading buffer to the protein sample to effect a final concentration of 1x, 
followed by incubation for 10 min at 100˚C. The samples were loaded onto the SDS 
gel by pipetting 20 µl into each lane.  Electrophoresis of gels was conducted in a 
reservoir of 1x Running Buffer using a mini PROTEAN 3 cell (Biorad) at 160 V for 1 
hour. To visualize protein samples, SDS gels were soaked in the coomassie-based 
staining solution for ~ 15 minutes followed by removal of excess coomassie dye by 
soaking SDS gels for several hours in the destaining solution. Sample migration in 
SDS-PAGE experiments was monitored visually by comparison to the known-MW 
protein ladder. Acrylamide/Bis Solution, 30% 19:1 crosslinker ratio (Biorad), APS, 
TEMED (Biorad) and Tris buffers were stored at 4 ˚C.  The Low Range MW ladder 
was stored at -20˚C. All other solutions were stored at room temperature. SDS-PAGE 
gels were made in-lab and stored at 4˚C for up to 2 weeks. The resolving portion of 
the gel was cast and allowed to solidify first, then topped by a ~ 1.5 cm stacking 
portion. The list of ingredients for each solution follows: 
Resolving portion, SDS Gel: 
4 ml 30 % Acrylamide/Bis solution 
100 µl 10 % (w/v) SDS 
2.5 ml 1.5 M Tris (pH 8.8) 
3.36 ml H2O 
80 µl 10 % (w/v) APS 
10.0 µl TEMED  
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Stacking Portion, SDS gel:  
650 µl 30 % Acrylamide/Bis solution 
50 µl 10 % SDS 
1.25 ml 0.5 M Tris (pH 6.8) 
3.05 ml H2O 
40 µl 10 % APS 
5 µl TEMED  
5X SDS-PAGE Loading Buffer: 
1.82 g Tris (pH 8.5) 
5 g SDS  
12.5 ml β-mercaptoethanol 
25 ml glycerol 
1.28 ml HCl 
0.028 g bromophenol blue 
Fill to 50 ml with H2O 
Low-Molecular-Weight Marker: 
50 µl concentrated Low-Range marker (Biorad) 
100 µl 5X loading dye 
350 µl H2O 
Heat 5 min at 100˚C.   
Store at -20˚C.   
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Apply 5 µl marker to visualize ladder.  
MW of ladder bands correspond to 97.4, 66.2, 45, 31, 21.5 and 14.4 kDa.   
10X SDS-PAGE Running Buffer: 
30 g Tris (pH 8.5) 
144 g glycine 
10 g SDS 
Fill to 1 L with H2O 
Coomassie Staining Solution: 
1.25 g Coomassie brilliant blue R-250 
500 ml 95 % EtOH 
450 ml H2O.  
50 ml 100 % acetic acid.  
Filtered and stored in a dark bottle. 
Destaining Solution: 
500 ml EtOH 
100 ml acetic acid  
400 ml H2O 
Competent cells- E. coli chemically competent cell strains utilized were: BL21(DE3), 
BL21 Star (DE3), and DH5α (Invitrogen). Commercial stocks of competent cells 
were generally utilized; in-house stocks of CaCl2 competent cells were generously 
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provided by Dr. Melanie Priestman, Dr. Bernhard Trinczek, Katinka Bahr, and 
Jennifer Biery. 
Transformations- Competent cells were transformed by adding 50 to 250 ng of 
plasmid to 95 µl of a glycerol stock of chemically competent cells.  This mixture was 
incubated on ice for 30 min, heat-shocked for 45 sec at 42˚C and incubated again on 
ice for 2 min.  After adding 900 µl of LB media, the mixture was incubated 1 h at 
37°C with shaking at 250 rpm.  The cells were then centrifuged for 4 min at 5,000 
rpm and 900 µl of supernatant was removed.  The pellet was resuspended in the 
remaining broth, plated on LB agar plates containing the appropriate antibiotic and 
incubated overnight at 37˚C.   
Plasmid preparation- Plasmids were isolated from cultures and purified using the 
Mini-Prep kit (Qiagen), according to the manufacturer’s protocol. Plasmid and DNA 
fragments were isolated from agarose gels using Gel Extraction kits (Qiagen) 
according to the manufacturer’s protocol. In either case, DNA was typically eluted in 
30 µl sterile H2O. 
DNA Sequencing- DNA sequences were verified by sequencing at the University of 
Kansas Medical Center’s Biotech Research Support Facility or at the Idaho State 
University Molecular Reaseach Core Facility, using appropriate primers.  
Mutagenesis- Site-directed mutagenesis was performed to introduce desired 
mutations using the QuikChange II site-directed mutagenesis kit (Stratagene), 
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according to the manufacturer’s instructions.  Appropriate primers were synthesized 
by MWG Biotech.   Following DpnI digestion,  products were transformed into DH5α 
competent cells, plated to agar, and incubated overnight. Colonies were selected for 
overnight cultures, plasmids were isolated as described, and the presence of the 
mutations were verified by DNA sequencing. 
Induction Studies- To assay soluble over-expression, positively sequenced plasmids 
were transformed into competent cell lines, colonies were picked from each 
transformation plate, and incubated in 5 ml LB media and the appropriate antibiotic 
overnight at 37°C with shaking. A 50 µl aliquot of the overnight culture was used to 
inoculate 5 ml of fresh LB-antibiotic media, and the culture was again incubated at 
37˚C while shaking at 250 rpm. After reaching an OD600 of 0.4 - 0.6, a 1 ml aliquot 
was removed to serve as a control, and the cells were induced with IPTG to a final 
concentration of 0.5 mM. After induction, cells were incubated for 4-6 hours at 37˚C 
with shaking.  A 1 ml aliquot was subsequently removed and all aliquots were 
centrifuged at 13,000 rpm for 1 minute. The supernatant was discarded and each cell 
pellet was resuspended in 200 µl extraction buffer then sonicated to lyse the cells.  
Following sonication, the uninduced control samples were set aside and the pellet 
solution from the induced samples were again centrifuged for 1 min at 13,000 rpm.  
The supernatant (containing soluble proteins) was removed, and the pellet (containing 
insoluble protein and cell debris) was resuspended in 200 µl of extraction buffer.  The 
uninduced control, induced supernatant, and induced pellet samples were mixed with 
50 µl 5X loading dye, vortexed briefly, and heated for 10 min at 100°C.  The levels of 
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soluble over-expression were visualized with SDS-PAGE. As needed, the induction 
studies were repeated with adjustments to the time and temperature of incubation, the 
cell density at the time of induction, and the final concentration of IPTG, in attempts 
to increase the amount of soluble protein.   
Glycerol stocks- A 900 µl aliquot of an overnight cell culture was mixed with 100 µl 
sterile 80% glycerol and stored at -80°C for use in future experiments. 
Protein overexpression- Typically, overexpression of protein was achieved by using 
50 µl of the appropriate glycerol stock to start a 50 ml overnight culture at 37°C, in 
LB media with the appropriate antibiotic. The following day, 5 ml aliquots of the 
overnight culture were added to each of 6 flasks containing 500 ml each of LB media 
with the appropriate antibiotic and 1 drop of antifoam solution (Triton-X100). These 
cultures were incubated with shaking at 37°C until log phase (OD600 of 0.4-0.8) was 
reached, then protein overexpression was induced by addition of IPTG to a final 
concentration of 0.5 mM.   After induction, the cells were allowed to grow 4-6 hours 
at 37°C, then the cells were pelleted by centrifugation (6,000 rpm for 10 minutes). 
The cell pellets were collected, weighed, and stored at -80°C.  
Protein extraction and purification buffers- All buffers for protein purification were 
prepared at 4°C using purified H2O, pH-adjusted with NaOH or HCl, filtered with a 
0.45 µm filter, and stored at 4°C.  
Extraction Buffer: 
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50 mM Tris-Cl (pH 7.8) 
2.5 mM DTT 
1 mM EDTA 
0.1 % (v/v) Tween 20 
Phenyl-sepharose Buffer A: 
50 mM Tris-Cl pH 7.8 
1 mM EDTA 
1 mM DTT 
Phenyl-sepharose Buffer B:  
50 mM Tris-Cl pH 7.8 
1 mM EDTA 
1 mM DTT 
1 M (NH4)2SO4 
Phenyl-sepharose cleaning solutions: 
a) 2 CV 1 M NaOH 
b) 2 CV 20 % Ethanol 
c) 2 CV 1 M HCl 
d) 2 CV H2O  
Q-sepharose Buffer A:  
50 mM Tris-Cl pH 7.8 
 44 
1 mM EDTA 
1 mM DTT 
Q-sepharose Buffer B:  
50 mM Tris-Cl pH 7.8 
1 mM EDTA 
1 mM DTT 
0.4 M KCl or NaCl 
Q-sepharose cleaning solutions:  
a) 2 CV 1 M NaOH 
b) 2 CV 20 % Ethanol 
c) 2 CV 2M NaCl 
d) 2 CV H2O 
Resource-Q Buffer A:  
50 mM Tris-Cl pH 7.8 
1 mM EDTA 
1 mM DTT 
Resource-Q Buffer B:  
50 mM Tris pH 7.8 
1 mM EDTA 
1 mM DTT 
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0.4 M KCl or NaCl 
Resource-Q cleaning solutions:  
a) 5 CV 1 M NaCl 
b) 5 CV H2O 
c) 5 CV 1 M NaOH 
d) 5 CV H2O 
e) 5 CV 1 M HCl 
f) 5 CV H2O 
g) 5 CV 1 M NaCl 
h) 5 CV H2O 
Size-exclusion chromatography protocol:  
Utilized pre-equilibrated gel filtration columns,  
Maximum flow rate = 0.5 ml/min,  
Isocratic elution of samples  
Specific buffer conditions as described. 
Size-exclusion cleaning procedure:  
a) 2 CV 1 M NaOH 
b) 2 CV 20 % Ethanol 
c) 2 CV 2M NaCl 
d) 2 CV H2O  
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Standard protein purification- Enzymes were purified at 4°C using ÄKTA FPLC 
systems and prepacked columns, typically according to standard procedures described 
by Eschenburg et al. (2002)43. Cell pellets obtained from overexpression cultures 
were resuspended in extraction buffer plus lysozyme and stirred for 1 hour at 4°C, 
using 10 ml extraction buffer and 1 mg lysozyme per 1 g of cell pellet weight.   The 
solution was then sonicated on ice for 2x30 seconds.   After sonication, insoluble cell 
debris was removed by centrifugation for 30 min at 14,000 rpm. The supernatant was 
pooled and undesired proteins were precipitated by stirring for 1 hour at 4°C in the 
presence of a 25% saturating concentration of (NH4)2SO4. Following the (NH4)2SO4 
precipitation, samples were clarified by centrifugation at 18,000 rpm for 1 hour. The 
supernatants were then applied to a Phenyl Sepharose 26/10 hydrophobic interaction 
column, pre-equilibrated with Buffer B (50 mM Tris, 1 mM DTT, 1 mM EDTA, pH 
7.8 + 1 M (NH4)2SO4, and protein fractions were eluted from the column by 
decreasing the salt concentration in the mobile phase (gradient: 0 % Buffer A to 
100% Buffer A over 10 CV). The fractions containing the target protein were 
identified by size using SDS-PAGE, or by enzymatic activity using the appropriate 
assay.  The fractions containing the target protein were combined, and removal of salt 
was accomplished by concentrating samples on an Amicon protein concentration cell 
(with the appropriately-sized Millipore filter) with serial addition of Q-sepharose 
Buffer A until salinity readings were less than 10 mS/cm2 were recorded using a 
conductivity meter. This desalted and concentrated protein solution was loaded onto a 
Q-Sepharose 26/10 and the protein was eluted from the column by increasing the salt 
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concentration in the mobile phase (gradient: 100% Buffer A to 0% Buffer A over 10-
15 CV). As previously, fractions containing the target protein were pooled, 
concentrated, and buffer exchanged using to reach a conductivity of < 10 mS/cm2. 
The protein was then applied to a 6 ml Resource-Q column and subjected to a 
secondary anion-exchange purification. Again, the protein was eluted by increasing 
the salt in the mobile phase (gradient: 100 % Buffer A to 0% Buffer A over 25 CV). 
Fractions containing the target protein were identified by SDS-PAGE or enzymatic 
activity, and homogeneity of at least 95% was verified by coomassie-stained SDS-
PAGE. For kinetic analysis, the purified proteins were aliquoted, shock-frozen in 
liquid nitrogen, and stored at -80°C. For crystallographic analysis, the purified 
proteins were concentrated in 50 mM Tris-Cl pH 8.0 and 2 mM dithiothreitol using 
Centricon-30 devices (Millipore) at 4°C. Again, these were aliquoted, shock-frozen in 
liquid nitrogen, and stored at -80°C. 
Protein concentration determination- Protein concentrations were determined 
spectroscopically using coomassie reagent (Pierce) according to the Bradford44 
method, with bovine serum albumin as a standard. For cuvette-based assays, 5 µl 
protein sample, 95 µl H2O, and 900 µl coomassie reagent were utilized. For 
microtiter-plate-based assays, 5 µl protein sample, 15 µl H2O, and 180 µl coomassie 
reagent were utilized. Absorbance was measured at 595 nm and the data were fit to a 
BSA standard curve to determine the protein concentration.   
 48 
Standard Production of S3P- The enzymatic synthesis of S3P was typically achieved 
according to the protocol described by Priestman et al. (2005)45 using a His6-tag-
Methanococcus jannaschii SK46 (gift from Integrated Genomics Inc.). For all 
experiments, the M. jannachii SK enzyme was provided by Dr. Melanie Priestman or 
Martha Healy-Fried.  
Briefly, to obtain the SK, a pET-derived vector with ampicillin resistance containing 
the M. jannaschii SK gene was transformed into BL21(DE3) E. coli cells, large-scale 
cultures were grown to log phase (OD600 = 0.4 to 0.6) at 37ºC , induced by the 
addition of IPTG, and grown an additional 24 hours at 20ºC. Cells were collected by 
centrifugation, resuspended and lysed. The supernatant was clarified, loaded onto Ni-
NTA resin, and eluted by an imidazole gradient. Fractions containing purified SK 
were detected by SDS-PAGE and were stored at -80ºC.  
Typically, S3P was enzymatically synthesized in a reaction mixture containing 100 
mM magnesium chloride, 75 mM shikimic acid, 50 mM ATP, 2 mM DTT, and 7 
µg/mL SK. The pH was adjusted to 6.0 with concentrated sodium hydroxide and the 
reaction was allowed to proceed at RT for 16 hours. 
To purify S3P by anion exchange, the reaction mixture was diluted 1 to 10 with H20 
to reduce the conductivity to < 10 mS/cm and loaded onto a Q-Sepharose 26/10 
column (Amersham Biosciences) which had been equilibrated with H2O.   The 
column was washed with 5 CV of H2O to wash any unbound sample from the resin, 
then the S3P was eluted by a Triethylammonium bicarbonate (TEAB) gradient from 0 
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to 0.4 M over 20 CV. S3P-containing samples were detected by catalytic activity 
upon addition of PEP and EPSPS (malachite green indicator used to detect phosphate 
release). S3P and ADP were found to partially co-elute; to remove greater amounts of 
ADP, only the fractions in the front half of the elution peak were combined. These 
fractions were again diluted with H20 to reduce the conductivity to < 10 mS/cm and 
loaded onto a Q-Sepharose 26/10 column, repeating all procedures as just described. 
The S3P-containing fractions were pooled and concentrated by rotary evaporation. 
The volatile TEAB buffer was removed by rotary evaporation and/or lyophilization 
and an ammonium salt of S3P was obtained. The S3P was redissolved in water, the 
purity of the samples was examined by UV scanning, and the concentration was 
determined using the enzymatic reaction with EPSPS. Because of difficulty in 
removing ADP, the overall yield of this process was typically ca. 25%. 
Malachite green phosphate indicator solution- To prepare this reagent, used for the 
detection and quantification of inorganic phosphate47, 4.25 g of ammonium 
molybdate was fully dissolved in 41 ml 12 N HCl, then diluted with 81 ml water.   
Seperarately, 169 mgs of malachite green were dissolved in 375 ml water.  These 
solutions were then combined and stirred for 1 hour at room temperature, then filtered 
though a 0.45 µm filter. The solution was stored at 4 °C in the dark. The change in 
absorbance at ~ 660 nm is proportional to the amount of inorganic phosphate in the 
sample, within the constraints of Lambert-Beers law.  Visually, this can be observed 
by a color change from brown-yellow to emerald green in the presence of inorganic 
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phosphate. The enzymatic release of inorganic phosphate was compared to a 
phosphate standard curve to obtain EPSPS activity data. 
Kinetic analysis of enzymes- These procedures varied substantially and were 
performed as described for each experiment. In every case, enzyme activity is 
expressed as micromoles of product (Pi for EPSPS or ADP in the case of SK) 
produced per minute of reaction time per milligram of enzyme. All activity data were 
fit to the appropriate equations using the program SigmaPlot (SPSS Science). 
Standard crystallization of E. coli EPSPS- “Closed”-form E. coli EPSPS was 
crystallized by hanging-droplet vapor diffusion, using 4.5 M sodium formate as the 
precipitant according to standard procedures described by Eschenburg et al. (2002)43. 
Briefly, the enzyme was concentrated to 75 mg/ml in 50 mM Tris–HCl pH 8.0, 
desired ligands were added to a concentration of ~ 10 mM, and 5 µl of this enzyme 
preparation was mixed on a cover slide with 5 µl of the precipitant solution, then 
sealed over a reservoir containing 500 µl of the precipitant solution. The initial 
droplets of 10 µl each thus contained 37.5 mg/ml EPSPS (= 810 µM), 5 mM ligand, 
and 2.25 M sodium formate. The crystals were found to be stable in a harvesting 
buffer containing 5 M sodium formate with the presence of 2 mM of each ligand, and 
this harvesting buffer provided cryoprotection. 
Standard data collection procedure- X-ray diffraction data were recorded at −180°C 
using the rotation method on single flash-frozen crystals [Detector: R-axis IV++ 
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image plate detector (MSC) X-rays: CuKα, focused by mirror optics (MSC); 
generator: Rigaku RU300 (MSC)].  
Standard structure determination- Individual steps within the structure determination 
process were performed variously by Dr. Ernst Schönbrunn, Dr. Andreas Becker, 
Huijong Han, Martha Healy-Fried, or Todd Funke. Except as otherwise described, 
indexing and data reduction were performed with XDS48 or HKL200049, the program 
package CNS50 was used for phasing and refinement, and model building was 
performed with program O51. The structures were solved by molecular replacement 
using E. coli EPSPS (PDB ID 1g6s22), S. pnumoniae EPSPS (PDB ID 1rf521), or CP4 
EPSPS (PDB IDs 2gg4 or 2gg652), stripped of solvent molecules, ions, and ligands, as 
search models. Refinement was performed using data to the highest resolution with 
no cut-off applied. Solvent molecules were added to the models at reasonable 
positions, and ligands were modeled according to the clear electron density maps. 
Several rounds of minimization, simulated annealing (2500 K starting temperature), 
and restrained individual B-factor refinement were carried out. Data collection and 
refinement statistics are summarized in the representative publications, as cited. 
Structure figures were prepared by Todd Funke with Pymol53 or by Dr. Schönbrunn 
using MolScript54, BobScript55, and Raster3D56. 
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Chpt. 2: Shikimate as a Substrate of E. coli EPSPS: Structural Bases 
for Glyphosate Insensitivity and Catalytic Activity 
Portions of this work were included in: Priestman M.A.; Healy M.L.; Funke T.; 
Becker A.; and Schönbrunn E., Molecular basis for the glyphosate-insensitivity of the 
reaction of 5-enolpyruvylshikimate 3-phosphate  synthase with shikimate. FEBS 
Letters 2005, 579, 5773-80.  
Introduction: 
In final three steps of the shikimate pathway, shikimate kinase converts shikimate to 
S3P, EPSP synthase converts S3P to EPSP, and chorismate synthase converts EPSP 
to chorismate (Fig. 2.1a). EPSP synthase, or EPSPS, preferentially binds its substrate, 
S3P57, and while this selectivity ensures that this enzyme is monofunctional in vivo, 
the molecular recognition mechanism is presently not well understood. EPSPS is 
composed of two globular domains connected by a short “hinge” region, and S3P-
binding induces a global conformational change (the “open-closed” transition)21-24, 52. 
S3P apparently first forms a transient “collision complex” with the N-terminal 
domain of the “open”-form EPSPS58. Upon S3P binding, the enzyme undergoes a 
global conformational change, and the two globular domains approach each other, 
forming the active site at the interdomain cleft (of “closed”-form EPSPS).  This two-
step process requires that, for full binding, any analog of S3P must first interact 
favorably with the apo-enzyme in the collision complex, and additionally must trigger 
the global open-closed transition.  Only the genuine substrate (S3P) and select 
substrate57, 59-61 and tetrahedral reaction intermediate (TI) analogs28, 62 have 
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Fig. 2.1b: Shikimate as a substrate of EPSPS. EPSPS can also utilize shikimate 
as a substrate for the enolpyruvyl transfer, resulting in the formation of EPS and 
Pi; this reaction is glyphosate-insensitive. 
Fig. 2.1a: The final three steps of the shikimate pathway.  
(Left) Shikimate kinase catalyzes the phophorylation of shikimate to form S3P 
(shikimate-3-phosphate). (Middle) EPSP synthase catalyzes the transfer of the 
enolpyruvyl moiety of PEP, forming EPSP (5-enolpyruvylshikimate-3-phosphate). 
This reaction is inhibited by glyphosate. (Right) Chorismate synthase catalyzes 
elimination of the phosphate to produce chorismate, a precursor to essential 
aromatic metabolites. 
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been demonstrated to induce formation of closed-form EPSPS.  Of these non-
substrate ligands, the enolpyruvyl transfer reaction was only demonstrated to occur 
when utilizing shikimate (the precursor to shikimate-3-phosphate) or select ring-
contracted shikimate-3-phosphate analogs. 
EPSPS utilization of shikimate as a substrate for the enolpyruvyl transfer reaction 
results in formation of enolpyruvylshikimate (EPS) (Fig. 2.1b); this reaction was 
examined previously and found to be glyphosate insensitive57, 61. Lacking from the 
previous work was a structural basis for catalysis of this reaction or the insensitivity 
to inhibition by glyphosate.  The effect of ions on this reaction had not been probed, 
and no structures were available showing the alternate products or substrates bound to 
the active site. Here, the reaction of EPSPS with shikimate as a substrate was probed 
using steady-state kinetics and the reaction product was produced, purified, and 
analyzed. EPSPS was co-crystallized with shikimate, with and without glyphosate, 
and these structures were utilized to explain the observed kinetic characteristics. We 
assess the broader implications of these studies. 
Experimental Procedures: 
Materials- Chemicals and reagents were purchased from Sigma (St. Louis, MO) 
unless otherwise noted. S3P was synthesized and purified by Dr. Melanie Priestman 
according to the standard procedure described45. E. coli EPSPS was overexpressed 
and purified by Dr. Melanie Priestman according to the standard procedure 
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described43. Protein concentration was determined spectroscopically according to the 
standard procedure described (see Chapter 1, General Protocols). 
Kinetics- Steady-state enzyme activity assays were performed by Dr. Melanie 
Priestman and Todd Funke. The activity of EPSPS was calculated by determining the 
amount of inorganic phosphate produced in the reaction using a colorimetric 
malachite green phosphate indicator47. The effect of anions on the reaction of EPSP 
synthase with shikimate was assayed with saturating concentrations of the substrates 
(10 mM PEP and 250 mM shikimate) and 100 mM of the respective ion. The reaction 
of EPSPS with either shikimate or S3P as substrate was typically assayed in 100 µl of 
500 mM Na-MES pH 5.5 with 2 mM DTT in the absence or presence of 100 mM 
NaHCO3 or 100 mM KCl. For the titration with carbonate, assays were carried out in 
100 µl of 500 mM Tris, pH 8.0 + 2 mM DTT. The substrate concentrations 
considered saturating for these assays were 250 mM shikimate with 10 mM PEP, or 1 
mM S3P with 1 mM PEP. The IC50 comparison was performed using 0.1 mM PEP in 
the case of the S3P-utilizing reaction or 1 mM PEP for the shikimate-utilizing 
reaction. The concentration of EPSPS was 22 nM for all assays utilizing S3P, 220 nM 
for assays utilizing shikimate and carbonate, and 1.1 µM for all other shikimate-
utilizing reactions (chloride ion, varied salts or no salt). The reactions were started by 
the addition of enzyme and stopped after 3 minutes by the addition of 800 µl of the 
malachite green reagent, and color development was arrested after 5 minutes by the 
addition of 100 µl of a 34% w/v sodium citrate solution (final sample volume = 1 ml). 
The absorbance at 660 nm was determined spectroscopically and product formation 
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was determined by comparison to inorganic phosphate standards. Enzyme activity is 
expressed as micromoles of phosphate produced per minute of reaction time per 
milligram of EPSPS (U/mg). To determine the steady-state kinetic parameters of the 
reaction of EPSPS, the concentration of enzyme and one substrate were held constant 
while concentrations of the other substrate were varied as shown. The Km and Vmax 
values were determined by fitting the data to  
Equation 1: v = Vmax * [S] / (Km + [S]) 
where v is the initial velocity, Vmax is the maximum velocity, Km is the Michaelis 
constant and [S] is the concentration of the varied substrate (Shikimate, S3P, or PEP). 
To determine the glyphosate-sensitivity of these reactions, enzyme activity was 
measured in the presence of saturating concentrations of S3P or Shikimate, near-Km 
concentrations of PEP, and varied concentrations of glyphosate (Glp). IC50 values for 
EPSPS inhibition were determined by fitting data to  
Equation 2: 
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where v is the initial velocity, Vmax is the maximum velocity, Vmin is the minimum 
velocity, [I] is the concentration of glyphosate and n is the Hill slope.  
Synthesis of alternate product- On the basis of the kinetic results, an enzymatic 
synthesis was designed for the production of the alternate product. The 1 mL 
synthesis reaction mixture contained 100 mM MES, 2 mM DTT, 250 mM shikimate, 
10 mM PEP, and 100 mM sodium bicarbonate. After adjusting the pH to 5.5, the 
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reaction was started by addition of 100 µg E. coli EPSPS and allowed to proceed at 
ambient temperature for 16 hours.  
Purification of alternate product- Purification of the alternate product was 
accomplished with the assistance of Dr. Andreas Becker. Protein was removed by 
passing the crude mixture was passed through a 30 kDa-Centricon membrane, 
followed by a short C18 column, and the reaction substrates and products were then 
separated by HPLC using a Hi-Trap QFF anion exchange column subjected to a 40 
min, 0 to 1 M NaCl gradient with flow rate set to 1 ml per minute. EPS was detected 
by monitoring UV absorbance at 213 nM.  A small sample was examined by 
analytical HPLC, performed according to the same procedure, to estimate purity and 
yield. 
Identification of alternate product- Analysis by mass spectrometry (MS) necessitated 
removal of the NaCl, so the sample was re-applied to the anion-exchange column and 
subjected to a NH4HCO3 gradient. The EPS-containing fractions were collected and 
concentrated via lyophilization. Mass spectra were acquired by Dr. Todd Williams 
using an electrospray time of flight mass spectrometer equipped with a lock spray 
reference probe. The sample was analyzed for exact mass formula confirmation using 
electrospray ionization with time of flight mass analysis. Spectra were mass corrected 
using a standard infused in a reference channel on a dual spray source. 
Crystallization and structure determination- Protein crystals were produced by Todd 
Funke and Dr. Melanie Priestman using the standard crystallization conditions 
 58 
previously described43. E. coli EPSPS was crystallized in the presence of 100 mM 
NaCl or NaHCO3 and 10 mM shikimate, ± 30 mM glyphosate, with sodium formate 
as a precipitant, using hanging-droplet vapor diffusion. Crystallography was 
performed according to standard procedures (see Chapter 1, General Protocols); data 
collection and refinement statistics table included in the publication59. 
Results and Discussion: 
Seeking a fuller understanding of the substrate recognition, induced fit mechanism, 
and catalytic potential of EPSPS, we used kinetic and structural approaches to 
investigate the reaction of EPSPS utilizing shikimate as a substrate.  
Enzyme activity and ion-sensitivity- Steady-state kinetics analyses were performed 
utilizing a phosphate-release activity assay.  The optimal buffer and pH as determined 
for the shikimate-utilizing reaction (Na-MES, pH 5.5) were used throughout our 
studies, and the reaction with S3P was analyzed in parallel to aid direct comparison. 
The reaction with shikimate proceeds very slowly compared to the S3P-utilizing 
reaction. In an attempt to increase the rate of this reaction, the activity was measured 
in the presence of 100 mM of diverse salts. While the S3P-utilizing reaction is 
insensitive to ions, the rate of the shikimate-utilizing reaction was increased by select 
anions. A more detailed examination of the anion effect was performed using 100 
mM of each anion and combining the data obtained with various counter-ions (i.e., 50 
mM MgCl2 was considered equivalent to 100 mM KCl, and all activity data obtained 
using chloride salts were averaged together to describe the effect of 100 mM Cl-). A 
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substantial increase in activity was observed in the presence of certain anions (Fig. 
2.2a). The most marked effect was seen with carbonate, which increased the rate of 
the shikimate-utilizing reaction by 340-fold (without salt activity = 0.02 U/mg; with 
100 mM carbonate activity = 6.8 U/mg). Enzyme activity was then analyzed as a 
function of carbonate concentration; while enzyme activity was decreased under the 
high buffer concentrations utilized in the assay, normal enzyme saturation behavior 
was observed (Fig. 2.2b). These data were fit to Equation 1 to derive the dissociation 
constant (Kd carbonate = 17 mM). Carbonate concentrations are not stable in solution 
due to the formation of carbon dioxide and further kinetic analysis was performed in 
the presence of 100 mM KCl or 100 mM NaHCO3.  
Substrate binding- The activity of EPSPS measured as a function of substrate 
concentration (Fig. 2.3) displayed normal Michaelis-Menten kinetics and the data 
were fit to Equation 1 to obtain the values for kinetic parameters listed in Table 2.1. 
The activity (Vmax) observed with 100 mM NaHCO3 was approximately 6-fold that 
observed in the presence of 100 mM KCl, but similar Km values were observed for 
shikimate and PEP using either salt. Compared to the kinetic parameters obtained 
from the parallel S3P-utilizing substrate saturation experiments the utilization of 
shikimate by EPSPS results in both decreased substrate binding and lower catalytic 
activity. Compared to the S3P-utilizing reaction, the optimal (HCO3--activated) 
shikimate-utilizing reaction had 7-fold lower specific activity. The Km shikimate was 
500-fold the Km S3P, and the Km PEP was increased 8-fold in the shikimate-utilizing 
reaction (Table 2.1). If the substrate affinity is considered as inversely proportional to 
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Fig. 2.2a: Ion Sensitivity. Select 
anions increase the rate of the 
EPSPS reaction with shikimate 
utilized as a substrate.  
Fig. 2.2b: Carbonate Saturation. 
EPSPS activity was plotted as a 
function of [HCO3-]. Data were fit 
to Equation 1 to derive a Kd of 17 
mM. 
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Fig. 2.3: Substrate Saturation. 
(Top) EPSPS activity was plotted as a 
function of PEP concentration in the 
presence of Cl- (◼) or HCO3- (⦁).  
(Bottom) EPSPS activity was plotted 
as a function of shikimate 
concentration in the presence of Cl- 
(◼) or HCO3- (⦁). 
Data were fit to Equation 1 to 
determine the parameters shown in 
Table 2.1. 
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Table 2.1: Summary of kinetic data. Steady-state kinetic parameters for the 
reaction of EPSPS with S3P or shikimate were determined by fitting the activity 
data to the appropriate equation. 
1.0
± 0.03
6.0
± 0.09
58
± 2.3
Vmax (PEP) 
(U/mg)
1.2
± 0.04
6.8
± 0.15
53
± 3.0
Vmax (S1) 
(U/mg)
1.2 
± 0.13
84*102 
± 1.2*102
1.1 
± 0.12
2.5*101 
± 0.28*101
31 
± 4.1
Shikimate 
+ Cl-
1.7 
± 0.11
5.4*103 
± 0.33*103
0.86 
± 0.05
1.1*102 
± 0.07*102
47
± 2.9
Shikimate 
+ HCO 3
-
0.006 
± 0.0001
4.5*105 
± 0.18*105
0.10 
± 0.004
4.5*105 
± 0.25*105
0.09
± 0.005
S3P
IC50 (Glp )
(mM)
kcat /Km (PEP)
(M-1 s-1)
Km (PEP)
(mM)
kcat /Km (S1)
(M-1 s-1)
Km (S1)
(mM)
Substrate
(S1)
 
 
 63 
the Km, these data indicate that the 3’-phosphate of S3P contributes substantially to 
substrate binding, while the activity data show that the phosphate moiety is not 
required for the induced-fit mechanism or catalytic activity. Notably, the moderate 
decrease in specific activity of the shikimate-utilizing reaction is not proportionate to 
the dramatically reduced affinity for shikimate; it is also not immediately evident why 
the PEP-binding affinity appears to decrease. 
Glyphosate sensitivity- Parallel glyphosate-inhibition studies were performed 
utilizing either shikimate or S3P as a substrate for the enolpyruvyl transfer reaction. 
Relative enzyme activity as function of glyphosate concentration is shown in Fig. 2.4, 
and the inhibition data were fit to Equation 2 to derive the IC50 values reported in 
Table 2.1. Glyphosate is not an effective inhibitor of EPSPS when shikimate is used 
as a substrate. The IC50 data show that the shikimate-utilizing reaction is about 200 
times less sensitive to glyphosate, independent of the anion used for activation, but 
these data do not explain the basis for this loss of glyphosate sensitivity. 
Alternate product synthesis and purification- To verify that EPS was, in fact, the 
product of the shikimate-utilizing reaction (as shown in Fig. 2.1b), we synthesized, 
purified, and analyzed the reaction product. An enzymatic synthesis utilizing EPSPS 
was designed according to the optimal kinetic parameters determined in the preceding 
section. Saturating concentrations of shikimate, PEP, and NaHCO3 were used, along 
with an excess of the enzyme and an extended reaction time. Purification was 
accomplished using anion-exchange HPLC with a 40 minute, 0 to 1 M NaCl gradient
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Fig. 2.4: Glyphosate inhibition. 
EPSPS activity was assayed with 
1 mM S3P and 0.1 mM PEP (▴), or 
with 250 mM shikimate, 1.0 mM 
PEP plus either 100 mM NaHCO3 
(⦁) or 100 mM NaCl (◼). Data 
were fit to Equation 2 to yield the 
IC50 values shown in Table 2.1. 
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(flow rate = 1 ml/min). A representative chromatogram is shown in Fig. 2.5a, with 
time on the X-axis plotted against Abs214 on the Y-axis. The unreacted substrate 
elutes in the major peak at 5.84 minutes, while EPS elutes in the minor peak at 13.26 
minutes. The EPS-containing fractions were reapplied to examine purity. Fig. 2.5b 
shows the product eluting in the major peak at 11.27 minutes, while shikimate 
impurity is seen in the minor peak at 5.98 minutes. Area-under-the-curve (AUC) 
analysis indicated 92% purity, and, based on the extinction coefficient of shikimate, 
the estimated yield was ca. 3 µmoles of EPS. 
Alternate product identification- The purified product was analyzed using an 
electrospray time of flight mass spectrometer. The most abundant signals, in mass 
regions corresponding to M+H+, M+Na+, or M-H- are 245.667 (+0.6mmu), 267.0477 
(+0.5mmu) and 243.0492 (-1.3mmu), provide positive identification of the product 
(EPS molecular weight = 242.183) (mass spectra shown in Fig. 2.6).  This 
purification and analysis procedure should be applicable to other shikimate or EPSP 
analogs as well, and with AUC analysis, this procedure provides an alternative (non-
phosphate-based) method for measurement of enzyme activity. 
Crystal structure analysis- The sodium formate crystallization conditions previously 
described for closed-form E. coli EPSPS were utilized in ultimately unsuccessful 
attempts to obtain an EPSPS•EPS co-crystal structure. The EPSPS•shikimate and 
EPSPS•shikimate•glyphosate complexes did crystallize, allowing the structures to be 
solved at 1.5 Å resolution. This analysis revealed that the enzyme–shikimate complex
 66 
Fig. 2.5a: EPS purification. This 
chromatograph displays time 
(min) on the X-axis and Abs214 
(a.u.) on the Y-axis. EPS elutes at 
13.26. 
Fig. 2.5b: Analytical HPLC. 
This chromatograph displays time 
(min) on the X-axis and Abs214 
(a.u.) on the Y-axis. EPS elutes at 
11.27. 
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Fig. 2.6: Product Identification. 
The isolated product was 
subjected to electrospray time of 
flight mass spectrometry resulting 
in these spectra, which confirm 
that the product is EPS. 
(a) Positive ion mode 
(b) Negative ion mode 
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exists in the closed state, providing further evidence that the 3’-phosphate of S3P is 
not required for substrate binding or to induce the EPSPS open-closed transition. It 
was hypothesized that shikimate may shift slightly in the active site relative to S3P, 
impeding the binding of PEP and glyphosate and accounting for the functional 
changes, but this was not observed in comparisons of binary EPSPS•shikimate and 
EPSPS•S3P complexes. Instead, comparison of the active sites complexes of 
EPSPS•shikimate•glyphosate and EPSPS•S3P•glyphosate (Fig. 2.7) revealed that the 
binding of shikimate induces changes around the backbone of the active site, which in 
turn impacts the efficient binding of glyphosate. Comparison of the root mean square 
deviations (rmsd) of the shikimate- and S3P-liganded structures revealed that the 
greatest structural change occurred around Val168 (Fig. 2.8, Top). The corresponding 
portions of the ternary structures are overlaid in the stereofigure (Fig. 2.8, Bottom) to 
illustrate the shift of active site residues toward the shikimate-occupied active site. 
This appears to constitute the major basis for the glyphosate insensitivity of the 
reaction of EPSPS with shikimate. 
Basis of ion sensistivity- It was hypothesized that the observed ion effect (see Fig. 
2.2) could result from anions occupying the portion of the EPSPS active site that 
normally binds the phosphate moiety. To probe this, carbonate and chloride were 
included in the crystallization buffers; neither of these were observed in the active 
site. However, formate ions also activated shikimate-utilizing reaction (Fig. 2.2a) and 
two formate ions are, in fact, observed in place of the missing phosphate (Fig. 2.8); 
these likely out-compete the “preferred” ions due to their much higher concentration 
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Fig. 2.7: Active site ternary structure. Stereofigures show shikimate and S3P in 
yellow, glyphosate in orange, formate ions are in green, water molecules are aqua 
spheres and hydrogen bonds are indicated by dashed lines. (Top) Structure of 
EPSPS•Shikimate•Glyphosate complex.  (Bottom) Structure of 
EPSPS•S3P•Glyphosate complex. 
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Fig. 2.8: Alterations in enzyme structure from shikimate binding. (Top) 
Comparison of the root mean square deviations (rmsd) of the Cα-atoms of 
EPSPS liganded with S3P or S3P/glyphosate (black line; average rmsd = 0.1 
Å) and that of EPSPS liganded with shikimate or shikimate/glyphosate (dotted 
line; average rmsd = 0.13 Å).   
(Bottom) Stereo view of the hydrophobic pocket built up by 
Pro125/Val168/Val339, altered upon binding of shikimate to the enzyme.  
EPSPS residues in the complex with S3P and glyphosate are shown in yellow; 
residues in the complex with shikimate and glyphosate in cyan.  S3P and 
glyphosate are displayed in grey, hydrogen bonding interactions as black 
dotted lines and hydrophobic interactions as green dotted lines. 
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in the crystallization solution. The observed stimulation of catalytic activity by anions 
likely does result from binding at the positions occupied by formate ions in this 
structure. 
Conclusions: 
A full understanding of substrate recognition, the open-closed transition, and the 
catalytic potential of EPSPS is desired to facilitate the design of novel inhibitors.  
Enzyme inhibition is often achieved with competitive inhibitors (such as glyphosate), 
which occupy the substrate-binding site, and it is thus desirable to understand the 
molecular bases for substrate recognition. From these results, it appears that 
shikimate alone can induce the open-closed transition of E. coli EPSPS; while the 3-
phosphate moiety of S3P is not required, select anions do appear to aid in the induced 
fit mechanism (as indicated by the observed stimulation of catalytic activity). 
Apparently these anions bind to the EPSPS active site in place of the 3’-phosphate of 
S3P. Competitive or allosteric inhibitors could potentially be designed to disrupt the 
global induced-fit mechanism of EPSPS, trapping the enzyme into non-productive 
“dead-end” complexes (for example, E•S•Iopen, or E•Iclosed).  Additionally, the 
products formed by the alternate-substrate reactions may themselves be useful as 
probes or inhibitors of downstream enzymes. Chorismate synthase utilizes the 3’-
phosphate of EPSP as a leaving group, suggesting that EPS may inhibit chorismate 
synthase; this remains to be tested. 
The procedures established for the production, purification, and identification of EPS 
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should be useful for the production and purification of other substrate, product, or TI 
analogs. Our structural data illuminate the subtle changes responsible for the observed 
differences in kinetic behavior for the reactions of EPSPS with shikimate and S3P. 
Overall, these results should facilitate and stimulate further research concerning the 
global induced fit mechanism of EPSPS. 
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Chpt.  3: Expression, Purification, Kinetic Characterization, and 
Glyphosate Insensitivity of S. aureus EPSPS 
Portions of this work were included in: Priestman M.A.; Funke T.; Singh I.M.; 
Crupper S.S.; Schönbrunn E., 5-Enolpyruvylshikimate-3-phosphate synthase from 
Staphylococcus aureus is insensitive to glyphosate. FEBS Letters 2005, 579, 728-32. 
Introduction: 
The pathogen Staphylococcus aureus is a major cause of death due to nosocomial 
infections63, 64. The increasing frequency of multi-drug resistance, including 
methicillin-resistant S. aureus38, is particularly worrisome given the paucity of novel 
classes of antibiotic introduced in the last decades65, 66. Novel antimicrobial agents are 
required (see Fig. 1.9), so detailed characterization of suitable S. aureus drug targets 
is desirable. The shikimate pathway is essential for the growth and survival of plants, 
bacteria, fungi, and apicomplexan parasites12-14, 20, and inhibitors of the S. aureus 
shikimate pathway are sought as potential antimicrobial drugs.  
The herbicide glyphosate10 (active ingredient in Roundup) specifically targets EPSPS9 
(see Fig. 1.6), but the patent record suggested that S. aureus EPSPS was insensitive to 
glyphosate35, but no kinetic, inhibition, or structural data were available in the peer-
reviewed literature. While glyphosate has generally poor antimicrobial properties, 
EPSPS-null mutants of S. aureus are not pathogenic, indicating that this enzyme is 
required for the growth and/or pathogenicity of this organism15.  S. aureus EPSPS 
exhibits substantial amino acid sequence variation compared to the model enzyme 
from E. coli and the optimal global alignment (Fig. 3.1) shows only 27% amino acid 
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Fig. 3.1: S. aureus and E. coli EPSPS sequence alignment. Amino acid 
sequence alignment (PAM250 similarity matrix) reveals that the EPSPS enzymes 
from E. coli and S. aureus share 27% amino acid sequence identity and 56% 
similarity. Boxes indicate conserved amino acids. 
S. aureus 1 MVNEQIIDIS GPLKGEIEVP GDKSMTHRAI MLASLAEGVS TIYKPLLGED 50
E. coli 1 -MESLTLQPI ARVDGTINLP GSKSVSNRAL LLAALAHGKT VLTNLLDSDD 49
S. aureus 51 CRRTMDIFRH LGV--EIKED DEK--LVVTS PGYQVNTPHQ VLYTGNSGTT 96
E. coli 50 VRHMLNALTA LGVSYTLSAD RTRCEIIGNG GPLHAESARE -LFLGNAGTA 98
S. aureus 97 TRLLAGLLSG LGNESVLSGD VSIGKRPMDR VLRPLKLMDA NIEGIE-DNY 145
E. coli 99 MRPLAAALCL GSNDIVLTGE PRMKERPIGH LVDALRQGGA KITYLEQENY 148
S. aureus 146 TPLIIKPSVI KG-INYQMEV ASAQVKSAIL FASLFSKEPT I-IKELDVSR 193
E. coli 149 PPLRLQGGFT GGNVDVDGSV SSQFLTALLM TAPLAPEDTV IRIKGDLVSK 198
S. aureus 194 NHTE---TMF KHFNIPIEAE GLSINTTPEA IRYIKPADFH VPGDISSAAF 240
E. coli 199 PYIDITLNLM KTFGVEIENQ HYQQFVVKGG QSYQSPGTYL VEGDASSASY 248
S. aureus 241 FIVAALITPG SDVTIHNVGI NQTRSGI--I DIVEKMGGNI QLFNQTTGAE 288
E. coli 249 FLAAAAI-RG GTVKVTGIGR NSMQGDIRFA DVLEKMGATI -----CWGDD 292
S. aureus 289 PTASIRIQYT PMLQPITIEG ELVPKAIDEL PVIALLCTQA VGTSTIKDAE 338
E. coli 293 YISCTR---G E-LNAIDMDM NHIPDAAMTI ATAALF---A KGTTTLRNIY 335
S. aureus 339 ELKVKETNRI DTTADMLNLL GFELQPTNDG LIIHPSE-FK TNATDILTDH 387
E. coli 336 NWRVKESDRL FAMATELRKV GAEVEEGHDF IRITPPEKLK FAEIATYNDH 385
S. aureus 388 RIGMMLAVAC VLSSEPVKIK QFDAVNVSFP GFLPKLKLLQ NEG 430
E. coli 386 RMAMCFSLV- ALSDTPVTIL DPKCTAKTFP DYFEQLARIS QPG 427
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sequence identity.  This sequence variation may account for substantial structural or 
functional differences, but the structure of S. aureus EPSPS is not known. To 
facilitate the development of novel chemotherapies, we report the expression, 
purification, and biochemical characterization of S. aureus EPSPS and explore the 
implications of our findings. 
Experimental Procedures 
Materials- Chemicals and reagents were purchased from Sigma (St. Louis, MO) 
unless otherwise noted. Dr. Priestman utilized the shikimate kinase from 
Methanococcus jannaschii46 to produce S3P from shikimate and ATP, and purified 
the product by anion exchange chromatography, as described45. DNA of S. aureus 
EPSPS (Japan strain) in a pT7 Blue3 plasmid was provided by Scott Crupper 
(Emporia State University, Emporia, KS). The target gene was excised and inserted 
into the desired pET-24d (Novagen) by Dr. Priestman. This construct was 
transformed into E. coli Stbl2(DE3) (Invitrogen) cells. On the basis of induction 
studies performed by Dr. Priestman, large scale cell cultures were incubated at 37°C 
initially, with the temperature reduced to 20°C prior to induction by the addition of 
0.5 mM IPTG. Cell cultures were incubated at 20°C for 16-20 hours post-induction. 
S. aureus EPSPS was originally purified by Dr. Priestman using a slightly altered 
protocol: the crude extract was subjected to a preliminary anion-exchange  column 
(Q-sepharose resin from GE Healthcare). EPSPS-containing fractions were collected 
and pooled and applied to a hydrophobic interactions column (P-sepharose resin from 
GE Healthcare). A secondary anion-exchange column (Resource-Q column from GE 
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Healthcare) was then utilized. Subsequently, the standard protein purification 
procedures described43 were utilized and produced similar results. EPSPS from E. 
coli was produced by Dr. Priestman, according to the standard procedures 
described43. 
Activity and salt sensitivity- Steady-state activity assays were performed by Dr. 
Priestman and Todd Funke. The activity of EPSPS was calculated by determining 
inorganic phosphate production using the malachite green phosphate indicator47. The 
effect of specific cations and anions on the activity of E. coli and S. aureus EPSPS 
was assayed in 100 µl of 150 mM HEPES-NaOH (pH 7.0), 2 mM DTT + 100 mM 
salt. To determine the concentration of KCl required for optimal activity of S. aureus 
EPSPS, assays were carried out in 100 µl of 500 mM Tris pH 8.0 + 2 mM DTT with 
varied concentrations of KCl. The substrate binding of E. coli EPSPS  and S. aureus 
EPSPS were assayed in 100 µl of 50 mM HEPES-NaOH (pH 7.0), 2 mM DTT ± 100 
mM KCl. The final concentration of enzyme in the assay mixture was 660 nM and 
1.65 µM for S. aureus EPSPS with and without KCl, respectively. In every case, 
reactions were started by the addition of enzyme and stopped after 3 minutes by 
addition of the malachite green reagent (800 µl); color development was arrested after 
an additional 5 min by the addition of 100 µl 34% (w/v) sodium citrate (1 ml total 
sample volume). The optical density was measured at 660 nm and the amount of 
inorganic phosphate formed in each reaction was determined by comparison to 
phosphate standards.  
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Substrate binding- To find the steady-state kinetic parameters, the concentration of 
enzyme and one substrate were held constant while the concentration of the other 
substrate were varied (as shown). The Km and Vmax values were determined by fitting 
the data to  
Equation 1: v = Vmax * [S] / (Km + [S]) 
where v is the initial velocity, Vmax is the maximum velocity, Km is the Michaelis 
constant and [S] is the concentration of the varied substrate.  
Glyphosate sensitivity- The IC50 values for EPSPS inhibition were determined by 
fitting data to  
Equation 2: 
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where v is the initial velocity, Vmax is the maximum velocity, Vmin is the minimum 
velocity, [I] is the concentration of glyphosate and n is the Hill slope.  
Fluorescence- Fluorescence spectroscopy studies were also conducted utilizing S. 
aureus EPSPS. For intrinsic fluorescence experiments, the excitation wavelength was 
280 nm, and emission spectra were recorded between 290 and 400 nm. Experiments 
were conducted in a buffer consisting of 50 mM Na-HEPES pH 7.0, 2 mM DTT, ± 
100 mM KCl with 150 µg of S. aureus EPSPS per 1 ml sample. Emission spectra 
were recorded prior to the addition of ligands, and again after the addition of each 
ligand (S3P, PEP, KCl, or glyphosate). Final concentration of each ligand was 1 mM. 
Extrinsic fluorescence experiments were conducted the utilizing the fluorophore 
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ANS. The assay was performed in 50 mM Na-HEPES pH 7.0, 2 mM DTT, ± 100 mM 
KCl, and 50 µg of S. aureus EPSPS was used for each 1 ml sample. For ANS 
fluorescence, the excitation wavelength was set to 366 nm and emission spectra were 
recorded between 400 and 600 nm. The ANS fluorescence emission spectra were 
recorded prior to the addition of enzyme or ligands and this free-ANS fluorescence 
signal was subtracted from that obtained after addition of enzyme, so that the 
fluorescence intensity reported is proportional to the amount of ANS•EPSPS complex 
in the sample. The maximum fluorescence intensity (λ = 475) was recorded, plotted 
as a function of ANS concentration, and fit to  
Equation 3: y = Ymax * [ANS] / (Kd + [ANS]) 
where y is the observed fluorescence intensity, Ymax is the maximal fluorescence 
intensity, Kd is the dissociation constant and [ANS] is the concentration of the 
fluorophore. 
Crystallization- Extensive crystallization trials were performed, utilizing a variety of 
S. aureus EPSPS preparations.  Commercial sparse-matrix screens Crystal Screen I 
and II (Hampton Research) and Wizard Screen I and II (Emerald Biosystems) were 
utilized along with in-house screening conditions (listed in Fig. 3.2). Hanging drop 
vapor diffusion trials were set up by combining 2 µl of the enzyme preparation and 2 
µl of the precipitant solution on a siliconized cover slide, forming a 4 µl droplet. The 
cover slides were inverted and sealed over reservoirs containing 500 µl of the 
precipitant solution, and the crystal setups was stored at 19 °C indefinitely. All 
crystallization screens were inspected regularly for the formation of protein crystals. 
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Fig. 3.2a: Formulation of in-house crystallization screen, Ernst I 
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Fig. 3.2b: Formulation of in-house crystallization screen, Ernst II 
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Results and Discussion: 
The expression system and purification protocol developed enabled isolation and 
characterization of highly purified, catalytically active S. aureus EPSPS enzyme.   
Salt-sensitivity- Preliminary assays showed substantially decreased enzyme activity 
compared to our model enzyme, E. coli EPSPS. Based on reports of ion-sensitive 
EPSPS isolated from organisms such as Bacillus subtilis67 and Streptococcus 
pneumoniae68, EPSPS activity was examined in the presence of 100 mM of diverse 
salts. Preliminary screening (data not shown) indicated that while E. coli EPSPS 
activity was ion-independent, S. aureus EPSPS activity was stimulated by select 
cations. S. aureus EPSPS was re-tested with 100 mM of each cation (100 mM of salts 
with monovalent anions, and 50 mM of salts with divalent anions) and the data 
obtained with different counter-ions was combined (i.e., 50 mM (NH4)2SO4 was 
considered equivalent to 100 mM NH4Cl, and all activity data obtained using 
ammonium salts were averaged together to isolate the effect of 100 mM NH4+). 
Several monovalent cations effected a substantial increase in S. aureus EPSPS 
activity (see Fig. 3.3a), and nearly 8-fold rate enhancement was observed with the 
preferred cation, K+. To further examine the cation effect, the enzyme activity was 
assayed in the presence of varied KCl concentrations (Fig. 3.3b). Normal enzyme 
saturation behavior was observed and the activity data were fit to Equation 1, yielding 
a dissociation constant (Kd) of 58 mM for the potassium ion. 
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Fig. 3.3a: Ion sensitivity. The 
activity of S. aureus EPSPS is 
increased in the presence of 
specific monovalent cations. 
Fig 3.3b: Potassium Saturation. 
EPSPS activity plotted as a 
function of [K+] shows normal 
enzyme saturation behavior. These 
data were fit to Equation 1, 
yielding a Kd of 58 mM for K+. 
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Substrate binding and catalytic activity- The binding of S3P and PEP and production 
of EPSP by S. aureus EPSPS (±100 mM KCl) and E. coli EPSPS were examined in 
parallel steady-state kinetic experiments. Activity was plotted as a function of 
substrate concentration (Fig. 3.4) and these data were fit to Equation 1 to obtain the 
kinetic parameters shown in Table 3.1. The specific activity (kcat) varies dramatically; 
E. coli EPSPS is 13-fold more active than S. aureus EPSPS + KCl, and 260-fold more 
active than salt-free S. aureus EPSPS.  The substrate saturation curves, in contrast, 
are remarkably similar. The Michaelis constant (Km) of S3P ranges from 0.14 mM (E. 
coli EPSPS) to 0.18 mM (salt-free S. aureus EPSPS); similarly, the Km PEP ranges 
from 0.14 mM for the E. coli enzyme to 0.18 mM (for S. aureus EPSPS + KCl) 
(Table 3.1). The inverse of the Km is often used as a proxy for substrate affinity; in 
this case, the minor variations observed in substrate binding do not account for the 
substantial decrease in catalytic activity, suggesting that substrate binding may not 
constitute the rate-limiting step for the S. aureus EPSPS.  
Glyphosate sensitivity- Parallel inhibition experiments were conducted to determine 
the IC50 of glyphosate for S. aureus EPSPS (± 100 mM KCl) and E. coli EPSPS (see 
Fig. 3.5). The data were fit to Equation 2 to obtain the IC50 values reported in Table 
3.1. These experiments demonstrated that glyphosate is a poor inhibitor of S. aureus 
EPSPS, and this glyphosate-insensitivity is essentially cation-independent. The IC50 
values indicate that, compared to E. coli EPSPS, S. aureus EPSPS (± KCl) is 100- to 
180-fold less sensitive to inhibition by glyphosate. Since glyphosate occupies the 
PEP-binding site of EPSPS, enzymes with decreased glyphosate sensitivity often  
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Fig. 3.4: Steady-state kinetics of E. coli and S. aureus EPSPS. (Left) S. aureus 
EPSPS activity was plotted as a function of substrate concentration: with 100 mM 
KCl (left axis - ●) or without KCl (right axis - ■). (Right) E. coli EPSPS activity 
was plotted as a function of substrate concentration. Data were fit to Equation 1 to 
derive the parameters shown in Table 3.1. 
 
 S. aureus EPSPS     E. coli EPSPS 
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Table 3.1: Summary of steady-state enzyme kinetic parameters. 
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Fig. 3.5: Glyphosate inhibition. 
IC50 determination for E. coli (●), 
and S. aureus EPSPS, with 100 
mM KCl (■) or without salt (▲). 
Data were fit to Equation 2 to 
obtain the values reported in Table 
3.1.  
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exhibit a corresponding decrease in PEP affinity, but this is not observed for the S. 
aureus enzyme. These data indicate that S. aureus EPSPS preferentially binds PEP, 
sustaining substantial catalytic activity even in the presence of 1 mM glyphosate. 
S. aureus EPSPS fluorescence- Intrinsic and extrinsic fluorescence trials were 
conducted with S. aureus EPSPS.  Intrinsic fluorescence was observed, but no change 
in signal could be detected upon addition of up to 1 mM substrate or 200 mM KCl 
(data not shown). ANS, an extrinsic fluorophore utilized to probe ligand-induced 
conformational change in other enolpyruvyltransferases1 was also utilized. An 
increase in ANS fluorescence signal upon addition of S. aureus EPSPS indicates 
formation of an ANS•EPSPS complex, so fluorescence spectra were collected in the 
presence of increasing concentrations of ANS (Fig. 3.6a). The fluorescence intensities 
at 475 nm, replotted as a function of ANS concentration, showed normal enzyme 
saturation behavior (Fig. 3.6a) and these data were fit to Equation 3 to determine the 
dissociation constant. For S. aureus EPSPS, the calculated Kd ANS was 5.2 µM. 
ANS•EPSPS fluorescence was monitored upon sequential addition of ligands (1 mM 
S3P, 100 mM KCl, 1 mM glyphosate, and 1 mM PEP) (Fig. 3.6b), but no substantial 
change was observed, precluding further ANS-based ligand-binding studies. The 
saturation curve indicates that there is a discreet ANS binding site, but the lack of 
fluorescence quench with substrate addition implies that ANS binding (or the ANS-
binding site) is not sensitive to the induced fit confomational change. Other 
fluorophores or experimental systems may be better suited for characterization of the 
conformational change in this enzyme. 
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Fig. 3.6a: S. aureus EPSPS extrinsic fluorescence. Fluorescence intensity was 
plotted as a function of ANS concentrations and fit to Equation 3, yielding Kd 
ANS = 5.2 µM for S. aureus EPSPS. 
 
Fig. 3.6b: Fluorescence 
quench trials. The addition of 
ligands did not substantially 
affect ANS•EPSPS 
fluorescence. 
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Crystallization- Substantial efforts were made to obtain crystals of S. aureus EPSPS. 
Commercial and in-house precipitant solutions were used (as described in the 
Experimental Procedures section) to screen the various enzyme preparations listed in 
Fig. 3.7. Protein crystals were not observed, and the structural details of S. aureus 
EPSPS are still unknown.  
Conclusions: 
Catalytically active S. aureus EPSPS was expressed, purified, and characterized by 
steady-state kinetics. E. coli EPSPS was utilized as a control and for comparison, and 
substantial differences were observed in catalytic activity, ion sensitivity, and 
glyphosate sensitivity. In contrast binding of the substrates, PEP and S3P, appeared to 
be quite similar for both enzymes. The basis for the observed cation-activation of the 
S. aureus enzyme is not known - based on the steady-state kinetic parameters, cations 
likely aid the global induced fit mechanism. This interpretation would be consistent 
with the observation that ions affect the rate of catalysis, but do not appear to 
influence substrate or glyphosate binding. In retrospect, the KCl saturation plot (Fig. 
3.3b) indicates that 100 mM KCl was sub-saturating and insufficient for maximal 
catalytic activity. Higher salt concentrations should be used in future experiments. 
Elucidation of the specific basis for the ion sensitivity likely requires knowledge of 
the three-dimensional atomic structure of S. aureus EPSPS.  
Structural data are also required to fully explain the glyphosate tolerance of EPSPS 
from S. aureus. An inspection of the sequence alignment (Fig. 3.1) reveals a leucine  
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Fig. 3.7: S. aureus EPSPS preparations used for crystal screens: 
 
 
 
 [enzyme] Buffer (+ 2 mM DTT) Additives, etc 
1. 40 mg/ml  50 mM Tris-Cl  - 
2. 40 mg/ml  50 mM Tris-Cl   5 mM S3P 
3. 40 mg/ml 50 mM Na/K Phosphate 5 mM S3P, 100 mM KCl 
4. 10 mg/ml  50 mM Na/K Phosphate 5 mM S3P, 100 mM KCl, post gel-filtration 
5. 24 mg/ml  50 mM Na/K Phosphate 5 mM S3P, 100 mM KCl 
6. 8 mg/ml  50 mM Na/K Phosphate 5 mM S3P, 100 mM KCl 
7. 8 mg/ml 50 mM Na-HEPES 5 mM S3P, 100 mM KCl 
8. 8 mg/ml  50 mM Tris-Cl  5 mM S3P, 100 mM KCl 
9. 8 mg/ml 50 mM Na/K Phosphate 5 mM S3P, 5 mM glyphosate, 2 mM ANS, 100 mM KCl 
10. 8 mg/ml  50 mM Na/K Phosphate 5 mM S3P, 100 mM KCl, 2% DMSO 
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residue at the site corresponding to Pro101 in the E. coli enzyme. Mutations at this 
conserved Pro101 residue are known to result in moderate levels of glyphosate 
tolerance69-71, but other unknown features likely contribute to the high levels of 
glyphosate insensitivity observed in S. aureus EPSPS. 
Other EPSPS with intrinsic glyphosate tolerance have been described as “class II” 
EPSPS29, 72, and were utilized to produce transgenic glyphosate resistant (Roundup 
Ready) crop lines. Class II EPSPS are characterized by the ability to maintain 
catalytic efficiency in the presence of glyphosate; they typically exhibit substantial 
sequence dissimilarity compared to the EPSPS found in plants or E. coli; and they 
tend to be ion-sensitive. On the basis of these criteria, S. aureus EPSPS can be 
considered a prototypical class II EPSPS. 
Inhibitors and structural data remain unavailable for class II EPSPS enzymes, 
including S. aureus EPSPS. The work described here should facilitate further 
examination of this important enzyme. 
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Chpt. 4: CP4 EPSPS: Catalysis, Inhibition, and Structural Basis for 
the Glyphosate Insensitivity of transgenic Roundup Ready Crops 
 
Portions of this work were included in: Funke T.; Han H.; Healy-Fried M.L.; Fischer 
M.; Schönbrunn E., Molecular Basis for the Herbicide Resistance of Roundup Ready 
Crops. PNAS 2006, 103, 13010-15. 
Introduction: 
Glyphosate, the active ingredient in Roundup, is the world’s most-used pesticide73. 
Glyphosate possesses broad-spectrum herbicidal activity and kills essentially all 
plants upon foliar application10, 29, 42. This phytotoxicity is a result of the specific and 
potent inhibition of EPSPS, the penultimate enzyme of the shikimate pathway9, 29, 74.  
The toxicological and herbicidal profiles of glyphosate are very favorable29-31, 42. To 
broaden the utility of this herbicide, a degree of selectivity was desired to facilitate 
application during the growing season - killing weeds without damaging crops. 
Substantial efforts to create a selective herbicide by modifying the chemical structure 
of glyphosate were unsuccessful – the herbicidal activity of glyphosate analogs was 
either broad-spectrum or non-existent27, 29. The identification of EPSPS as the 
molecular target of glyphosate spurred extensive research into the structure, function, 
and inhibition of this enzyme by scientists seeking to engineer glyphosate tolerant 
crop varieties22, 23, 33, 35, 71, 75-80. 
EPSPS catalyzes the transfer of the enolpyruvyl moiety of PEP to the 5’-hydroxyl of 
S3P to produce EPSP (See Fig. 1.3). Glyphosate is a reversible inhibitor of this 
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reaction, binding competitively with respect to PEP11; structural studies have 
confirmed that PEP and glyphosate share a common binding site21, 22, 24. In plants, 
EPSPS is a soluble, nuclear encoded, plastid localized, ca. 44-48 kDa enzyme14, 29. 
Two classes of EPSPS have been described based on the intrinsic glyphosate 
sensitivity of the enzyme. Glyphosate-sensitive EPSPS enzymes are termed “Class I” 
and have been isolated from plants (Petunia x hybrida, Zea mays, etc.)29, 80-82 and 
bacteria (E. coli, Salmonella typhimurium, Klebsiella pneumoniae, etc.)29, 71, 76, 83. In 
constrast, bacterial EPSPS enzymes, isolated from species including Staphlococcus 
aureus, Pseudomonas sp. strain PG2982, and Agrobacterium sp. strain CP4, show 
substantial sequence divergence compared to the prototypical class I EPSPS enzymes 
and are not sensitive to inhibition by glyphosate. On the basis of their ability to 
maintain catalytic efficiency in the presence of glyphosate, these enzymes were 
termed “class II” EPSPS29, 35, 36, 72, 82. 
A number of glyphosate resistance mechanisms have been demonstrated, including 1) 
reduced glyphosate uptake and/or translocation (non-target site mechanisms)70, 84-86; 
2) overproduction of the target (class I EPSPS)76, 79, 87-89; 3) alteration of the target 
(mutated class I EPSPS)71, 75, 82, 90-92; 4) utilization of a glyphosate-degrading enzyme 
(e.g., glyphosate oxidoreductase)93-96; and 5) utilization of an intrinsically glyphosate-
insensitive target (Class II EPSPS)29, 35, 72, 82, 97. Of these, mechanisms 1) and 3) have 
been significant in the development of glyphosate tolerant weeds, while methods 3) 
and 5) have been significant in the development of glyphosate tolerant crops. 
Notably, a prototypical class II enzyme isolated from Agrobacterium sp. strain CP4 
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EPSPS, was utilized to produce commercially successful transgenic glyphosate-
resistant crop varieties (Roundup Ready 2 corn; Roundup Ready soybeans, canola, 
and cotton) that currently dominate North and South American agriculture (52% of 
corn, 70% of cotton, and 91% of soybeans planted in the United States in 2007 were 
such transgenic glyphosate-resistant varieties32). Despite being widely used and 
commercially significant, little was known about the structure or glyphosate-tolerance 
mechanism of CP4 EPSPS; in fact, no structural data was available for any class II 
EPSPS enzyme. Using the published amino acid sequence, a synthetic CP4 EPSPS 
gene was constructed with codon-usage optimized for bacterial expression. We 
produced, purified, and analyzed the structural and kinetic properties of CP4 EPSPS. 
We describe the structural basis of glyphosate insensitivity and discuss the 
implications of our results. 
Experimental Procedures: 
Materials- Chemicals and reagents were purchased from Sigma (St. Louis, MO) 
unless otherwise noted. S3P was synthesized and purified according to the standard 
procedure described45. The amino acid sequence of Agrobacterium sp. strain CP4 
EPSPS was obtained from U.S. Patent 563343572.  
Molecular Biology- This gene’s codon usage was optimized for bacterial expression, 
a synthetic gene was produced, and this was inserted into the plasmid pNCO113 by 
Dr. Markus Fischer, as described52. This construct was subjected to restriction digest 
using HindIII and NdeI restriction endonucleases in NEB Buffer 2 (New England 
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BioLabs), according to the manufacturer’s instructions. The products of the digest 
were separated by size using agarose gel electrophoresis and the CP4 EPSPS gene 
was isolated using the QIAquick Gel Extraction Kit (Qiagen), according to the 
manufacturer’s instructions. The pET-21a vector (Novagen) was linearized by the 
same restriction digest purification process, and the CP4 EPSPS gene was ligated into 
this pre-digested vector using T4 DNA polymerase from the Quick Ligation kit (New 
England BioLab), again according to the manufacture’s instructions.  The product of 
this cohesive-end ligation was utilized directly for transformation of chemically 
competent E. coli DH5-α cells. These cells were plated on LB-Agar plates containing 
100 µg/ml ampicillin and incubated overnight. The resulting bacterial colonies with 
ampicillin-resistance were picked and grown in LB media overnight and the plasmids 
were isolated using the QIAprep Spin Miniprep kit (Qiagen) according the 
manufacturer’s instructions. Samples of the isolated plasmids were subjected again to 
restriction digest by HindIII and NdeI and analyzed by agarose gel electrophoresis. 
Several of the restriction digest analyses displayed a CP4-sized gene; one of these 
was submitted for sequence analysis at the University of Kansas Medical Center 
biotech research support facility. The sequence obtained utilizing the T7 primer 
confirmed the presence of the CP4 EPSPS open reading frame, and this CP4 EPSPS-
pET-21a construct was transformed into E. coli BL21(DE3) cells.  
Expression and Purification- Small-scale studies showed that soluble expression of 
CP4 EPSPS could by induced at 37°C by addition of 0.5 mM IPTG. Large scale 
cultures were grown to log stage (OD600 = 0.4 to 0.6) at 37°C in LB media in the 
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presence of 100 µg/ml ampicillin, induced with 0.5 mM IPTG, and cells were 
harvested by centrifugation 4 to 6 hours post-induction and stored at -80 °C. CP4 
EPSPS was originally purified using a protocol similar to that used by Dr. Priestman 
for S. aureus EPSPS45: briefly, the cell pellet was resuspended in extraction buffer 
with lysozyme, sonicated 2x 30 seconds, and centrifuged for 60 min at 18,000 RPM. 
The crude extract was subjected to a preliminary anion-exchange column (Q-
sepharose resin from GE Healthcare). EPSPS-containing fractions were collected and 
pooled and applied to a hydrophobic interactions column (P-sepharose resin from GE 
Healthcare). A secondary anion-exchange column (Resource-Q column from GE 
Healthcare) was then utilized. Subsequently, standard EPSPS purification 
procedures43 (25% ammonium sulfate precipitation, P-sepharose column, and Q-
sepharose) were utilized and produced similar results. The resulting highly purified 
CP4 EPSPS was used for kinetic characterization and crystallization. EPSPS from E. 
coli was produced and purified according to the standard protocol43. The Ala100Gly 
mutant CP4 EPSPS was produced by site-directed mutagenesis with the Quik Change 
II mutagenesis kit (Stratagene) according to the manufacturer’s instructions, using 
appropriate primers (MWG Biotech), and overexpressed and purified according to the 
standard protocol43. Coomassie reagent (Pierce, Rockford, IL) with BSA as a standard 
was used to determine protein concentrations.  
Kinetics- CP4 EPSPS activity assays were typically conducted at 25 °C in 100 µl of 
50 mM HEPES-NaOH, pH 7.5 with 2 mM DTT ± KCl (as indicated), in parallel with 
E. coli EPSPS. E. coli EPSPS is salt-insensitive and assays utilized 0.001 mg/ml 
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enzyme, and 1 mM PEP or S3P were considered saturating substrate concentrations. 
CP4 EPSPS activity is salt sensitive; assays performed in the presence of 100 mM 
KCl used 0.002 mg/mL enzyme with 1 mM PEP or 1 mM S3P for saturation, while 
the experiments performed in the absence of salt required increased enzyme (0.0075 
mg/ml CP4 EPSPS) and increased PEP (10 mM PEP considered saturating). The 100 
µl reactions were started by the addition of enzyme, stopped after 3 minutes by the 
addition of 800 µl malachite green reagent, and  color development was arrested after 
5 minutes by the addition of 100 µl 34% w/v sodium citrate (final assay volume = 1 
ml). Enzyme activity was determined by the amount of inorganic phosphate 
produced, as determined in comparison to phosphate standards. 
Salt-sensitivity- The salt sensitivity test utilized saturating substrate concentrations (1 
mM S3P, 1 mM PEP) ± 100 mM various salts (as shown) in Na-HEPES with 0.002 
mg/mL CP4 EPSPS and was performed as described for S. aureus EPSPS (Chapter 
3). 
Optimal pH- The pH sensitivity test utilized saturating substrate concentrations (1 
mM S3P, 1 mM PEP), 100 mM KCl, and 100 mM of a variety of sulfonate buffers, 
adjusted to the pH indicated. The heat sensitivity test was performed by Huijong Han 
by incubating the enzyme at various temperatures (as shown) for increasing times (as 
shown) in 50 mM HEPES, 100 mM KCl, 2 mM DTT, pH 7.5. Standard assays were 
then performed according to the method above at 25ºC in HEPES buffer and reactions 
were started by addition of heat-treated enzyme. 
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Substrate saturation- Enzyme activities were measured as a function of substrate 
concentration and the Km and Vmax values were determined by fitting the data to 
Equation 1:  v = Vmax * [S] / (Km + [S]) 
where v is the initial velocity, Vmax is the maximum velocity, Km is the Michaelis 
constant and [S] is the substrate (S3P or PEP) concentration.  
Glyphosate sensitivity- Enzyme activity as a function of glyphosate concentration 
was measured and the reported IC50 values for EPSPS inhibition were determined by 
fitting the data to  
Equation 2: 
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where v is the initial velocity, Vmax is the maximum velocity, Vmin is the minimum 
velocity, [I] is the concentration of glyphosate and n is the Hill slope.  Enzymatic 
activities at increasing PEP and varied glyphosate concentrations were recorded and 
the data were fit to Equation 1, and the Ki was determined by linear regression of the 
replot of the Km(obs) values versus the concentration of glyphosate, [I] according to  
Equation 3:  Km(obs) = (Km / Ki) * [I] + Km 
where Km(obs) is the observed Michaelis constant in the presence of inhibitor, Km is the 
true Michaelis constant, and Ki is the inhibition constant. 
Fluoroescence studies- Fluorescence spectroscopy studies were also conducted 
utilizing CP4 EPSPS. For intrinsic fluorescence experiments, the excitation 
wavelength was 280 nm, and emission spectra were recorded between 290 and 400 
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nm. Experiments were conducted in 50 mM Na-HEPES pH 7.0, 2 mM DTT, with 150 
µg of CP4 EPSPS per 1 ml sample. Emission spectra were recorded prior to the 
addition of ligands, and again after the addition of each ligand (S3P, PEP, KCl or 
glyphosate) to a final concentration of 1 mM (except in the case of KCl, which was 
added to a final concentration of 100 mM). Extrinsic fluorescence experiments were 
conducted utilizing ANS as a fluorophore. The assays were performed in 50 mM Na-
HEPES pH 7.0, 2 mM DTT, and 150 µg of CP4 EPSPS was used for each 1 ml 
sample. For ANS fluorescence, the excitation wavelength was set to 366 nm and 
emission spectra were recorded between 400 and 600 nm. The ANS fluorescence 
emission spectra were recorded prior to the addition of enzyme or ligands and this 
free-ANS fluorescence signal was subtracted from that obtained after addition of 
enzyme, so that the fluorescence intensity reported is proportional to the amount of 
ANS•EPSPS complex in the sample. To determine the Kd ANS, maximum 
fluorescence intensity (λ = 475 nm) was recorded, plotted as a function of ANS 
concentration, and fit to  
Equation 4:  y = Ymax * [ANS] / (Kd + [ANS]) 
where y is the observed fluorescence, Ymax is the maximal fluorescence, Kd is the 
dissociation constant and [ANS] is the concentration of the fluorophore. To determine 
the Kd of S3P, KCl, PEP, and glyphosate using this assay, ANS concentration was 
held constant at 200 µM. Fluorescence spectra were recorded after addition of 150 µg 
of CP4 EPSPS to the 1 ml sample to obtain FO, the “original” fluorescence intensity. 
Varied concentrations of the ligands were then added and the spectra were again 
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recorded to obtain the FL, the “liganded” fluorescence intensity. The addition of 
ligands resulted in fluorescence quench as ANS was displaced from the enzymes; to 
fit this to the Kd equation, the raw fluorescence intensity data were converted to the 
relative change in fluorescence intensity (equal to: 1- FL/ FO). This relative change in 
fluorescence intensity was plotted as a function of substrate concentration and fit to 
Equation 5:  y = Ymax * [L] / (Kd + [L]) 
where y is the observed relative change in fluorescence, Ymax is the maximal relative 
change in fluorescence, Kd is the dissociation constant and [L] is the concentration of 
the ligand.  
Crystallization screens- CP4 EPSPS was concentrated to 40 mg/ml in 50 mM 
Tris·HCl, pH 8.0 with 2 mM DTT and crystallized by hanging drop vapor diffusion. 
Initial crystallization trials were conducted in parallel using enzyme at 40 mg/ml and 
20 mg/ml, ± 5 mM S3P, with 200 mM KCl included in every case. Crystallization 
conditions were found and optimized for both the “closed-form” (found with CP4 
EPSPS + S3P ± glyphosate) and the substrate-free “open-form” (apo-enzyme) CP4 
EPSPS.  
Open-form CP4 EPSPS crystallization- For the open-form crystallization conditions, 
an enzyme mixture containing 20 mg/ml CP4 EPSPS, 100 mM KCl, 5% DMSO, 50 
mM Tris-Cl pH 8.0, and 2 mM DTT and a precipitant solution consisting of 100 mM 
Tris-Cl pH 8.5 and 25% w/v PEG 4000 were mixed in a 1:1 ratio (4 µl + 4 µl), and 
the droplet was sealed over a reservoir containing 500 µl of the precipitant solution. 
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Needle-like crystals typically formed spontaneously after several days and persisted 
for several months in the crystallization droplet; stable harvesting conditions were not 
identified. Just prior to freezing for data collection, the crystals were soaked briefly (< 
10 sec) in a cryoprotection buffer consisting of 50 mM KCl, 50 mM Tris-Cl pH 8.5, 
25% w/v PEG 200, 25% w/v PEG 4000, and 2% DMSO. Since the resolution of 
individual open-form crystals varied substantially and cracks were frequently 
observed, particularly in larger crystal specimens, multiple open-form CP4 EPSPS 
crystals were typically screened prior to data collection.  
Closed-form CP4 EPSPS crystallization- For the closed form crystallization 
conditions, an enzyme mixture containing 5-10 mg/mL CP4 EPSPS, 0.2 M KCl, 50 
mM Tris-Cl, 10 mM S3P, and 2 mM DTT and a precipitant solution consisting of 2% 
PEG 400, 0.1 M Na-HEPES pH 7.5, and 2.0 M (NH4)2SO4 were mixed in a 1:1 ratio 
(4 µl + 4 µl) and the droplet was sealed over a reservoir containing 500 µl of the 
precipitant solution. Blade-like crystals formed spontaneously after several days, or 
more rapidly with microseeding. These crystals were stable in a harvesting buffer 
consisting of 2.25 M (NH4)2SO4, 0.1 M KCl, 1 mM S3P, and 50 mM Tris-Cl. Just 
prior to freezing for data collection, the crystals were soaked briefly (< 10 sec) in a 
cryoprotection buffer consisting of harvesting buffer diluted by addition of 25% v/v 
glycerol. These crystals showed better diffraction, greater stability, and less 
variability compared to the open-form CP4 EPSPS crystals. The best resolution was 
observed with the largest crystals, the growth of which can be favored by utilization 
of low concentrations of CP4 EPSPS and longer crystal growth times without 
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microseeding. To achieve the co-crystallization of CP4 EPSPS with glyphosate, the 
previously-described enzyme mixture and a small amount of the precipitant solution 
were prepared in a 0.5 M glyphosate solution (used in place of water). The 
concentration of glyphosate in the crystal droplet was approximately 80 mM. 
Structure determination- X-ray diffraction data were collected according to the 
standard procedures described. The data were reduced with XDS48 or HKL-200049. 
The structures were solved by molecular replacement. With the unliganded S. 
pneumoniae EPSPS (PDB 1rf5) as search model, the structure of the unliganded 
(open-form) CP4 EPSPS was determined at 2.1-Å resolution. Subsequently, the 
structure of the S3P-liganded CP4 EPSPS was determined at 1.64-Å resolution with 
both globular domains of the open-form CP4 enzyme utilized as search models. This 
binary complex served as the search model for the determination of the ternary 
complexes of the WT and A100G CP4 EPSPS enzymes. Refinement and structure 
building were performed as previously described. Data collection and structure 
refinement statistics are included in the publication52. Ab initio energy calculations of 
the two glyphosate conformations were performed by Huijong Han with GAMESS 
using MP2/6–31+G*98. 
Results and Discussion: 
The highly purified product of the synthetic CP4 EPSPS gene showed catalytic 
activity and glyphosate insensitivity. Parallel experiments were performed to compare 
the characteristics of the prototypical class I EPSPS enzyme from E. coli and the 
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prototypical class II EPSPS from CP4. The global sequence alignment between CP4 
EPSPS and E. coli EPSPS (Fig. 4.1) indicates that the amino acid sequences of these 
orthologs share only 27% identity and 48% similarity. By comparing CP4 and E. coli 
EPSPS amino acid sequences, kinetic properties, and 3-dimensional structures, we 
illuminate the differences between these EPSPS enzymes and describe the structural 
basis for the glyphosate insensitivity of CP4 EPSPS.  
Catalytic activity and salt effect- The catalytic activity observed in preliminary 
experiments was much decreased compared to the E. coli EPSPS, prompting 
experiments to test the effect of ions on this prototypical class II EPSPS. Much like 
the EPSPS enzyme from S. aureus45, the CP4 enzyme is sensitive to ions, showing an 
increase in catalytic activity in the presence of specific monovalent cations (Fig. 4.2). 
The greatest activation was seen with potassium ions, and the enzyme activity plotted 
as a function of KCl concentration (Fig. 4.2) shows that this effect is saturable; these 
data were fit to Equation 1 to derive the dissociation constant for K+ (Kd = 26 µM). 
To examine the basis of the cation-activation of CP4 EPSPS, we examined the 
steady-state kinetic properties in the presence and absence of 100 mM KCl (Fig. 4.3). 
Enzyme activity was plotted as a function of substrate concentration and fit to 
Equation 1 to derive the kinetic parameters reported in Table 4.1. In the presence of 
KCl, the specific activity of CP4 EPSPS was about 30 U/mg, half that of E. coli 
EPSPS. In the presence of KCl, the substrate binding affinity of CP4 EPSPS (Km S3P 
= 140 µM; Km PEP = 200 µM) appeared very comparable to that of E. coli EPSPS. In  
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CP4 1 MAHGASSRPA TARKSSGLSG TVRIPGDKSI SHRSFMFGGL ASGETRITGL
E.coli 1 -MESLTLQP- -I--AR-VDG TINLPGSKSV SNRALLLAAL AHGKTVLTNL
CP4 51 LEGEDVINTG KAMQAMGARI RKEGDTWIID GVGNGGLLAP E-AP-LDFGN
E.coli 45 LDSDDVRHML NALTALGVSY TLSADRTRCE IIGNGGPLHA ESARELFLGN
CP4 99 AATGCR-LTM GL-VGVYDFD STFIGDASLT KRPMGRVLNP LREMGVQVK-
E.coli 95 AGTAMRPLAA ALCLGSNDI- -VLTGEPRMK ERPIGHLVDA LRQGGAKITY
CP4 146 SEDGDRLPVT LRGPKTPTPI TYRVPMASAQ VKSAVLLAGL NTPG-ITTVI
E.coli 143 LEQENYPPLR LQGGFTGGNV DVDGSVSSQF LTALLMTAPL APEDTVIRIK
CP4 194 -EPIMTR--D HTEKMLQGFG ANLTVETDAD GVRTIRLEGR GKLTGQVIDV
E.coli 193 GDLVSKPYID ITLNLMKTFG --VEIENQHY QQFVVK-GGQ SYQSPGTYLV
CP4 242 PGDPSSTAFP LVAALLVPGS DVTILNVLMN PTRTGLILT- -LQEMGADIE
E.coli 240 EGDASSASY- FLAAAAIRGG TVKVTGIGRN SMQGDIRFAD VLEKMGA---
CP4 290 VINPRLAGGE DVADLRVRSS TLKGVTVPED RAPSMIDEYP ILAVAAAFAE
E.coli 286 TI----CWGD DY--ISCTRG ELNAIDMDMN HIP---DAAM TIATAALFAK
CP4 340 GATVMNGLEE LRVKESDRLS AVANGLKLNG VDCDEGETSL VVRGRPDGKG
E.coli 327 GTTTLRNIYN WRVKESDRLF AMATELRKVG AEVEEGH-D- FIRITPPEK-
CP4 390 LGNASGAAVA THLDHRIAMS FLVMGLVSEN PVTVDDATMI ATSFPEFMDL
E.coli 373 ---LKFAEIA TYNDHRMAMC FSLVAL-SDT PVTILDPKCT AKTFPDYFE-
CP4 440 MAGLGAKIEL SDTKAA
E.coli 418 --QL-A--RI --SQPG
Fig. 4.1: Optimal global alignment of CP4 and E. coli EPSPS. The prototypical 
class I and class II EPSPS synthases, from E. coli and CP4, respectively, share 27% 
amino acid sequence identity and 48% similarity. Boxes residues are identical. 
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Fig. 4.2: The cation sensitivity of CP4 EPSPS (Top) The activity of CP4 EPSPS 
depends strongly on the presence of cations, such as NH4+, Rb+, and K+. (Bottom) 
Activation by K+ is saturable with an apparent dissociation constant of 26 mM. 
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Fig. 4.3: CP4 EPSPS steady state kinetics: The effect of K+. Steady-state kinetics 
of CP4 EPSPS (Top) The activity of CP4 EPSPS at various concentrations of PEP 
was assayed in the presence (filled circles) or absence (filled squares) of 100 mM 
KCl. Data were fit to Equation 1, yielding Km PEP = 0.20 mM in the presence of 100 
mM KCl and Km PEP = 3.5 mM in the absence of salt. (Bottom) The activity of CP4 
EPSPS at various [S3P] was assayed in the presence of 100 mM KCl (filled circles) 
or 10 mM PEP in the absence of salt (filled squares). Data were fit to Equation 1, 
yielding Km S3P = 0.14 mM in the presence of 100 mM KCl, and Km S3P = 0.18 mM 
in the absence of salt. 
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Table 4.1: Steady-state kinetic constants. 
EPSPS 
Enzyme 
Km S3P 
(mM) 
kcat/Km S3P 
(M-1 sec-1) 
Km PEP 
(mM) 
kcat/Km PEP 
(M-1 sec-1) 
IC50 Glp 
(mM) 
Ki Glp 
(mM) 
WT E. coli 
No KCl 0.16 2.8* 10
5 0.17 2.8* 105 0.0025 0.40 
WT CP4 
+ KCl 0.14 1.4 * 10
5 0.20 1.0 * 105 11 6.4 
A100G CP4 
+ KCl 0.28 8.2 * 10
4 0.18 1.4 * 105 0.16 0.092 
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the absence of salt, the specific activity of CP4 EPSPS decreased by 3-fold, while the 
binding of S3P by CP4 EPSPS was not substantially affected (Km S3P = 180 µM). 
The Km PEP was increased by 17-fold in the absence of salt, (Km PEP = 3500 µM) 
suggesting that the cations facilitate the binding of PEP at the active site of CP4 
EPSPS to produce the observed increase in specific activity. The concentration of 
potassium in plant cells is reportedly sufficient to produce the cation-activation of this 
enzyme in situ99.  
pH sensitivity- The log plot of enzyme activity as a function of sulfonate buffer pH 
(Fig. 4.4) shows that while both enzymes maintain activity over a broad pH range, the 
CP4 EPSPS is inhibited by more acidic conditions, while the E. coli EPSPS activity is 
decreased under more basic conditions.  
Heat sensitivity- Thermal denaturation assays performed by Huijong Han (Fig. 4.5) 
indicated that CP4 EPSPS more thermally stable than the E. coli enzyme. The activity 
of the enzyme was measured after incubation at the temperature listed for the length 
of time indicated. Studies performed at 45 °C and 60 °C demonstrated that the CP4 
enzyme is at least 17-fold more stable than EPSPS from E. coli. These results indicate 
that CP4 EPSPS is well-suited to harsh environmental conditions and suggest that the 
CP4 enzyme is much more rigid than E. coli EPSPS. 
Glyphosate inhibition- The glyphosate-sensitivity of CP4 EPSPS was assessed by 
determining the Ki of glyphosate with respect to PEP (Fig. 4.6). Enzyme activity as a 
function of PEP concentration was measured in the presence of varied glyphosate  
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Fig. 4.4: Comparison of E. coli and CP4 EPSPS pH dependence. This plot shows 
the log of the activity of E. coli EPSPS (filled circles) and CP4 EPSPS (open circles) 
as a function of pH. The reactions were performed in 100 mM of various sulfonate 
buffers in the presence of 1 mM S3P, 1 mM PEP, and 100 mM KCl. 
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Fig. 4.5: Heat sensitivity of CP4 and E. coli EPSPS. (Top) The decline in activity 
of CP4 EPSPS (filled circles) and E. coli EPSPS (open circles) was assayed at 45 °C. 
Data were fit to a single exponential equation, yielding T0.5 = 133 min for CP4 EPSPS 
and T0.5 = 11 min for E. coli EPSPS. (Bottom) The decline in activity of CP4 EPSPS 
(filled circles) and E. coli EPSPS (open circles) was assayed at 60 °C. Data were fit to 
a single exponential equation, yielding T0.5 = 6.8 min for CP4 EPSPS and T0.5 = 0.2 
min for E. coli EPSPS. 
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Fig. 4.6: Inhibition of CP4 EPSPS by glyphosate. (Top) The activity of CP4 EPSPS 
at various concentrations of PEP was assayed in the presence of 100 mM KCl with 
varied glyphosate concentrations: 0 mM (filled circles), 0.1 mM (filled diamonds), 
0.5 mM (filled inverted triangles), 2.5 mM (filled triangles), 10 mM (filled squares), 
and 25 mM (open squares). The Vmax and Km(obs) PEP were determined by fitting the 
data to Equation 1. (Bottom) Replot of the Km(obs) PEP as a function of glyphosate 
concentration. Data were fit to Equation 3, yielding a Ki of 6.4 mM. 
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concentrations. These data were fit to Equation 1 to determine the Km(obs). The Km(obs) 
values were replotted as a function of glyphosate concentration and the data were fit 
to Equation 3 to determine the Ki values for glyphosate. Class I EPSPS enzymes are 
typically inhibited by low-micromolar-range concentrations of glyphosate, as 
demonstrated by E. coli EPSPS (Ki = 0.4 µM glyphosate). As expected, the class II 
EPSPS enzyme from CP4 is insensitive to glyphosate (Ki = 6.4 mM).  This 16,000-
fold difference in glyphosate-sensitivity roughly corresponds to the herbicide 
application window, or the difference between the minimum glyphosate 
concentrations required to kill weeds, and the maximum glyphosate concentrations 
that can be applied without damage to (the CP4 EPSPS-expressing) Roundup Ready 
crops.  
Crystal structures- To examine the mechanism by which CP4 EPSPS discriminates 
between PEP and glyphosate to selectively binds PEP, crystallization conditions were 
discovered and optimized, enabling determination of apo-enzyme (unliganded CP4 
EPSPS), binary complex (CP4 EPSPS•S3P), and ternary complex (CP4 
EPSPS•S3P•glyphosate) structures. The gross morphology and folding pattern of CP4 
EPSPS is similar to the S. pneumoniae21 and E. coli22 EPSPS enzymes; as observed in 
the other EPSPS enzymes, the binding of S3P to the active site of CP4 EPSPS 
induces a global conformational change (the open-closed transition) (Fig. 4.7). 
Despite the relatively low overall sequence conservation between E. coli and CP4 
EPSPS, the active-site residues appear quite well conserved. The S3P-complexed 
active sites of CP4 and E. coli EPSPS are compared in Fig. 4.8. One obvious  
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Fig. 4.7: Global CP4 EPSPS structures. The open-closed transition is shown in this 
cartoon diagrams of CP4 EPSPS. Unliganded CP4 EPSPS exists in an open 
conformation (Left). The binding of S3P to the enzyme’s active site induces a global 
conformational change to form the closed-form enzyme (Right). 
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Fig. 4.8: Comparison of binary active-site structures of EPSPS.  
(Top) S3P-complexed CP4 EPSPS; (Bottom) S3P-complexed E. coli EPSPS.  
S3P (yellow) binds to the 
magenta-colored residues 
through multiple hydrogen-
bonding/electrostatic 
interactions (shown as white 
dotted lines). Light-blue-
colored residues constitute the 
PEP/glyphosate binding site. 
Water molecules are shown as 
cyan spheres. 
 
The accumulation of positive 
charges in the space normally 
occupied by the phosphate 
moiety of PEP or the 
phosphonate moiety of 
glyphosate attracts anions 
(shown green) from the 
crystallization solutions 
(sulfate ions in CP4 EPSPS 
structure (upper), or formate 
ions in the E. coli EPSPS 
structure (lower)).  
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difference in the active site of these enzymes is that the front face of the S3P-binding 
pocket in the CP4 enzyme is formed by an arginine residue (Arg200) instead of the 
tyrosine residue (Tyr200) observed in E. coli EPSPS; additionally, in the CP4 
enzyme, the phosphate moiety of S3P is predominantly hydrogen-bonded to water 
molecules, rather than directly to amino acid residues as observed in E. coli EPSPS. 
Less noticeable in this view is the presence of an alanine residue in position 100, 
replacing a strictly conserved glycine residue (corresponding to Gly96 of the E. coli 
EPSPS). The Gly96Ala mutation in E. coli EPSPS has been shown to result in 
glyphosate insensitivity43, 90; we therefore hypothesized that the glyphosate 
insensitivity of CP4 EPSPS is largely a result of the substitution of this alanine 
residue for the conserved, active-site glycine. To test this hypothesis, A100G CP4 
EPSPS was produced, and we analyzed the activity, inhibition, and structure of the 
mutant enzyme. 
A100G CP4 EPSPS Kinetics- The steady-state kinetic properties of A100G CP4 
EPSPS are very similar to those of the WT CP4 EPSPS (Fig. 4.9). Compared to the 
WT CP4 enzyme, the S3P-binding affinity appears to be slightly decreased for this 
A100G mutant EPSPS (Km S3P = 0.28 mM in the presence of 100 mM KCl; Km S3P 
= 0.23 mM in the absence of salt). The binding of PEP to this enzyme is, again, 
influenced by the presence of potassium ions, with the PEP-binding affinity slightly 
increased (Km = 0.18 mM) in the presence of 100 mM KCl or slightly decreased (Km 
PEP = 5.0 mM) in the absence of salt as compared to WT CP4 EPSPS. These data are 
notable, because the reverse mutation at the equivalent site (Gly96Ala) in E. coli  
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Fig. 4.9:  Steady-state kinetics of A100G CP4 EPSPS (Top) The activity of A100G 
CP4 EPSPS at various concentrations of PEP in the presence (filled circles) or 
absence (filled squares) of 100 mM KCl. Data were fit to Equation 1, yielding Km 
PEP = 0.18 mM in the presence of 100 mM KCl and Km PEP = 5.0 mM in the 
absence of salt. (Bottom) The activity of A100G CP4 EPSPS at various S3P 
concentrations was assayed in the presence of 100 mM KCl (filled circles), or in the 
absence of salt (filled squares). Data were fit to Equation 1, yielding Km S3P = 0.28 
mM in the presence of 100 mM KCl and Km S3P = 0.23 mM in the absence of salt. 
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EPSPS resulted in dramatically decreased affinity for PEP43. If the Ala-100 residue of 
CP4 EPSPS interfered with PEP-binding, one would expect the A100G mutant to 
show higher affinity for PEP. Based on the conserved active-site architecture 
observed in the crystal structures and the consistent Km values for PEP obtained with 
all three enzymes, it appears that subtle structural differences exist in WT CP4 EPSPS 
to compensate for the presence of the Ala-100 side chain and maintain PEP binding 
affinity. The specific activities observed for A100G CP4 EPSPS are, in every case, 
comparable to those of WT CP4 EPSPS. Overall, the substrate binding and catalytic 
activity of CP4 EPSPS appear unaffected by the A100G mutation.  
A100G CP4 EPSPS Inhibition by Glyphosate- The glyphosate sensitivity of WT CP4, 
A100G CP4, and WT E. coli EPSPS enzymes are directly compared in Fig. 4.10, with 
relative enzyme activity measured as a function of glyphosate concentration. These 
plots show that the A100G mutation results in a substantially increased glyphosate 
sensitivity. These data were fit to Equation 2 to determine the IC50 values, revealing 
that the IC50 of the A100G mutant enzymes is decreased by nearly 2 orders of 
magnitude compared to WT CP4 EPSPS, suggesting that the presence of this alanine 
residue in the active site of CP4 EPSPS is, in large part, responsible for the observed 
glyphosate-insensitivity. For a more precise analysis, we determined the Ki of 
glyphosate with respect to PEP for A100G EPSPS (Fig. 4.11). The results are similar 
to the IC50 data, with the A100G Ki glyphosate = 0.092 mM. We conclude that the  
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Fig. 4.10: IC50 of Glyphosate. Studies with WT CP4 EPSPS (filled squares), A100G 
CP4 EPSPS (open circles), and WT E. coli EPSPS (closed circles) reveal that CP4 
EPSPS is inhibited only by high millimolar concentrations of glyphosate (IC50 = 11 
mM). The A100G CP4 EPSPS is approximately two orders of magnitude more 
sensitive to glyphosate (IC50 = 160 µM). The E. coli enzyme is inhibited by much 
lower glyphosate concentrations (IC50 = 2.5 µM).  
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Fig. 4.11: Inhibition of Ala100Gly CP4 EPSPS by glyphosate. (Top) The activity 
of A100G CP4 EPSPS was assayed at various concentrations of PEP in the presence 
of 100 mM KCl, with varied glyphosate concentrations: 0 mM (filled circles), 0.01 
mM (filled diamonds), 0.025 mM (filled inverted triangles), 0.05 mM (filled 
triangles), 0.1 mM (filled squares), and 0.25 mM (open squares). The Vmax and Km(obs) 
PEP were determined by fitting the data to Equation 1. (Bottom) Replot of the Km(obs) 
PEP as a function of glyphosate concentration. Data were fit to Equation 3, yielding a 
Ki of 0.092 mM. 
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steric bulk of the Ala-100 side chain contributes substantially to the glyphosate 
insensitivity of CP4 EPSPS. 
A100G CP4 EPSPS Crystallization- To further analyze the basis of glyphosate 
tolerance, we crystallized the A100G CP4 EPSPS enzyme in the presence of S3P and 
glyphosate and compared this structure to the WT CP4 EPSPS ternary complex (Fig. 
4.12). This analysis revealed that the active site of CP4 EPSPS is very stable; aside 
from the alanine-to-glycine mutation, all amino acid residues are in essentially 
identical positions. In fact, the major change observed is in the conformation of the 
glyphosate molecule itself (shown green). The presence of the Ala-100 side chain 
effectively shortens the glyphosate binding site; the glyphosate molecule must adopt 
an alternate, condensed conformation in order to bind. In this condensed 
conformation, the carbon atom of glyphosate’s phosphonate moiety is positioned very 
close to the glutamate side chain of residue Glu-354, introducing a steric clash. Thus, 
not only is glyphosate unable to bind CP4 EPSPS in the normal, extended 
conformation, but even binding of the condensed conformation is disfavored due to 
interactions with residue Glu-354. The conformational change of glyphosate is further 
explored in Fig. 4.13, which displays the fitting of the glyphosate structure into the 
electron density maps.  The condensed conformation on the left side was observed 
only in CP4 EPSPS, while the extended conformation on the right side is observed in 
A100G CP4 EPSPS, E. coli EPSPS22, and S. pneumoniae EPSPS21, and indeed is the 
lower energy conformation that exists in solution29. Ab initio energy calculations (by 
Huijong Han) showed that the condensed conformation of glyphosate has an  
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Fig. 4.12: Ternary active-site structures of CP4 EPSPS. 
Glyphosate (green) binds adjacent to S3P (yellow) in the active site of EPSPS. 
Hydrogen bonding/electrostatic interactions are indicated by white dashed lines; 
Steric clashes shown as red dotted lines; Water molecules shown as cyan spheres. 
 
(Top) WT CP4 EPSPS: 
Glyphosate adopts a 
condensed conformation as a 
the result of a clash between 
the Ala-100 side chain and 
oxygen atoms of glyphosate’s 
phosphonate group. This 
alternate conformation causes 
the carbon atom of the 
phosphonate group to clash 
with the side chain of Glu-354 
(red dotted line). 
 
 
  
 
 
 
 
 
(Bottom) A100G CP4 EPSPS:  
Replacing Ala-100 with a 
glycine residue allows 
glyphosate to bind in the 
extended conformation that it 
adopts in solution and as 
observed in other crystal 
structures. In this extended 
conformation, the nitrogen 
atom of glyphosate is 
equidistant from the 5’-
hydroxyl of S3P and the 
carboxyl of Glu-354.  
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Fig. 4.13: Conformational change of glyphosate. Two distinct conformations of 
glyphosate. Displayed are the electron densities, contoured at 3σ, derived from 1Fo – 
1Fc Fourier syntheses to 1.7-Å resolution, omitting the model of glyphosate during 
the refinement of the ternary complexes of CP4 EPSPS (Left) and A100G CP4 
EPSPS (Right). (Right) The conformation of glyphosate upon interaction with the 
A100G CP4 EPSPS is identical to the one observed in the E. coli or S. pneumoniae 
enzymes. (Left) With an Ala residue in position 100, the glyphosate molecule is ~ 0.6 
Å shorter, mainly because of a rotation around the CN bond next to the carboxyl 
group. 
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estimated 17 kcal/mol higher energy than the extended conformation. It is not clear 
whether glyphosate adopts this condensed conformation prior to interacting with CP4 
EPSPS or upon binding to the enzyme. Since higher energy conformations are 
statistically disfavored in solution, only a small percentage of the glyphosate 
molecules would occupy the condensed conformation at any given moment. Thus, if 
only a high-energy conformation is able to bind to the enzyme, then the actual 
concentration of the ligand (the glyphosate molecules in the high-energy, condensed 
conformation) is much lower than the molarity of glyphosate in the solution, and high 
glyphosate concentrations may be needed to obtain moderate concentrations of the 
active confomer. Alternatively, CP4 EPSPS may initially interact with the low 
energy, “extended” glyphosate molecule, and induce the conformational change upon 
binding. If this transition to the higher-energy conformation were enzyme-induced, 
the free energy required for binding would be increased, thereby disfavoring 
formation of the EPSPS•glyphosate complex. Either explanation seems to account for 
the observed conformational change of glyphosate and both provide a rationale for 
the insensitivity of CP4 EPSPS to this inhibitor.  
Fluorescence Studies- Intrinsic and extrinsic fluorescence trials were conducted with 
CP4 EPSPS. This enzyme exhibits intrinsic fluorescence (Fig. 4.14, top), but the 
addition of saturating amounts of salt or substrates (colored lines) did not alter the 
fluorescence signal, and these experiments were discontinued. CP4 EPSPS extrinsic 
fluorescence trials were performed using the fluorophore ANS (Fig. 4.14, bottom). 
The brown line shows the fluorescence signal of ANS alone; the black line shows the  
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Fig 4.14: CP4 EPSPS fluorescence trials.  
 
 
(Top) CP4 EPSPS 
shows intrinsic 
fluorescence, but no 
change is observed 
upon addition of 
ligands (colored lines). 
 
 
 
 
 
 
 
 
 
(Bottom) The extrinsic 
fluorophore ANS 
shows a fluorescence 
increase upon binding 
to CP4, and the 
addition of ligands 
results in fluorescence 
quench. 
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increase in fluorescence observed upon addition of CP4 EPSPS, due to formation of a 
CP4 EPSPS•ANS complex. The CP4 EPSPS•ANS fluorescence signal was quenched 
upon addition of 1 mM S3P, and further decreased by addition of 1 mM PEP, 
suggesting that ANS fluorescence quench assays may be useful for examination of 
the ligand binding and induced fit mechanism of CP4 EPSPS. The results of the 
extrinsic fluorescence experiments are shown in Figs. 4.15a-e.  In Fig. 4.15a, the 
maximum fluorescence intensity was replotted as a function of ANS concentration. 
Normal enzyme saturation behaviour was observed and these data were fit to 
Equation 4 to derive the dissociation constant for ANS (Kd = 42 µM). The ANS 
fluorescence experiments summarized in Fig. 4.15b-e were performed in the absence 
of salt, with constant concentrations of enzyme and fluorophore, and varied 
concentrations of ligands (S3P, PEP, glyphosate, or KCl), as indicated. Fig. 4.15b 
shows the quenching of CP4 EPSPS•ANS fluorescence upon addition of S3P. The 
relative change in fluorescence intensity was replotted as a function of S3P 
concentration and data were fit to Equation 5, yielding Kd S3P = 2.4 µM. This is 
nearly two orders of magnitude lower than the Km S3P determined from the activity 
assays. Fig. 4.15c shows the quenching of CP4 EPSPS•ANS fluorescence upon 
addition of PEP. The relative change in fluorescence intensity was replotted as a 
function of PEP concentration and data were fit to Equation 5, yielding Kd PEP = 8.6 
µM. This result was unexpected, as S3P-induced conformational change is thought to 
result in formation of the PEP-binding site at the interdomain cleft of closed-form 
EPSPS. It is remarkable that PEP binds to CP4 EPSPS with such high affinity in the  
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Fig. 4.15b: Dashed line displays average CP4 + ANS fluorescence (FO). Solid 
lines display CP4 + ANS + S3P fluorescence (FL). Kd S3P = 2.4 µM 
 
Fig. 4.15c: Dashed line displays average CP4 + ANS fluorescence (FO). Solid 
lines display CP4 + ANS + PEP fluorescence (FL). Kd PEP = 8.6 µM 
 
Fig 4.15a-e: CP4 extrinsic fluorescence: Kd determinations.   
Fig 4.15a: Fluorescence intensity as a function of [ANS]. ANS Kd = 35 µM
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Fig 4.15d: Dashed line displays average CP4 + ANS fluorescence (FO). Solid 
lines display CP4 + ANS + KCl fluorescence (FL). Kd KCl = 11.2 mM 
 
Fig. 4.15e: Dashed line displays average CP4 + ANS fluorescence (FO). Solid 
lines display CP4 + ANS + glyphosate fluorescence (FL).  
Kd glyphosate= 2.1 mM 
 
Fig 4.15: CP4 extrinsic fluorescence: Kd determinations, cont. 
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absence of S3P when the activity assays performed in the absence of salt showed that 
the Km for PEP was in the low millimolar range. Fig. 4.15d shows the quenching of 
CP4 EPSPS•ANS fluorescence upon addition of KCl. The relative change in 
fluorescence intensity was replotted as a function of KCl concentration and data were 
fit to Equation 5; in this case, the Kd value of 11.2 mM agrees relatively well with that 
determined in the activity assays (26 mM). Finally, Fig. 4.15e shows the quenching of 
CP4 EPSPS•ANS fluorescence upon addition of glyphosate – again, the observed 
fluorescence quenching was somewhat unexpected; like PEP, the glyphosate binding 
site was not expected to exist in the absence of S3P. The relative change in 
fluorescence intensity was replotted as a function of glyphosate concentration and 
data were fit to Equation 5, yielding a Kd of 2.1 mM for glyphosate, roughly 
comparable to the Ki for glyphosate previously determined.  
Further crystallization trials- To better explain the effect of cations on CP4 EPSPS, 
we attempted to define the cation-binding site by crystallization in the presence of the 
more electron-dense Rb+ ion. To better explain the ANS fluorescence quench data, 
we attempted to define the ANS-binding site by crystallization of CP4 EPSPS in the 
presence of ANS. Neither cations nor ANS were observed in the resulting crystal 
structures. These experiments were not entirely uninformative, however. In the 
unliganded state, the CP4 EPSP synthase contains a highly flexible, 12-residue loop 
in the C-terminal domain around the strictly conserved active site residue E354 
(shown orange in Fig. 4.16). In the open-form crystal structure, this loop is only 
barely visible in the electron density map. In the closed-form crystal structure, this  
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Fig. 4.16: Putative ANS/cation binding site. Shown in orange is a loop spanning 
residues 347–358, which is highly flexible in the open conformation but becomes 
ordered in the closed conformation. This loop contains the strictly conserved EPSP 
synthase residues Glu-354 and Arg-357, which are involved in PEP/glyphosate 
binding. Monovalent cations may influence the conformation of this loop and 
facilitate binding of PEP. 
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loop becomes ordered and interacts with the N-terminal domain, forming a portion of 
the active site. The structures of the open-form CP4 EPSPS crystallized in the 
presence of ANS or with high concentrations of cations show this loop adopting a less 
flexible, more ordered structure, suggesting that ANS or cations may bind at this 
loop, essentially acting as chaperones to restructure the loop region. While neither the 
cations nor the ANS are observed at this site in the crystal structures, it may be the 
case that they essentially act as chaperones to restructure the loop; once the loop 
adopts a more regular conformation, the binding sites may be lost. The interaction of 
this loop with PEP and glyphosate, and putatively with ions and ANS, would account 
for the fluorescence quench data and could explain the dissociation constants for PEP 
and glyphosate that we obtained in the absence of S3P. 
Crystallization and inhibition experiments with DMSO- CP4 EPSPS co-
crystallization trials were conducted with newly-identified inhibitors of the E. coli 
EPSPS (see chapter 8). The DMSO solution used to solubilize the inhibitors 
prevented crystallization of E. coli EPSPS but resulted in formation of closed-form 
CP4 EPSPS crystals even in the absence of S3P. Instead of finding the inhibitor 
bound at the active site, it was observed that the enzyme, while indeed in the closed 
conformation, was largely “empty” (Fig. 4.17). Several conserved water molecules 
were observed at the positions normally found, and several additional water 
molecules and two sulfate ions were also observed. Strong additional electron density 
was observed (yellow balls in Fig. 4.17) which could not be definitively identified,  
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Fig. 4.17: Closed-form “Apo”-CP4 EPSPS active site structure. Waters shown in 
cyan, sulfates in green, and unmodeled electron density in yellow. 
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but may be DMSO or glycerol. Further experiments are underway. The crystals were 
reproducible in the absence of S3P and inhibitors by including 5 to 8 % DMSO in the 
precipitation buffer (2.5 to 4% DMSO in the crystal droplet). The basis for the 
formation of the closed-form apo-CP4 EPSPS in the absence of S3P is unknown, but 
this structure demonstrates that S3P is not required to induce the open-closed 
transition in this enzyme, and may be particularly useful for purposes of fragment-
based drug design.  The sensitivity of CP4 EPSPS to DMSO was subsequently tested 
(Fig. 4.18) and fit to Equation 2 to determine an IC50 for DMSO of 1.4 M, or about 
10% v/v, as shown in the figure. In the crystallization droplet, only about 4% DMSO 
was present, suggesting that the DMSO is not directly responsible for the substrate-
free open-closed conformational change of CP4 EPSPS. It may be that the role of 
DMSO is simply to keep the apo-form CP4 EPSPS enzyme in solution under the 
closed-form crystallization conditions. In this case, the open-closed transition could 
be induced either spontaneously or by the binding of anions, and the closed-form of 
the enzyme could be “trapped” and removed from the solution by crystal formation. 
Further experiments may illuminate the basis for this phenomenon and the identity of 
molecule responsible for the unmodeled electron density. 
Conclusions: 
We determined the catalytic activity, steady-state kinetic constants, cation-
dependence, multiple crystal structures (apo-open, apo-closed, binary, and ternary 
complexes) and the major structural basis for glyphosate tolerance of CP4 EPSPS, a 
representative class II enzyme. The activity and substrate binding appear similar to E.  
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Fig. 4.18: CP4 EPSPS DMSO sensitivity. CP4 EPSPS is inhibited by DMSO. The 
IC50 for DMSO is 1.4 M (approximately 10% v/v). 
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coli EPSPS and other class I enzymes.  The glyphosate-tolerance and cation-
dependence of CP4 EPSPS are markedly different.  The steric bulk added by the 
methyl group of the alanine residue (A100), found in CP4 EPSPS in place of a 
conserved active-site glycine residue, appears to be largely responsible for the 
glyphosate insensitivity. The added bulk at this position forces the glyphosate 
molecule to adopt a higher-energy condensed conformation that has not been 
observed previously. The mutation of this alanine back to glycine (A100G CP4 
EPSPS) largely, but not completely, restored glyphosate sensitivity, without altering 
the binding of PEP. It seems that other, more subtle changes must also occur in CP4 
EPSPS to account for the residual glyphosate insensitivity of the A100G CP4 EPSPS 
and to facilitate PEP-binding in the WT CP4 enzyme. Glyphosate insensitivity has 
also been reported due to mutations of the residue corresponding to Pro101 of E. coli 
EPSPS69, 71, 100, and the CP4 EPSPS contains a leucine at the equivalent position (see 
Fig. 4.2); this residue may also contribute toward the ability of CP4 EPSPS to 
distinguish between PEP and glyphosate.  
Overall, these data explain the agricultural success of Roundup Ready crops at a 
molecular level. The continued presence of glyphosate in the environment will favor 
the accumulation of mutations that reduce the glyphosate sensitivity of EPSPS while 
maintaining catalytic efficiency. The speed at which glyphosate resistance develops 
depends on the organisms’ generation time and fidelity of gene replication.  It is 
perhaps therefore not surprising that the CP4 gene was isolated from bacteria found in 
a glyphosate-production facility. The current low rate of appearance of plants with 
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evolved glyphosate resistance may be attributed to the relatively high-fidelity 
replication and long generation times of most plants, along with glyphosate’s 
phytotoxicity and lack of persistence or residual activity in the environment. 
However, extensive use of glyphosate increases the likelihood that glyphosate-
resistant weeds will emerge on a large scale. Indeed, the introduction of glyphosate-
tolerant crops resulted in greatly increased application of glyphosate, and this has 
coincided with an exponential increase in the number of weed species with evolved 
glyphosate resistance39. 
It appears that the confined space of the active site of EPSPS prohibits even slight 
alterations of the glyphosate molecule. More than 1,000 analogs of glyphosate were 
produced and tested, but relatively minor structural alterations resulted in 
dramatically reduced potency, and no compound superior to glyphosate was 
identified for inhibition of class I EPSPS enzymes29, 42. Further, while EPSPS is 
considered a promising target for the treatment of diseases caused by pathogenic 
bacteria or eukaryotic parasites101, 102, glyphosate displays little antimicrobial 
activity6, 16, 29. Together, these findings demonstrate the need for entirely new 
inhibitors that target this agriculturally and medicinally significant enzyme. 
 
 136 
Chpt. 5: Kinetic Effects and Structural Bases of Glyphosate 
Tolerance Resulting from Mutations at Pro101 of E. coli EPSPS 
 
This work was included in: Healy-Fried M.L.; Funke T.; Priestman M.A.; Han H.; 
Schönbrunn E., Structural basis of glyphosate tolerance resulting from mutations of 
Pro101 in Escherichia coli 5-enolpyruvylshikimate-3-phosphate synthase. J. Biol. 
Chem. 2007, 282, 32949-55. 
Introduction: 
Glyphosate exhibits broad-spectrum herbicidal activity, yet is essentially nontoxic to 
animals and does not persist in the environment30, 31. These characteristics have made 
it the world's most popular herbicide, and usage continues to increase with the 
adoption of glyphosate-utilizing technologies, such as herbicide-tolerant crops and 
minimal tillage (no-till) agriculture40, 103. The enormous reliance on glyphosate and 
the absence of suitably safe alternative herbicides mean that the widespread 
emergence of glyphosate-tolerant weeds could have devastating agricultural and 
environmental consequences39, 41, 42. 
EPSPS catalyzes the transfer of the enolpyruvyl moiety of PEP to the 5-hydroxy 
position of S3P (See Fig 1.3). Structures of the EPSPS•S3P•glyphosate complex 
show glyphosate bound to the PEP-binding site of EPSPS21, 22, 24, 52, corroborating 
early kinetic data indicating that glyphosate inhibition is competitive with respect to 
PEP11, 83. Before bacterial enzymes with innate glyphosate tolerance (class II EPSPS) 
were discovered and used to produce Roundup Ready crops, scientists described 
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several mutations that decreased glyphosate sensitivity in the “plant-like” EPSPS 
from Escherichia coli, Klebsiella pneumoniae, and Salmonella typhimurium29, 71, 75, 90, 
104. However, these mutant enzymes typically exhibited an increased Km for PEP and 
a correspondingly decreased catalytic efficiency, indicative of decreased fitness in the 
absence of glyphosate, and were thus considered unsuitable for the development of 
commercial glyphosate-tolerant crops29, 82. 
Glyphosate-resistant organisms have developed both through natural evolution in situ 
and by directed evolution or mutagenesis in vitro, and glyphosate tolerance can be 
induced by either target-site or non-target-site mechanisms. Non-target-site tolerance 
mechanisms include overexpression of EPSPS76, 87, 88 and decreased uptake or 
translocation of glyphosate70, 84-86. Target-site glyphosate tolerance can be induced by 
specific EPSPS point mutations including T42M105; G96A43, 90, 104; T97I106, 107; 
P101L, P101T, P101A, and P101S71, 85, 86, 100, 108, 109; and A183T92, 110; (all numbering 
according to E. coli EPSPS). Notably, field-evolved plants exhibiting target-site 
glyphosate tolerance invariably contain single-residue substitutions at the site 
corresponding to Pro101 of E. coli EPSPS. 
Pro101 is not directly involved in glyphosate binding (see Fig. 5.1), and the basis for 
Pro101-mutation-induced glyphosate tolerance has remained unclear in the absence 
of further kinetic and structural characterization. To probe the effects of mutations at 
this site, a series of E. coli EPSPS mutant enzymes were produced with glycine, 
alanine, serine, or leucine substituted for Pro101. These mutant enzymes were 
analyzed by steady-state kinetics, and the crystal structures of the substrate binary and  
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Fig 5.1: Global structure of E. 
coli EPSPS. Cartoon diagram 
shows the location of Pro101 
(shown in red) relative to the 
location of S3P (blue) or 
glyphosate (orange). 
 
 
 139 
substrate·glyphosate ternary complexes of P101S and P101L EPSPS were determined 
to between 1.5- and 1.6-Å resolution. The results indicate that any substitution at this 
site causes small but significant structural changes in the active site. The implications 
of our findings concerning the development and spread of glyphosate-resistant weeds 
are discussed.  
Experimental Procedures:  
Materials- Chemicals and reagents were purchased from Sigma (St. Louis, MO) 
unless otherwise noted. S3P was synthesized and purified as described previously45. 
The pET-24d vector (Novagen) containing the open reading frame of WT EPSPS 
from E. coli was used as a template for the mutations.  Single-site Pro101 mutations 
were introduced by Martha Healy-Fried and Dr. Melanie Priestman using the 
QuikChange mutagenesis kit (Stratagene) and appropriate primers (MWG Biotech). 
Pro101 mutant EPSPS enzymes were over-expressed in BL21(DE3) competent cells 
(Invitrogen) and purified according to the general protocol previously described43.  
Steady-state kinetics- The enzymatic activities of WT and Pro101 mutant EPSPS 
enzymes were measured in 96-well microtiter plates by Todd Funke and Martha 
Healy-Fried at 25 °C using a colorimetric phosphate-release assay. Each 60 µl 
reaction mixture contained 50 mM HEPES (pH 7.5), 100 mM KCl, 2 mM 
dithiothreitol, and varied concentrations of S3P, PEP, or glyphosate, as indicated. The 
reactions were initiated by addition of enzyme (3.4 nM WT; 8.5 nM P101S, P101G, 
and P101A; or 34 nM P101L) and allowed to proceed for 30 minutes. The reactions 
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were stopped by addition of 140 µL malachite green phosphate indicator47 and 
samples were incubated for ten minutes to allowed for color development. Change in 
absorbance at 650 nm was measured on a Spectra-Max 340PC plate reader, and 
product formation was determined by comparison to phosphate standards. The Km 
and Vmax values were determined by fitting the data to  
Equation 1:  v = Vmax * [S] / (Km + [S]) 
where v is the initial velocity, Vmax is the maximum velocity, Km is the Michaelis 
constant and [S] is the concentration of the varied substrate. The Ki values for 
glyphosate inhibition were derived by determining the Km(obs) of PEP in the presence 
of increasing concentrations of glyphosate. The resulting data were fit to  
Equation 2:  Km(obs) = (Km / Ki) * [I] + Km 
where Km(obs) is the Michaelis constant for PEP in the presence of glyphosate, [I] is 
the glyphosate concentration, and Km is the Michaelis constant for PEP in the absence 
of glyphosate. 
Crystallization and Structure determination- P101S and P101L EPSPS enzymes were 
crystallized using the standard protocol for E. coli EPSPS, as described43, in the 
presence of 5 mM S3P, ± 5 mM glyphosate. X-ray diffraction data was collected 
according to standard procedures previously described. The collected data were 
reduced with XDS48 or HKL200049. Crystallography was performed as previously 
described (see General Protocol, Chpt. 1); data collection and refinement statistics 
table included in the publication69.  
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Results and Discussion: 
Four single-site mutations were introduced into E. coli EPSPS, replacing Pro101 with 
glycine, alanine, serine, or leucine, to examine the structural and function effects of 
Pro101 mutations.  
Catalytic activity- All four mutant enzymes were catalytically active and were 
analyzed by steady-state kinetics. Enzyme activity asssayed as a function of substrate 
concentration (data not shown) showed normal saturation kinetics and the data 
obtained were fit to Equation 1 to derive the kinetic parameters listed in Table 5.1. In 
every case, the Pro101-mutations result in decreased catalytic activity. WT EPSPS is 
6 times more active than P101L and over twice as active as P101S. P101A and 
P101G show the highest activity, about 60% that of WT EPSPS. Similarly, PEP 
binding is slightly decreased as a result of these mutations; the Km PEP for P101S, 
P101A, and P101G is increased slightly compared to WT EPSPS, and P101L shows 
the most increase (Km = 150 µM, compared to 60 µM for WT EPSPS). S3P binding 
appears little affected by these mutations; again, P101L show the most substantial 
change (Km = 100 µM, compared to 60 µM for WT EPSPS). The catalytic 
efficiencies (kcat/Km) of the mutant enzymes are 2–10-fold lower than those of WT 
EPSPS, with P101L EPSPS having the lowest catalytic efficiency. Based on these 
data, it appears that residues smaller than leucine may be substituted for Pro101 
without substantially altering the substrate affinity or catalytic activity of EPSPS. 
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Table 5.1. Summary of steady-state kinetic parameters.  
 
 
 
 
 
 
 
EPSPS 
Enzyme 
Km S3P 
(µM) 
Vmax 
(U/mg) 
kcat/Km(S3P) 
(M-1s-1) 
Km PEP 
(µM) 
kcat/Km(PEP) 
(M-1s-1) 
Ki  (µM) Km(PEP)/Ki 
WT 60 ± 6 50 ± 1 6.4 x 105 60 ±6 6.4 x 105 0.4 ± 0.06 150 
Pro101Ser 80 ± 6 22 ± 0.4 2.0 x 105 70 ± 5 2.9 x 105 5.5 ± 0.3 13 
Pro101Gly 60 ± 10 28 ± 1 3.9 x 105 90 ± 10 2.4 x 105 12 ± 4 7.5 
Pro101Ala 60 ± 4 31 ± 0.5 3.9 x 105 80 ± 5 2.8 x 105 19 ± 3 4.2 
Pro101Leu 100 ± 7 8 ± 0.2 6.2 x 104 150 ± 20 4.1 x 104 66 ± 2 2.3 
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Inhibition by glyphosate- The glyphosate sensitivity of each enzyme was examined 
by Ki determination. Since glyphosate is a competitive inhibitor with respect to PEP, 
EPSPS activity as a function of PEP concentration was assayed in the presence of 
varied concentrations of glyphosate. The data were fit to Equation 1 to derive the 
Km(obs) PEP, and the Km(obs) PEP, plotted as a function of glyphosate concentration, 
was fit to Equation 2 to determine the Ki glyphosate for each enzyme, reported in 
Table 5.1. The substrate saturation plots and the data replots used for Ki 
determinations are shown in Fig. 5.2a-e. Unlike WT EPSPS, which is very sensitive 
to glyphosate (Ki = 0.4 µM), these mutant enzymes are 10–165-fold less sensitive. 
The most glyphosate-sensitive mutant enzyme is P101S (Ki = 5.5 µM) and the most 
glyphosate-tolerant mutant is P101L (Ki = 66 µM). The Km(PEP)/Ki ratio provides a 
measure of the selectivity of each  enzyme, and indicates that P101L is the most 
discriminating of these mutants.  
Summary of kinetic characterization: These data show that substitution of any of 
these residues for Pro101 decreased the binding affinity of glyphosate, reducing the 
potency of this inhibitor. Overall, the substitution of residues smaller than leucine for 
Pro101 results in a glyphosate-tolerant, catalytically efficient enzyme. 
Crystallization- In WT EPSPS from E. coli, Pro101 is part of an internal helix 
(residues 97–105) in the N-terminal globular domain, ~ 9 Å distant from glyphosate 
(Fig. 5.1), so it is not obvious how glyphosate binding at the active site is affected by 
Pro101 mutations. To probe the specific effects, the binary (EPSPS•S3P) and ternary  
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Fig. 5.2a: WT E. coli EPSPS inhibition by glyphosate. (Left) PEP saturation 
curves in the presence of increasing concentrations of glyphosate: 0 (●), 0.16 (○), 
0.31 (▲), 0.63 (Δ), 1.25 (■), 2.5 (□), 5 (▼), and 10 (∇) mM glyphosate. The 
concentration of S3P was 1 mM.  Data were fit to the Equation 1. (Right)  Replot of 
the observed Km values as a function of glyphosate concentration. Data were fit to 
equation 2, yielding a Ki of 0.4 ± 0.06 µM.  
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Fig. 5.2b: Pro101Ser E. coli EPSPS inhibition by glyphosate. (Left) PEP 
saturation curves in the presence of increasing concentrations of glyphosate: 0 (●), 
0.31 (○), 0.63 (▲), 1.25 (Δ), 2.5 (■), 5 (□), 10 (▼), 53 (∇), and 106 (♦) µM 
glyphosate. The concentration of S3P was 1 mM.  Data were fit to Equation. 1. 
(Right) Replot of the observed Km values as a function of glyphosate 
concentration. Data were fit to equation 2, yielding a Ki of 5.5 ± 0.3 µM. 
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Fig. 5.2c: Pro101Leu E. coli EPSPS inhibition by glyphosate. (Left) PEP 
saturation curves in the presence of increasing concentrations of glyphosate: 0 
(●), 0.31 (○), 0.63 (▲), 10 (Δ), 20 (■), 40 (□), 53 (▼), and 106 (∇) µM 
glyphosate. The concentration of S3P was 1 mM.  Data were fit to Equation 1. 
(Right) Replot of the observed Km values as a function of glyphosate 
concentration. Data were fit to Equation 2, yielding a Ki  of 66 ± 2 µM. 
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Fig. 5.2d: Pro101Ala E. coli EPSPS inhibition by glyphosate. (Left) PEP 
saturation curves in the presence of increasing concentrations of glyphosate: 0 (●), 
0.07 (○), 0.13 (▲), 0.26 (Δ), 0.53 (■), 1.0 (□), 2.1 (▼), 4.2 (∇), 8.3 (♦), 16.6 (◊), 50 
(●) and 200 (○) µM glyphosate. The concentration of S3P was 1 mM.  Data were fit 
to Equation 1.  (Right) Replot of the observed Km values as a function of glyphosate 
concentration. Data were fit to Equation 2, yielding a Ki of 19 ± 3 µM. 
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Fig. 5.2e: Pro101Gly E. coli EPSPS inhibition by glyphosate. (Left) PEP 
saturation curves in the presence of increasing concentrations of glyphosate: 0 (●), 
0.13 (○), 0.26 (▲), 0.52 (Δ), 4.2 (■), 8.3 (□), 16.6 (▼), 33.3 (∇), 100 (♦), and 300 
(◊) µM glyphosate. The concentration of S3P was 1 mM.  Data were fit to 
equation 1. (Right): Replot of the observed Km values as a function of glyphosate 
concentration. Data were fit to equation 2, yielding a Ki of 12 ± 4 µM. 
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 (EPSPS•S3P•glyphosate) complexes of P101S and P101L EPSPS were crystallized, 
and the structures were determined to between 1.5- and 1.6-Å resolution.  
Structural analysis- The structures of the P101S and P101L mutant enzymes are 
nearly identical to that of WT EPSPS. To highlight the subtle changes induced by 
these mutations, the main chain atoms of the P101S and P101L EPSPS ternary 
complexes were compared to WT EPSPS. The root mean square deviation (rmsd), 
values are plotted in Fig. 5.3, with the inset showing rmsd values for residues 93-106 
relative to the overall rmsd. The largest differences are observed in the backbone of 
Gly96, Thr97, and Ala98. Figs. 5.4 and 5.5 display this region (residues 95-102) with 
the increased r.m.s.d. The altered amino acids, Ser101 and Leu101, are shown 
modeled into the respective electron density from the 1Fo - 1Fc Fourier syntheses 
(Fig. 5.4). Fig. 5.5 displays the electron density from the 1Fo(WT) - 1Fo(mutant) Fourier 
syntheses. These Fo – Fo maps show difference peak heights of 23σ and 18σ in the 
backbone around Thr97 for the P101S and P101L enzymes, respectively, suggesting 
that the Pro101 mutations affect glyphosate binding through a shift in the position of 
the active-site reside Thr97. Fig. 5.6 shows residues 96-102 with S3P and glyphosate 
bound to the active site. Based on the α-helix backbone trace, it appears that the 
mutation of Pro101 does not disrupt the secondary structure; instead, the mutation of 
Pro101 disrupts the side chain bonding patterns. The hydrophobic interactions 
between Pro101 and the carbonyl oxygen of Thr97 observed in the WT EPSPS are 
absent in the P101S and P101L structures, and the backbone of Thr97 reorients, 
shifting Gly96 and Thr97 slightly toward glyphosate. Glyphosate binding is sterically  
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Fig. 5.3: Structural differences between WT and mutant EPSPS. Shown is the 
rmsd comparison of the main chain atoms of WT EPSPS and the P101L (solid line) 
and P101S (dotted line) mutant enzymes complexed with S3P and glyphosate. The 
inset shows the rmsd values of residues 93–106 in multiples of the overall rmsd. 
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Fig. 5.4: Fo-Fc density map of P101S and P101L mutant EPSPS. Electron 
density (contoured at 3σ) derived from 1Fo - 1Fc Fourier syntheses, omitting 
residues 96–101 during refinement of the P101S enzyme (left) or the P101L 
enzyme (right). For clarity, only the density of Gly96, Thr97, and Ser101 is 
displayed.  
 
P101S EPSPS     P101L EPSPS 
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Fig. 5.5: Fo –Fo density map of P101S and P101L mutant EPSPS. Electron density 
(contoured at 4σ) derived from 1Fo(WT) - 1Fo(mutant) Fourier syntheses using the 
coordinates of P101S (left) or P101L (right) as reference. The highest peaks (of 23 and 
18 sigma) correspond to the position of the carbonyl oxygen of Thr97 in WT EPSPS, 
which shifts substantially as a result of the mutation. The difference density to the 
right of Thr97 corresponds to the carbon atoms of the Pro101 ring.  
 
 P101S EPSPS     P101L EPSPS 
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Fig. 5.6: Effects of Pro101 mutations on ternary E. coli EPSPS structure. 
Stereo view of E•S•I structures: Orange traces show backbone, green lines indicate 
hydrophobic interactions, black dashed lines mark hydrogen bonding, and red lines 
denote clash distances. (Top) WT EPSPS; (Middle) P101S mutant EPSPS; 
(Bottom) P101L mutant EPSPS. 
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hindered by this narrowed glyphosate binding site. The subtlety of these effects 
results in retention of binding affinity for the (slightly shorter) PEP molecule. 
Together, these structural data indicate that the glyphosate tolerance of Pro101 mutant 
EPSPS enzymes results from long-range alteration of the spatial orientation of Gly96 
and Thr97 in the active site of the mutant EPSPS enzymes. 
Conclusions: 
The removal of undesired plant species (weeds) to increase nutrient availability and 
crop yields is an intrinsic component of agriculture. The current enormous (and 
growing) reliance on glyphosate indicates that the development and spread of 
glyphosate-resistant weeds would have far-reaching negative consequences39-42. 
Glyphosate-tolerant mutant EPSPS enzymes typically show decreased fitness in the 
absence of glyphosate (decreased substrate binding and/or decreased catalytic 
activity). Mutations at sites corresponding to Pro101 appear to incur the least fitness 
cost, and because point mutations are far more evolutionarily accessible than multiple 
mutations, target-site glyphosate tolerance seems most likely to arise via mutations of 
this residue. With continued selective pressure from glyphosate application, the 
evolution of weedy plants expressing such enzymes appears inevitable. Our study 
indicates that the structural basis for the glyphosate tolerance of such Pro101 mutant 
EPSPS enzymes is due to long-range alterations in the active site of the enzyme, in 
particular impacting the spatial orientation of Gly96 and Thr97. It has long been 
known that Gly96 is critical for the efficient binding of glyphosate. For E. coli 
EPSPS, mutation of Gly96 to alanine results in a complete loss of inhibitory potency 
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because of the methyl group protruding into the glyphosate-binding site; however, 
this glyphosate tolerance comes at the expense of a drastically lowered affinity for 
PEP and poor catalytic efficiency43. In general, because the degree of glyphosate 
tolerance depends on the extent to which the inhibitor-binding site is perturbed and 
because the catalytic efficiency depends on the extent to which the substrate-binding 
site is left intact, it appears that the Pro101 substitution is favorable precisely because 
the changes in the enzyme active-site structure are so slight. Residues other than 
proline substituted at position 101 reduce glyphosate binding, while residues smaller 
than leucine at this position essentially do not alter the S3P- and PEP-binding sites, 
retaining catalytic efficiency. 
To prevent the expected deterioration of the herbicidal properties of glyphosate, 
aggressive strategies for combating glyphosate-tolerant weeds should be 
implemented. Our data indicate that plants with these target-site mutations likely 
remain susceptible to glyphosate at high concentrations, but non-target-site mutations 
may act synergistically70, 85, 109, drastically decreasing the effectiveness of glyphosate. 
On the basis of the extensive structure-activity relationship studies performed with 
glyphosate analogs29 and the subtlety of the structural changes observed in 
glyphosate-tolerant enzymes, glyphosate analogs may not represent suitable 
replacements for glyphosate. Because plants with target-site glyphosate tolerance 
mutations remain susceptible to herbicides targeting enzymes other than EPSPS, 
herbicide rotation practices may delay the development and spread of glyphosate-
tolerant weeds, and integrated weed management programs should be encouraged111. 
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The engineering of crops with resistance to other herbicides, such as dicamba112, 
holds some promise, but such crops are not yet commercially available, and 
glyphosate has unique advantages because of its very low toxicity to animals and its 
broad-spectrum activity against plants. In the long run, the development of 
completely new inhibitors of EPSPS or other shikimate pathway enzymes is 
desirable, as new nontoxic herbicides will be required. 
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Chpt. 6: Kinetic and Structural Analysis of Glyphosate Insensitive E. 
coli EPSPS T97I and T97I/P101S Mutant Enzymes 
 
Manuscript in preparation 
Introduction: 
The safety and efficacy of glyphosate10, 30, 31, 42, coupled with the existence of 
glyphosate resistant crop varieties72, 91, 97, have made glyphosate the most-used 
herbicide in the world73. Glyphosate binds in the PEP-binding site of EPSPS21, 22, 24, 
preventing catalysis of the enolpyruvyl transfer reaction (Fig. 6.1)9.  EPSPS enzymes 
from different organisms have been divided into two classes according to intrinsic 
glyphosate sensitivity: in Class I enzymes, found in all plants and in bacteria such as 
Escherichia coli and Salmonella typhimurium, catalytic activity is inhibited at low 
micromolar concentrations of glyphosate11, 29, 83. Class II enzymes, found in bacterial 
species including Staphylococcus aureus, Pseudomonas spp., and Agrobacterium sp. 
strain CP4, are distinguished by their ability to sustain efficient catalysis in the 
presence of glyphosate29, 37, 45, 52, 72, 113.  
Glyphosate insensitivity has been achieved in Class I EPSPS enzymes through natural 
selection, directed evolution and site-directed mutagenesis. As suggested by the fact 
that glyphosate and PEP bind to the same site, EPSPS mutants with substantially 
decreased affinity for the inhibitor glyphosate typically also exhibited decreased 
affinity for the substrate PEP29, 43, 82. Single-site mutations such as T42M105, G96A43, 
90, 104 and P101S69, 71, 75 were found to be advantageous but insufficient for 
commercial development of glyphosate tolerant crops. Multi-site mutations with more 
 158 
favorable properties were sought and discovered, including Petunia hybrida EPSPS 
mutants G101A/G137D and G101A/P158S82; the E. coli EPSPS mutant 
G96A/A183T92, 110 and the Zea mays EPSPS mutant TI02I/P106S91, 107, 114. The 
TI02I/P106S double mutant EPSPS (corresponding to T97I/P101S in E. coli; here 
abbreviated as TIPS EPSPS) had particularly favorable characteristics. The TIPS 
mutations were introduced into the endogenous EPSPS enzyme of Z. mays (field 
corn) to produce Roundup Ready corn (GA21 event80, 115), the first commercial 
varieties of glyphosate-resistant maize. The Class II EPSP synthase from 
Agrobacterium sp. strain CP4 was eventually utilized to create the transgenic 
glyphosate-resistant crops (such as  Roundup Ready 2 corn, NK603 event72, 97) that 
currently dominate the market. 
We have utilized EPSPS from E. coli as a model to investigate the unique properties 
of TIPS EPSPS in parallel with the single site mutant T97I EPSPS. Both of these 
mutant enzymes exhibit glyphosate insensitivity, but also decreased catalytic activity 
compared to wild-type EPSPS. We consider the implications of our results 
concerning the development of glyphosate resistance in weeds or crops via these 
mutations. 
Experimental Procedures: 
Materials- Chemicals and reagents were purchased from Sigma (St. Louis, MO) 
unless otherwise noted. S3P was synthesized and purified according to standard 
methods as described previously45. The pET-24d vector (Novagen) containing the 
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open reading frame of EPSPS from E. coli was used as a template for the mutations.  
Single-site T97I mutations were introduced in the wild-type EPSPS and in the P101S 
mutant EPSPS from E. coli using the QuikChange II site-directed mutagenesis kit 
(Stratagene) and appropriate primers (MWG Biotech). The presence of the mutations 
was verified by DNA sequencing. The single-mutant T97I and double mutant TIPS 
EPSPS enzymes were overexpressed in BL21(DE3) competent cells (Novagen) and 
purified according to the standard methods previously described43. P101S and WT 
EPSPS enzymes were used as controls, and these kinetic constants were redetermined 
to facilitate direct comparisons. 
Enzyme activity assays- The catalytic activities of WT, T97I, and TIPS EPSP 
synthases were measured at 25°C using a colorimetric phosphate-release assay. The 
60 µl reactions were performed in 50 mM HEPES (pH 7.5), 2 mM DTT, with S3P, 
PEP and glyphosate concentrations varied as indicated. The reactions were initiated 
by addition of enzyme and allowed to proceed for 3 - 30 minutes. The reactions were 
stopped by addition of the malachite green phosphate indicator47 and the samples 
were incubated for five minutes to allow for color development. Change in 
absorbance at 650 nm was measured on a Spectra-Max 340PC plate reader, and 
product formation was determined by comparison to inorganic phosphate standards. 
The Km and Vmax values were determined by fitting the data to 
Equation 1:  v = Vmax * [S] / (Km + [S]) 
where v is the initial velocity, Vmax is the maximum velocity, Km is the Michaelis 
constant and [S] is the substrate (S3P or PEP) concentration. The IC50 values for 
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EPSPS inhibition were determined by fitting data to  
Equation 2: 
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where v is the initial velocity, Vmax is the maximum velocity, Vmin is the minimum 
velocity, [I] is the inhibitor concentration and n is the Hill slope.   
Crystallization and Structure determination- EPSPS enzymes were crystallized at 
19°C by the hanging-drop vapor diffusion method in the presence of 5 mM S3P, with 
or without 5 mM glyphosate, using the standard sodium formate crystallization 
conditions described previously43. X-ray diffraction data were collected and structures 
were solved as previously described69 (see also General Protocols, Chapter 1).  
Results and Discussion: 
The residues corresponding to 90 through 104 of E. coli are strictly conserved in 
representative species Class I EPSPS synthases (Fig. 6.1). Residues Pro101 and 
Thr97 are both part of an N-terminal helix (see Fig. 6.2), but only Thr97 is an active 
site residue.  Both T97I and the TIPS mutant enzymes showed catalytic activity and 
increased glyphosate tolerance; their activity, inhibition, and structure were 
examined. 
Enzyme activity- The results of substrate saturation experiments are shown in Fig. 
6.3. The data from these studies were fit to Equation 1 to derive the Km values shown 
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Escherichia coli  90LFLGN AGTAM RPLAA104 
Klebsiella pneumoniae  90LFLGN AGTAM RPLAA104 
Salmonella typhimurium  90LFLGN AGTAM RPLAA104 
Zea mays  95LFLGN AGTAM RPLTA109 
  Petunia hybrida 167LFLGN AGTAM RPLTA181  
Fig. 6.1: Alignment of strictly conserved region of Class I EPSPS. 
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Fig. 6.2: Global structure of E. coli EPSPS. Position of residues Pro101 and Thr97 
(shown red), relative to glyphosate (orange) and S3P (blue). Both residues are part of 
an internal, N-terminal helix. Thr97 (lower red reside) is an active site residue, while 
Pro101 (upper red residue) is ~9 Å distant from the active site. 
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Fig. 6.3: Substrate Km determinations. (Top) PEP saturation plot; (Bottom) S3P 
saturation plot. WT (●) P101S (○) T97I (▼) and TIPS (△) EPSPS.  Data were fit 
to Equation 1 to derive kinetic parameters shown in Table 6.1. 
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in Table 6.1. The WT EPSPS was clearly the most active enzyme, showing specific 
activity of over 60 U/mg. The activity of the single-site mutants T97I and P101S 
enzyme was decreased 5-fold compared to the WT enzyme, and the activity of TIPS 
EPSPS was decreased nearly 10-fold compared to WT EPSPS. Substrate binding 
affinity, assessed as the inverse of the Km values, was maintained in the P101S and 
TIPS mutants, but the T97I mutant shows decreased catalytic efficiency due to 
increased Km for both PEP and S3P.  
Glyphosate inhibition- To assess the glyphosate sensitivity of these mutants, parallel 
IC50 experiments were performed (see Fig. 6.4) and these data were fit to Equation 2 
to obtain the values listed in Table 6.1. All the mutant enzymes show decreased 
glyphosate sensitivity. P101S EPSPS (IC50 = 4.5 µM). exhibits only moderate 
glyphosate tolerance, with the IC50 of glyphosate increased by 7-fold compared to 
WT EPSPS (IC50 = 0.62 µM). The T97I glyphosate sensitivity is decreased by 3 
orders of magnitude compared to WT EPSPS (IC50 = 620 µM), and the TIPS mutant 
is essentially insensitive to glyphosate (IC50 = 4500 µM).  
T97I and TIPS EPSPS kinetic summary- The glyphosate tolerance exhibited by the 
TIPS enzyme is on the same order of magnitude observed for the class II EPSPS 
enzymes from S. aureus and CP4 EPSPS. However, the low specific activity of this 
enzyme suggests that it is not ideal for the development of glyphosate-resistant weeds 
or crops. To maintain levels of EPSPS activity in planta, any decrease in specific 
activity should be compensated by an increase in expression levels. Overexpression
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Table 6.1: Comparison of steady-state kinetic parameters 
E. coli 
EPSPS 
Km S3P 
(mM) 
Vmax S3P 
(U/mg) 
Km PEP 
(mM) 
Vmax PEP 
(U/mg) 
Average 
Kcat/Km 
(M-1 sec-1) 
IC50 
GLP 
(µM) 
WT 0.080 ± 0.02 
61.1 ± 
4 
0.053 ± 
0.01 
61.6 ± 
4 7.1 * 10
6 0.62 ± 0.05 
P101S 0.070 ± 0.02 
13.2 ±  
0.7 
0.057 ± 
0.01 
12.9 ± 
0.8 1.6 * 10
5 4.5 ± 0.1 
T97I 0.18 ± 0.01 
11.4 ±  
0.3 
0.15 ± 
0.01 
11.8 ± 
0.3 5.4 * 10
4 620 ± 50 
TIPS 0.12 ± 0.01 
6.46 ±  
0.2 
0.067 ± 
0.003 
6.50 ± 
0.08 5.3 * 10
4 4500 ± 100 
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Fig. 6.4: WT, P101S, T97I and TIPS EPSPS: glyphosate inhibition. IC50 
comparison of WT EPSPS (●); P101S EPSPS (▲); T97I EPSPS (■); and TIPS 
EPSPS (◆). Data were fit to Equation 2 to derive the IC50 values displayed in Table 
6.1. 
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of even an unaltered EPSPS enzyme has resulted in glyphosate-resistance in a number 
of organisms76, 88, 89, 116, but high-level, plastid-localized overexpression is reportedly 
difficult to achieve82, and to maintain functioning of the shikimate pathway, these 
high expression levels would need to be maintained in all plant tissues, and even in 
the absence of glyphosate. Mutations of the residue corresponding to Pro101 of E. 
coli EPSPS have been reported in a number of field-evolved glyphosate resistant 
weeds70, 100, 109. Such a T97I mutation has never been observed in a naturally 
occurring plant population - in fact, BLAST analysis revealed this residue is strictly 
conserved - only EPSPS from Chlaymydia spp. were observed to contain an 
isoleucine at the equivalent position. The decreased catalytic efficiency of the T97I 
mutant EPSPS may explain why it has not been observed in glyphosate-resistant 
weeds. The moderate levels of glyphosate tolerance resulting from Pro101-mutations 
are often enhanced by synergistic, non-target-site glyphosate resistance mechanisms, 
such as decreased uptake and translocation of glyphosate84, 86; it may be that these 
mechanisms are more efficient that the high-level overexpression of a more 
glyphosate-tolerant enzyme with low catalytic efficiency. 
Structural analysis- To better understand the effect of the T97I mutation and the 
mechanism by which subsequent mutation of P101S results in greater substrate 
affinity yet less glyphosate sensitivity, the T97I and TIPS mutant EPSPS enzymes 
were crystallized and the structures were compared to the those of WT EPSPS1 and 
the single-site P101S69 mutant. Figure 6.5 shows a stereoview of the active site 
architecture of T97I and TIPS EPSPS. The T97I mutation does not alter the backbone  
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Fig. 6.5: The glyphosate binding sites of TIPS and T97I EPSPS  
(Top stereofigure) Glyphosate (shown in green) bound to T97I EPSPS reveal 
potential clashes between a phosphonate oxygen and the Cα atom of Gly96 
(d=3.13 Å) and between a carbon atom of glyphosate and a carboxylate oxygen of 
Glu341 (d=2.93 Å) (red dotted lines). 
(Bottom stereofigure) In TIPS EPSPS these clashes are more pronounced (Gly96: 
d=3.02 Å; Glu341: d=2.82 Å) and additional unfavorable interactions occur 
between glyphosate and S3P (d=3.02 Å) and between glyphosate’s carboxylate 
and the Cδ atom of Arg386 (d=3.11 Å). S3P is shown in yellow. The helix 
between residues 97 to 101 is indicated in orange. Black dotted lines indicate polar 
interactions. The cyan spheres denote water molecules. 
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of the α-helix but disfavors glyphosate binding due to the shortened distance between 
the Cα of Gly96 and the phosphate oxygen of glyphosate, and between the 
carboxylate side chain of Glu341 and a carbon atom of glyphosate. The TIPS 
mutation produces more dramatic effects, further shortening the distances between 
Gly96 and glyphosate and Glu341 and glyphosate, and causing additional clashes 
between glyphosate and Arg386, and between glyphosate and S3P. It appears to be 
these steric effects that reduce the binding of glyphosate. To observe the change 
effected by T97I in more detail, Fig. 6.6 shows an overlay of the structures of the 
TIPS and the P101S EPSPS. In WT or P101S EPSPS enzymes, the side chain of T97I 
is hydrogen-bonded with the side chain of Asn26. Upon mutation (P101S), this 
residue shifts away from Asn26, resulting in a shift of Gly96 toward glyphosate. The 
S3P molecule is also shifted slightly downward in the TIPS mutant due to the 
hydrophobic side chain of Ile97. This shift causes a steric clash between glyphosate 
and the 5’-hydroxyl of S3P. 
Structural comparison- Fig. 6.7, turned 90 degrees to the left from the previous 
structure, shows an overlay of the structures of the T97I and the TIPS EPSPS. In the 
T97I mutant, the Ile97 and Pro101 establish hydrophobic interactions and the location 
of the Ile97 side chain results in a slight shifting away of the S3P molecule, 
apparently causing the observed increase in the Km of S3P; In the TIPS enzyme, the 
hydrogen bonding interactions between in Ser101 and the Ile97 shifts the Ile97 back 
away from the S3P molecule, restoring the S3P-binding site, while maintaining the 
altered position of Gly96, which distorts the glyphosate binding site. The binding of
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Fig. 6.6:  Effect of T97I mutation on the structure of EPSPS. 
Displayed is an overlay of active-site residues and ligands (S3P and glyphosate) 
of P101S (orange) and TIPS (cyan).  The side chain hydroxyl of Thr97 in P101S 
and WT EPSPS is in hydrogen bonding interaction with the side chain of Asn26 
(white dotted line).  The hydrophobicity of the Ile97 side chain results in a shift 
of this residue away from Asn26 (green dotted line); at the same time Gly96 
shifts towards glyphosate and causes a steric clash with glyphosates phosphonate 
moiety (red dotted line).  In addition, the side chain of Ile97 forces S3P to shift 
towards the glyphosate binding site (green dotted line), which gives rise to a 
potential steric clash between the target hydroxyl of S3P and one of glyphosate’s 
carbon atoms (red dooted line). 
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Fig. 6.7:  Effect of P101S mutation on the structure of T97I EPSPS. 
Displayed is an overlay of active-site residues and ligands (S3P and glyphosate) of 
T97I (orange) and TIPS EPSPS (cyan).  The Pro101 ring in the T97I enzyme 
exerts hydrophobic forces on the carbonyl oxygen of Ile97; the Ile97 side chain 
comes close to the S3P carboxylate causing the S3P molecule to shift away (green 
dotted lines).  In the TIPS enzyme, the Ile97 carbonyl oxygen establishes a 
hydrogen bond with the Ser101 side chain, which causes the Ile97 side chain to 
shift away from S3P.  These effects may explain the difference in binding of S3P 
to both enzymes as indicated by the different Km values.  In both mutant enzymes 
Gly96 shifts slightly towards the glyphosate binding site resulting in clash 
distances (red dotted line) towards the phosphonate moiety of glyphosate.   
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the shorter PEP molecule (which binds in the same site as glyphosate) is apparently 
not affected by the very slight shift of Gly96.  
Inhibition by TI analogs- The TIPS EPSPS is very insensitive to glyphosate. We 
hypothesized that analogs of the tetrahedral reaction intermediate (TI analogs), 
previously described as potent inhibitors of WT E. coli EPSPS26, 28, 62, 117 (See also 
chapter 8), would still act as potent inhibitors of this mutant enzyme due to their more 
global coverage of the active site and the maintained substrate binding affinity of 
TIPS EPSPS. Fig. 6.8 shows the inhibition of TIPS EPSPS and WT EPSPS by the 
(R)-difluoro-TI analog (2F-TI), the (R)-phosphonate-TI analog (RP-TI), and the (S)-
phosphonate-TI analog (SP-TI). Since these TI analogs are quite potent and are 
competitive inhibitors with respect to S3P, all reactions utilized equal amounts of 
enzyme (the greater specific activity of WT EPSPS was compensated for with shorter 
reaction times), with concentrations of S3P corresponding to the Km, in the presence 
of saturating concentrations of PEP. As hypothesized, the TIPS and WT EPSPS 
enzymes show nearly equal sensitivity to these inhibitors, with the greatest difference 
the almost 2-fold increased tolerance of TIPS toward 2F-TI. These data support our 
hypothesis that inhibitors with more global coverage of the active site are not as 
affected by these mutations. 
Conclusions: 
T97I and TIPS EPSPS from E. coli were produced and analyzed structurally and 
kinetically and compared to the WT and P101S EPSPS enzymes to isolate the effect  
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Fig. 6.8: Inhibition of TIPS by the tetrahedral intermediate analogs 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Top) 2F-TI inhibition 
IC50 TIPS (●) = 180 nM 
IC50 WT EPSPS (○) = 99 nM 
 
 
 
 
 
 
 
 
 
(Center) RP-TI inhibition 
IC50 TIPS (●) = 120 nm  
IC50 WT EPSPS (○) = 91 nm  
 
 
 
 
 
 
 
 
(Bottom) SP-TI inhibition 
IC50 TIPS (●) = 1.9 µM 
IC50 WT EPSPS (○) = 2.4 µM 
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of each mutation. The TIPS EPSPS enzyme shows high levels of glyphosate tolerance 
while maintaining affinity for its substrates, PEP and S3P. The single site T97I 
mutation is also glyphosate insensitive, but, in the absence of the compensating 
P101S mutation, exhibits decreased affinity for PEP and S3P. These phenomena can 
be attributed to specific structural features in the active site. Less clear is the 
molecular basis for the decreased catalytic activity observed in these mutant enzymes. 
It appears that substrate binding is not the rate-limiting step, at least for the P101S 
and TIPS EPSPS enzymes. It may be the case that mutation of these residues 
somehow affects the rate or induction of the open-closed transition. Further 
experiments may reveal the details of this effect, but for now it seems unlikely that 
plants exhibiting these mutations with be successful on a large scale due to the 
decreased catalytic activity. Overall, the structures illustrate how the mutations 
produce glyphosate tolerant enzymes but the kinetics illuminate why they are not 
optimal for the production of glyphosate resistant organisms. Our results also 
indicated that resistance to substrate analogs may occur more readily than the 
development of resistance toward TI analogs. Such phenomena should be taken into 
account in the design of second-generation EPSPS inhibitors. 
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 Chpt. 7: High Throughput Screening for Inhibitors of E. coli 
EPSPS: Identification of Diverse and Novel Chemical Scaffolds  
 
(unpublished)  
Introduction: 
The enzymes of the shikimate pathway represent attractive drug targets2, 14, 20, 27, 29, 101, 
102.  EPSPS is well known as the target of glyphosate, but this inhibitor has little 
antimicrobial activity. All EPSPS inhibitors described are analogs of substrate, 
product, tetrahedral reaction intermediate, or glyphosate (itself analogous to PEP)14, 
26, 27, 29, 60, 118-121, and of these, only a few fluorinated analogs of shikimate have shown 
potent antimicrobial activity101, 122. Identification of additional inhibitors could lead to 
the development of novel antibiotic drugs27, 102.   
High Throughput Screening (HTS) can facilitate identification of inhibitors by rapidly 
assaying a chemical library of compounds for activity against a given drug target. We 
conducted HTS using E. coli EPSPS with the goal of identifying novel chemical 
scaffolds of EPSPS inhibitors; since crystallization conditions are known for E. coli 
EPSPS, co-crystal structures can potentially be obtained with these compounds to aid 
in structure-based lead optimization. 
Experimental Procedures: 
Materials- The screen was conducted at the University of Kansas High Throughput 
Screening Laboratory, using the in-house compound collection composed of 45,000 
compounds from the ChemBridge library, 56,000 compounds from the ChemDiv 
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library, and 880 compounds from the Prestwick library. Training, assistance, and 
collaboration were provided by Dr. Veena Vasandani. E. coli EPSPS and S3P were 
produced according to the standard methods previously described. We utilized the 
malachite green reagent previously described to detect the production of inorganic 
phosphate.  
Activity assay and primary screening- The cuvette-based phosphate-release activity 
assays previously utilized were down-scaled and the screen was conducted in a 
manner similar to the previously performed HTS for MurA inhibitors (Huijong Han, 
unpublished, and Dr. Melanie Priestman, unpublished). The assay was performed in 
384-well microtiter plates having a maximum volume of 100 µl per well. Prior to the 
primary screen, 20 µl of each compound to be screened was added to the testing 
plates. In the primary screen, all compounds were dissolved in 2.5 % DMSO, and the 
concentration of all compounds was 25 mg/ml. Next, 20 µl of E. coli EPSPS, at 0.45 
µg/ml (in 50 mM Na-HEPES pH 7.5, 50 mM KCl, and 2 mM DTT) was added to 
each well using a multidropper apparatus. The reaction was started by addition of 20 
µl of a substrate mixture containing 600 µM PEP and 300 µM S3P (in 50 mM Na-
HEPES pH 7.5, 50 mM KCl, and 2 mM DTT), again using a multidropper apparatus. 
The testing plates were centrifuged briefly to ensure that each sample was mixed. 
Two columns on each plate contained no compound; to one column (18 wells), no 
inhibitor was added (volume replaced by 2.5% DMSO); to the other column (18 
wells), 0.1 mM glyphosate was added (in 2.5% DMSO); these rows served as controls 
to monitor the assay. In each case, the assay volume was 60 µl, and contained: testing 
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compound, at 8.3 mg/ml; E. coli EPSPS, at 0.15 µg/mL; PEP, at 200 µM; and S3P, at 
100 µM; the buffer for the reaction contained 33.3 mM Na-HEPES pH 7.5, 33.3 mM 
KCl, 1.33 mM DTT, and 0.83% DMSO. After addition of the substrate, the reactions 
were allowed to proceed for 30 minutes at room temperature. The assays were 
stopped by the addition of 40 µl of the malachite green reagent, 10 minutes was 
allowed for color development (no sodium citrate was used) and the absorbance at 
650 nm was measured on a SpectraMax 340C plate reader. Every 2 hours, fresh 
substrate and enzyme stock solutions were remade to limit the effects of PEP 
hydrolysis (which can result in false negatives) or enzyme denaturation (which can 
result in false positives). 
Secondary screening- The data from the primary screen were analyzed by Dr. 
Vasandani. Secondary screening, consisting of automated IC50 determination, was 
carried out for all compounds that showed greater than 40% inhibition of E. coli 
EPSPS – this corresponded to 83 samples, less than 1 out of every 1,000 compounds 
tested. These compounds were hit-picked from the daughter plates and 12 
concentrations of 2-fold dilutions were prepared in 2.5% DMSO. The highest 
inhibitor concentration in each case was 16.7 mg/ml. Enzyme and substrate was 
added to each dilution of each inhibitor using a multidropper apparatus, the microtiter 
plates were centrifuged to ensure mixing of the reactants, and enzyme reactions were 
allowed to proceed 30 minutes at room temperature, all as previously described. The 
reactions were stopped by the addition of 40 µl of the malachite green reagent and the 
absorbance at 650 nm was measured after 10 minutes.  
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Results: 
According to the automated IC50 determination, only 28 of the samples had IC50 
values of lower than 10 µM; of these, 18 of the most potent were selected as the lead 
compounds for further study. The vendor, vendor identification number, IC50 values 
determined in the secondary screening, and the in-house abbreviated name of these 
lead compounds are listed in Table 7.1, along with the chemical structures of these 
inhibitors (Fig. 7.1-3). Dry compounds were ordered from the supplier listed, stock 
solutions were resuspended in DMSO, and these compounds were subjected to in-
house hit verification and co-crystallization trials. Hit verification and co-
crystallization trials with these compounds are still underway.  
Conclusions: 
The lead compounds selected for further testing had IC50 values between 10.2 and 2.4 
µM. The molecular weights were between 222 and 432 g/M. These compounds 
appear significantly larger than glyphosate and it seems unlikely that they bind in the 
PEP-binding site, like glyphosate. The mode of action of these inhibitors is still 
unknown, and they may inhibit the open-closed transition of EPSPS. Alternatively, 
the six-carbon ring moieties could mimic S3P-binding, resulting in formation of a 
“dead-end” complex. Co-crystallization and Ki determination will be helpful in 
determining the basis for EPSPS inhibition by these compounds. 
Using the standard cuvette-based assay, the E. coli EPSPS stock utilized here was 
previously determined to have specific activity of 40 U/mg; Km S3P = 150 µM; Km  
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Vendor Vendor ID #  IC50 (uM) Abbr. ID: Structure 
ChemBridge 5140900 6.8 396 Fig. 7.1 
ChemBridge 5180253 7.2 230 Fig. 7.1 
ChemBridge 5222121 2.3 322 Fig. 7.1 
ChemBridge 5457980 10.2 241 Fig. 7.1 
ChemBridge 5465249 6.7 336 Fig. 7.1 
ChemBridge 5552585 7.2 428 Fig. 7.1 
ChemBridge 5651052 4.5 433 Fig. 7.2 
ChemBridge 6003431 2.4 222 Fig. 7.2 
ChemBridge 6520475 5.0 351 Fig. 7.2 
ChemBridge 6540479 4.5 298 Fig. 7.2 
ChemBridge 6648723 9.0 317 Fig. 7.2 
ChemBridge 6696755 3.8 345 Fig. 7.2 
ChemDiv 0263-0421 6.5 432 Fig. 7.3 
ChemDiv 2389-1031 3.1 429 Fig. 7.3 
ChemDiv 3976-0242 4.4 304 Fig. 7.3 
ChemDiv 4361-0397 4.2 325 Fig. 7.3 
ChemDiv 4456-2362 5.6 326 Fig. 7.3 
ChemDiv 5863-2113 3.6 306 Fig. 7.3 
Table 7.1: Inhibitors of E. coli EPSPS identified by HTS. The IC50 values listed 
correspond to those obtained in the secondary screen in the KU HTS laboratory. The 
abbreviated identification numbers were used to identify the compounds ordered 
from the suppliers, and roughly corresponds to the molecular weights. 
 180 
Fig. 7.1: Structures of E. coli EPSPS inhibitors identified by HTS: 
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Fig. 7.2: Structures of E. coli EPSPS inhibitors identified by HTS: 
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Fig. 7.3: Structures of E. coli EPSPS inhibitors identified by HTS: 
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PEP = 150 µM; and IC50 glyphosate = 1 µM. Subsequent 96-well microtiter kinetic 
analyses revealed that the Km values observed in the plate-based assay are lower than 
those estimated by the cuvette-based experiment. In the plate-based assay, the Km S3P 
and the Km PEP are both approximately 50 µM69. These data suggest that for greater 
sensitivity to competitive inhibitors, future HTS with this enzyme should utilized less 
substrate, with more enzyme added if necessary to achieve sufficient signal.  
Small amounts of DMSO appear to prevent the crystallization of E. coli EPSPS. The 
development of alternate enzyme crystallization conditions (or the utilization of 
alternate enzymes - see chapter 8) may be useful for future screens. In particular, due 
to the global induced fit mechanism of EPSPS21-23, 52, it would be useful to utilize an 
enzyme with reproducible “open”- and “closed”-form crystallization conditions.  
These experiments proved useful as the conceptual basis of utilization of microtiter 
plate-based assays for the determination of IC50, Km, and particularly Ki values, which 
were employed variously in Chapters 569, 6, 862, and 9.  
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Chpt. 8: Differential Inhibition of E. coli, S. aureus and CP4 EPSPS 
Enzymes by Analogs of the Tetrahedral Reaction Intermediate 
This work was included in: Funke T.; Healy-Fried M.L.; Han H.;  Alberg D.G.; 
Bartlett P.A.; and Schonbrunn E., Differential Inhibition of Class I and Class II 5-
Enolpyruvylshikimate-3-phosphate Synthases by Tetrahedral Reaction Intermediate 
Analogues. Biochemistry 2007, 46, 13344-51.  
Introduction: 
While glyphosate has proven to be a potent inhibitor of EPSPS from plants and 
Escherichia coli, several glyphosate-tolerant forms of EPSPS have been identified43, 
45, 71, 75, 104. EPSPS with intrinsic glyphosate insensitivity were isolated from 
organisms including S. aureus, S. pneumoniae, Pseudomonas sp. strain PG2982, and 
Agrobacterium sp. strain CP429, 52, 72, 113. These glyphosate tolerant enzymes are 
termed class II enzymes, while glyphosate sensitive plant and E. coli enzymes are 
considered prototypical class I EPSPS enzymes. A search of the literature reveals 
little concerning inhibition of class II EPSPS, and concerted efforts to identify novel 
EPSPS inhibitors have relied exclusively on class I enzymes26, 29. Intensive efforts to 
find a molecule better than glyphosate at inhibiting class I EPSPS largely failed; only 
a few analogues of the TI have been identified as more potent inhibitors (Fig. 8.1)26, 
27, 29, 117. Glyphosate itself has poor antimicrobial properties; detailed inhibition and 
structural data concerning are desired for non-glyphosate-based compounds to aid in 
the design and development of novel EPSPS inhibitors with potential antimicrobial 
activity.  
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Fig. 8.1: The TI analogs used in this study. 
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Crystallographic and chemical studies using E. coli EPSPS demonstrated that the 
addition-elimination reaction catalyzed by EPSPS proceeds through an (S)-configured 
tetrahedral reaction intermediate (TI) (See Fig. 1.7)24, 25. The most potent of the 
synthetic TI analogs, the (R)-difluoromethyl TI analog (2F-TI) and the (R)-
phosphonate TI analog (RP-TI), inhibit EPSPS at nanomolar-range concentrations26, 
28.  
Previously, the structure of E. coli EPSPS was examined in complex with RP-TI and 
the (S)-phosphonate TI analog (SP-TI) to explain the molecular basis for the much 
higher potency of RP-TI compared to SP-TI (which reflects the stereochemistry of the 
genuine TI). To further examine inhibition by these TI analogs, and to probe 
inhibition of the Class II EPSPS, here we investigated the molecular modes of action 
of RP-TI, SP-TI, and 2F-TI using representative class II EPSPS enzymes from S. 
aureus and Agrobacterium sp. strain CP4 in parallel with the prototypic class I 
EPSPS from E. coli. Our kinetic data indicate that class II EPSPS are generally less 
susceptible to inhibition by these TI analogues. We determined the crystal structures 
of the E. coli EPSPS in complex with 2F-TI and the CP4 EPSPS in complex with 2F-
TI and RP-TI to understand the structural basis for the inhibition data.  
Experimental Procedures:  
Materials- Chemicals and reagents were purchased from Sigma (St. Louis, MO) 
unless otherwise noted. S3P was synthesized and purified as described previously45. 
The stable TI analogs (2F-TI, RP-TI, and SP-TI) were provided by Dr. Paul Bartlett.  
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E. coli EPSPS43, Agrobacterium sp. strain CP4 EPSPS52, and S. aureus EPSPS45 
enzymes were overexpressed and purified as previously described.  
Enzyme activity assays- Colorimetric enzyme activity assays were conducted by 
Todd Funke and Martha Healy-Fried at 25 °C in using 96-well microtiter plates. The 
reactions, performed in 60 µL of 50 mM Na-HEPES, pH 7.5, 100 mM KCl, and 2 
mM DTT, were started by the addition of enzyme (final concentration of the EPSPS 
was 1.4 nM for E. coli, 3.2 nM for both the wild-type CP4 and the Ala100Gly CP4, 
and 13 nM for S. aureus), and stopped by addition of 140 µl of the malachite green 
phosphate indicator47  after 20 min (S. aureus EPSPS) or 30 min (E. coli, wild-type 
CP4, and Ala100Gly CP4 EPSPS). Samples were incubated for ten minutes to allow 
for color development, change in absorbance at 650 nm was measured on a Spectra-
Max 340PC plate reader, and product formation was determined by comparison to 
phosphate standards. Enzymatic activities at increasing S3P and varied inhibitor 
concentrations were recorded, and the data were fit to  
Equation 1:  v = Vmax * [S] / (Km + [S]) 
Ki values for 2F-TI, RP-TI, and SP-TI were determined by linear regression of the 
replot of the Km(obs) values versus the concentration of the inhibitor [I], according to  
Equation 2:  Km(obs) = (Km / Ki) * [I] + Km 
where Km(obs) is the observed Michaelis constant in the presence of inhibitor, Km is the 
true Michaelis constant, and Ki is the inhibition constant. To ensure that the results 
were directly comparable, the kinetic constants previously determined for E. coli 
EPSPS inhibition by RP-TI and SP-TI were redetermined using the plate-based assay. 
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Protein concentrations were determined on a Spectra-Max 340PC plate reader 
(Molecular Devices, Sunnyvale, CA) using Pierce (Rockford, IL) coomassie reagent 
with bovine serum albumin as a standard.  
Crystallization- CP4 EPSPS crystals and E. coli EPSPS crystals were grown as 
previously described (see Chapter 4 Experimental Procedures, and Chapter 1 General 
Protocols)43, 52. The structures were solved for E. coli EPSPS, crystallized in the 
presence of 10 mM 2F-TI, and WT CP4 and Ala100Gly CP4 EPSPS crystallized in 
the presence of 5 mM 2F-TI or 5 mM RP-TI. X-ray diffraction data were collected, 
and structure determination was performed as previously described (see General 
Protocols, Chapter 1). Data collection and structure refinement statistics are reported 
in the publication62. 
Results and Discussion: 
Comparison of these EPSPS enzymes- These orthologs of EPSPS have been studied, 
separately, previously in our lab. E. coli EPSPS and CP4 EPSPS are model Class I 
and Class II enzymes, respectively, with known structures. S. aureus EPSPS is a class 
II enzyme from a pathogenic source. Since CP4 and S. aureus EPSPS are insensitive 
to glyphosate, we examined their sensitivity to the TI analogs previously found to be 
the most potent EPSPS inhibitors. The amino acid sequences of these enzymes show 
substantial divergence (Fig. 8.2). Pairwise alignments (data not shown; matrix: 
EBlosum62) reveal that the orthologous enzymes from E. coli and CP4 share 27%  
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Fig. 8.2: Sequence alignment of EPSPS enzymes used in this study. 
Three-way amino acid sequence alignment of CP4, S. aureus, and E. coli EPSPS. 
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identity and 45% similarity; CP4 and S. aureus share 32% identity and 50% 
similarity, and E. coli and S. aureus share 27% identity and 46% similarity. 
Kinetic characteristics- The functional properties of these enzymes are compared in 
Fig. 8.3. The specific activity is highest in the E. coli EPSPS and lowest in the S. 
aureus EPSPS, which is approximately one order of magnitude less active.  The 
substrate binding affinity is well conserved, as evinced by the comparable Km values 
obtained from all three mutants. The biggest differences are observed in the IC50 
glyphosate; S. aureus EPSPS is 430-fold less sensitive than E. coli EPSPS, and CP4 
is over 5000-fold less sensitive to glyphosate than E. coli.   
Inhibition by TI analogs- For each of these EPSPS enzymes, we determined the Ki of 
2F-TI, RP-TI, and SP-TI using steady state kinetics. The substrate saturation plots 
and the Km(obs) replots utilized for Ki determination are shown in figure 8.4a-c, and the 
calculated Ki values are displayed in Table 8.1. Previously, Alberg et al. (1992) found 
both 2F-TI (Ki = 4 nM) and RP-TI (Ki = 15 nM) to be nanomolar-range inhibitors of 
Petunia hybrida EPSPS26, and Priestman et al. (2005) determined that RP-TI exhibits 
similar potency against E. coli EPSPS (Ki = 16 nM)28. Our results with the E. coli 
EPSPS enzyme correlate well with these previous findings, but substantial differences 
are observed in both the rank order and the magnitude of inhibition of the class II 
EPSPS from S. aureus and CP4. RP-TI is the most potent inhibitor of E. coli EPSPS, 
with Ki = 3.9 nM.  However, this inhibitor is 120-fold less potent against S. aureus (Ki 
= 450 nM) and 460-fold less potent against CP4 EPSPS (Ki = 1800 nM). The potency  
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EPSPS Km S3P:  
E. coli (●)= .05 mM,  
CP4 (▲) = .04 mM; 
S. aureus (■) = .06 mM 
 
 
 
 
 
 
 
EPSPS Km PEP: 
E. coli (●)= 0.14 mM; 
CP4 (▲) = 0.12 mM; 
S. aureus (■) = . 0.15 mM 
 
 
 
 
 
 
 
 
 
EPSPS IC50 GLP:  
E. coli (●)=0.002 mM; 
CP4 (▲) = 11 mM 
S. aureus (■) = 0.86 mM 
 
Fig. 8.3: Kinetic properties of EPSPS enzymes used in this study: S3P, PEP, and 
glyphosate binding comparisons.  
 
 
 
 
 
 
 
 
 
 
 
 192 
Fig. 8.4a: E. coli EPSPS inhibition by TI analogs (see following page): 
(Top) S3P saturation curves in the presence of increasing concentrations of 2F-TI: 
0 (●), 1.9 (○), 3.8 (▲), 7.5 (Δ), 15 (■), and 30 (□) nM 2F-TI. The concentration of 
PEP was 1 mM.  Data were fit to Equation 1.   
(Right) Replot of the observed Km values as a function of 2F-TI concentration. 
Data were fit to Equation 2, yielding a Ki of 7.8 ± 0.5 nM.  
 
(Center) S3P saturation curves in the presence of increasing concentrations of RP-
TI: 0 (●), 0.9 (○), 3.8 (▼), 7.5 (∇), 15 (■), and 30 (□) nM RP-TI. The 
concentration of PEP was 1 mM.  Data were fit to Equation 1.  
(Right)  Replot of the observed Km values as a function of RP-TI concentration. 
Data were fit to Equation 2, yielding a Ki of 3.9 ± 0.6 nM 
 
(Bottom) S3P saturation curves in the presence of increasing concentrations of SP-
TI: 0 (●), 0.47 (○), 0.94 (▼), 2.5 (∇), 5 (■), and 10 (□) µM SP-TI. The 
concentration of PEP was 2 mM.   Data were fit to Equation 1.  
(Right) Replot of the observed Km values as a function of SP-TI concentration. 
Data were fit to Equation 2, yielding a Ki of 0.76 ± 0.2 µM. 
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Fig. 8.4a: E. coli EPSPS inhibition by TI analogs   
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Fig. 8.4b: S. aureus EPSPS inhibition by TI analogs (see following page): 
(Top) S3P saturation curves in the presence of increasing concentrations of 2F-TI: 
0 (●), 4.7 (○), 9.4 (▲), 18.8 (Δ), 37.5 (■), 75 (□), and 150 (▼) nM 2F-TI. The 
concentration of PEP was 1 mM.  Data were fit to Equation 1.  
(Right) Replot of the observed Km values as a function of 2F-TI concentration. 
Data were fit to Equation 2, yielding a Ki of 30 ± 6 nM. 
 
(Center) S3P saturation curves in the presence of increasing concentrations of RP-
TI: 0 (●), 0.16 (○), 0.31 (▼), 0.63 (∇), 1.3 (■), and 2.5 (□) µM RP-TI. The 
concentration of PEP was 1 mM.  Data were fit to Equation 1.  
(Right) Replot of the observed Km values as a function of RP-TI concentration. 
Data were fit to Equation 2, yielding a Ki of 0.45 ± 0.07 µM. 
 
(Bottom) S3P saturation curves in the presence of increasing concentrations of SP-
TI: 0 (●), 3.1 (○), 6.3 (▲), 12.5 (Δ), 25 (■), 50 (□), 100 (▼), and 200 (∇) µM SP-
TI. The concentration of PEP was 1 mM.  Data were fit to Equation 1.  
(Right) Replot of the observed Km values as a function of SP-TI concentration. 
Data were fit to Equation 2, yielding a Ki of 11.0 ± 2 µM. 
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Fig. 8.4b: S. aureus EPSPS inhibition by TI analogs: 
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Fig. 8.4c. CP4 EPSPS inhibition by TI analogs (see following page): 
(Top) S3P saturation curves in the presence of increasing concentrations of 2F-TI: 
0 (●), 60 (○), 120 (▼), 240 (∇), and 480 (■) nM 2F-TI. The concentration of PEP 
was 2 mM.  Data were fit to Equation 1.  
(Right) Replot of the observed Km values as a function of 2F-TI concentration. 
Data were fit to Equation 2, yielding a Ki of 63 ± 15 nM. 
 
(Center) S3P saturation curves in the presence of increasing concentrations of RP-
TI: 0 (●), 2.5 (○), 5 (▲), 10 (Δ), and 20 (■) µM RP-TI. The concentration of PEP 
was 2 mM. Data were fit to Equation 1.  
(Right) Replot of the observed Km values as a function of RP-TI concentration. 
Data were fit to Equation 2, yielding a Ki of 1.8 ± 0.6 µM. 
 
(Bottom) S3P saturation curves in the presence of increasing concentrations of SP-
TI: 0 (●), 25 (○), 50 (▼), 100 (Δ), 200 (■), and 400 (□) µM SP-TI. The 
concentration of PEP was 2 mM.   Data were fit to Equation 1.  
(Right) Replot of the observed Km values as a function of SP-TI concentration. 
Data were fit to Equation 2, yielding a Ki of 76 ± 9 µM. 
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Fig. 8.4c. CP4 EPSPS inhibition by TI analogs: 
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Table 8.1: TI analogs: E. coli, CP4, and S. aureus EPSPS inhibition. Inhibition 
constants (Ki) of TI analogs with respect to S3P (see Figs. 8.4a-c). 
 
EPSPS 
Enzyme 
Ki 2F-TI 
(nM) 
Ki RP-TI 
(nM) 
Ki 2F-TI 
(nM) 
E. coli 7.8 ± 0.5 3.9 ± 0.6 760 ± 200 
CP4 63 ± 15 1800 ± 600 76000 ± 9000 
S. aureus 30 ± 6 450 ± 70 11000 ± 2000 
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of 2F-TI against the class II EPSPS is also decreased (by 3- to 7-fold) compared to E. 
coli EPSPS; despite this, 2F-TI is the most potent inhibitor of the Class II enzymes (S. 
aureus Ki = 30 nM; CP4 Ki = 63 nM). Of these three inhibitors, the SP-TI is the most 
similar to the genuine TI, yet shows the least potency. The inhibitory potency of SP-
TI against the class II EPSPS is, again, decreased (by 14- to 100-fold) compared to 
the class I E. coli EPSPS. Together, these findings indicate that class II enzymes such 
as S. aureus or CP4 EPSPS are tolerant not only toward glyphosate but are also 
considerably less susceptible to inhibition by these analogues of the TI. 
Crystallization- To probe the basis of the observed differential inhibition, we 
determined the structures of the dead-end complexes. The E. coli EPSPS•2F-TI 
structure was determined at 1.6 Å resolution, the CP4 EPSPS•2F-TI complex at 1.8 Å 
resolution, and the CP4 EPSPS•RP-TI complex at 1.6 Å resolution. Despite repeated 
efforts, we were unable to obtain crystals of the CP4 EPSPS•SP-TI complex, and 
crystallization conditions for the S. aureus enzyme are, as of yet, unknown. We 
utilized the previously determined E. coli EPSPS•TI24, E. coli EPSPS•RP-TI, and E. 
coli EPSPS•SP-TI structures28 to enable fuller comparison.  
Comparison of 2F-TI co-crystal structures- The active sites of the E. coli EPSPS•2F-
TI and the CP4 EPSPS•2F-TI structures are shown, in stereo, in Fig. 8.5. In the case 
of the E. coli EPSPS structure, the most prominent change (compared to the S3P-
bound  binary complex) is seen in the side chain of residue Glu341, which swings 
away from the active site in the 2F-TI complex. The position of this glutamate side  
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Fig. 8.5: 2F-TI, active site structures and bonding interactions. Stereofigure 
shows inhibitor (yellow) bound to active site of EPSPS enzymes. (Top) 2F-TI•E. coli 
EPSPS;  (Bottom) 2F-TI•CP4 EPSPS. Green residues show conformation of Glu341 
or Glu354 in the respective binary structures. Black dotted lines indicate hydrogen 
bonding interactions; cyan balls denote water molecules. 
 
 
 
 
 201 
chain in the S3P-complexed enzyme is instead occupied by the difluoro group of 2F-
TI. In comparison, the side chain conformations and bonding interactions of the CP4 
active site are nearly identical in the S3P-bound or 2F-TI-bound structure and the 
equivalent glutamate (residue Glu354) shifts only slightly. Compared to the position 
of this side chain in the S3P-complexed enzyme the plane of the carboxyl moiety 
rotates slightly, the side chain clearly does not translate out of the active site. Aside 
from this glutamate residue, the other major difference observed when comparing the 
CP4 EPSPS•2F-TI active site to the E. coli EPSPS•2F-TI active site is the position of 
residue Thr101 (equivalent to Thr97 in the E. coli enzyme). The position of this 
residue in CP4 EPSPS appears to induce a slight conformational change in the 2F-TI 
molecule.  
Comparison of RP-TI co-crystal structures- Fig. 8.6 shows the RP-TI liganded EPSPS 
structures in stereo (the E. coli EPSPS•RP-TI structure shown here was obtained 
previously). Again, the distinct conformational changes that are observed in the E. 
coli EPSPS•RP-TI active site are not reflected in the CP4 EPSPS structure. E. coli 
residues Glu341 and Arg124 shift out of the active site compared to their position in 
the S3P-binary structure. The equivalent residues in the CP4 EPSPS•RP-TI active 
site, Glu354 and Arg128, shift only slightly compared to their position in the CP4 
EPSPS•S3P structure. The position of the Glu354 appears to cause a steric clash with 
respect to the RP-TI, providing one explanation for the dramatically reduced potency 
of this inhibitor. The Thr101 is in the same position as observed in the CP4 
EPSPS•2F-TI structure, causing a slight shift in the 3’-phosphate orientation, and a  
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Fig. 8.6: RP-TI, active site structures and bonding interactions. Stereofigure 
shows inhibitor (yellow) bound to active site of EPSPS enzymes. (Top) RP-TI•E. coli 
EPSPS;  (Bottom) RP-TI•CP4 EPSPS. Green residues show conformation of Glu341 
and Arg124 or Glu354 in the respective binary structures. Black dotted lines indicate 
hydrogen bonding interactions; red dotted lines indicate steric clashes; cyan balls 
denote water molecules. 
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conformational change is observed in the RP-TI molecule. It appears that the 
conformational flexibility exhibited by active site residues of E. coli EPSPS is an 
important determinant of the binding of the TI analogs. Alternatively, one may say 
that the conformational rigidity displayed by the active site of CP4 EPSPS prevents 
binding of the favored conformations of these TI analogs. The idea that CP4 EPSPS 
has a more rigid structure is correlated by the results of the thermal denaturation 
studies we previously performed, which indicated that CP4 EPSPS is more 
thermostable than the E. coli enzyme. Fig. 8.7 highlights the conformational change 
observed for the TI analogs bound the E. coli or CP4 enzymes. In both cases, higher-
energy inhibitor conformations are observed with CP4 EPSPS again suggesting that 
the conformational rigidity of the CP4 EPSPS may require conformational flexibility 
of the inhibitor molecule.  
Analysis of SP-TI and EPSPS interactions- The basis for the low inhibitory potency 
of the SP-TI for CP4 EPSPS is difficult to assess in the absence of structural data. 
Repeated crystallization trials simply failed to produce crystals. The crystallization 
conditions utilized are specific to the “closed”-form CP4, so it is possible that the SP-
TI failed to produce the required conformational change, perhaps due to intrinsic 
properties of the SP-TI itself, insufficient inhibitor concentration, or perhaps a 
contaminant from the synthesis process that interferes with crystallization at the high 
concentrations utilized. Docking experiments performed by Huijong Han (utilizing 
the closed-form CP4 EPSPS and the SPTI conformation as obtained with the E. coli 
enzyme) indicated that several electrostatic interactions observed in the E. coli  
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Fig. 8.7: Conformational change of TI analogs: The TI analogs bound to the CP4 
enzyme adopt higher-energy conformations. 
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EPSPS•SP-TI complex would be lost in the complex of CP4 EPSPS•SP-TI, 
suggesting one possible basis for the weak inhibition observed in our inhibition 
studies. 
Formation of dead-end complex- The global induced fit mechanism of EPSPS 
complicates the analysis and modeling of inhibition. Fig. 8.8 shows the two-step 
process that is required for formation of the closed-form inhibitor bound enzyme (also 
simply for binding of S3P). The initial binding of the S3P-moiety of these inhibitors 
with the N-terminal globular domain of the open-form EPSPS results in formation of 
a “collision complex”. The enzyme then undergoes the open-closed transition, and 
this step may, in fact, be a rate-limiting step, in which case the observed Ki would not 
be equivalent to the Kd of these inhibitors. The differential inhibition that we observe 
with respect to the inhibition of E. coli, S. aureus and CP4 EPSPS may result in part 
from alteration of the rate of the global open-closed transition. 
Conclusions: 
Previous EPSPS-inhibition studies have focused on class I EPSPS enzymes. Here, we 
have shown that the 2F-TI, a nanomolar-range inhibitor of class I EPSPS, is also a 
potent inhibitor of the class II EPSPS from CP4 and S. aureus (Ki = 63 and 30 nm, 
respectively). In general however, the results of this work show that TI structure-
activity-relationship studies conducted utilizing one EPSPS enzyme are not 
necessarily applicable to other EPSPS enzymes. The differential inhibition also 
suggests that the genuine TI of these enzymes may differ somewhat in energy and 
conformation. To probe this, we produced a D326A mutant of the CP4 enzyme  
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Fig. 8.8: Two steps are required to form the dead-end complex. Proposed 
molecular mode of action of TI analogues on EPSPS. On the basis of the 
structural data available to date, TI analogues (TIAs) would initially interact 
with the open state of EPSPS to form a collision complex, determined by the 
dissociation constant Kd(TIA), followed by an open-closed transition to the dead-
end complex, determined by the rate constants k3* and k4*. Under the steady-
state conditions applied here, the measured Ki values represent the Kd only if 
the ratio of k3* and k4* is not altered as a result of the inhibitor's interaction 
with the enzyme. 
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 (equivalent to the D313A mutation that allowed trapping of the TI in E. coli EPSPS).  
While this enzyme was indeed inactive, crystals were never observed. Very recently, 
the coordinates of the M. tuberculosis EPSPS bound to the genuine tetrahedral 
intermediate were reported by another group (PDB 2o0x, unpublished); a simple 
alignment of the carbon atoms of the S3P rings (Fig. 8.9) indeed shows some 
conformational changes. Our hypothesis that the properties of CP4 may allow it to be 
used as a structural model of the S. aureus EPSPS does not appear to be supported, 
and our study suggests that, for antibiotic purposes, inhibitor design and development 
is best conducted using EPSPS from pathogenic sources.  
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Fig. 8.9: The genuine TI may exist in different conformations. Shown are the 
structures of the tetrahedral reaction intermediates found in E. coli D313A EPSPS 
(PDB 1q36) (green) and M. tuberculosis EPSPS (PDB 2o0x) (cyan). The cyclohexene 
moieties of each molecule were aligned using PyMol. 
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Chpt. 9: Synthesis of S3P or S3P-analogs from Shikimate or 
Shikimate-analogs using a Monitored Enzymatic Phosphorylation 
(unpublished) 
 
Introduction: 
The enzyme shikimate kinase (SK) catalyzes the phosphorylation of shikimate, 
producing ADP and S3P (see Fig. 9.1). S3P is a key intermediate in the shikimate 
pathway toward the biosynthesis of aromatic compounds. As the substrate of EPSPS, 
S3P is required to examine the structure, function, and inhibition of this enzyme. S3P 
has been isolated from culture123, 124, obtained from chemical synthesis125, and 
produced by enzymatic synthesis45. While S3P can be obtained commercially 
(Toronto Research Chemicals, Inc.) the cost of $125 per milligram limits the 
experiments that can be contemplated; for example, screening of the 100,000+ 
compound collection at the KU HTS laboratory for inhibitors of E. coli EPSPS 
consumed nearly 200 milligrams of S3P. To enable such experiments, an enzymatic 
synthesis developed by Dr. Melanie Priestman45 (see General Protocols, Chapter 1) 
was utilized, to produce S3P from shikimate and ATP, using Methanococcus 
jannaschii SK46, and S3P was then purified using anion-exchange. This process was 
time-consuming, reproducibility was poor, and the process was inefficient (overall 
yield of approximately 25%).  
An optimized synthesis of S3P was desired to increase yield, simplify procedures and 
improve reproducibility. Further, a variety of shikimate analogs had been produced 
(see Fig. 9.2) with the goal of utilizing S3P-analogs to probe the catalytic mechanism  
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Fig. 9.1: The reaction catalyzed by Shikimate Kinase (SK) 
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Fig. 9.2: Structure of shikimate and the analogs examined here. 
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and inhibition of EPSPS. Chemical synthesis methods were found to result in non-
specific phosphorylation of theses shikimate analogs, resulting in unresolvable 
mixtures. We hypothesized that SK enzymes could be used to phosphorylate these 
shikimate analogs at the proper position and with the desired stereochemistry. To 
meet these needs, two new SK genes were obtained, an assay was developed to 
monitor S3P production, and a more efficacious method was developed for removing 
nucleotides from the crude reaction mixture.  
SK enzymes are quite diverse. Two types of SK have been characterized (SK I and 
SK II), and many organisms have genes for both. In E. coli, for example, the SK I is 
encoded by the aroK gene, while SK II is encoded by the aroL gene. These two genes 
are not highly similar, and it is believed that only SK II normally functions in the 
shikimate pathway126, 127. The structure of SK II from E. coli is not known. 
Mycobacterium tubercuolosis, on the other hand, has only the aroK-encoded SK I. 
This enzyme is not highly similar (optimal global alignment: 28% identity and 45% 
similarity) to SK II of E. coli, but more resembles SK I128, 129. Extensive structural 
data are available concerning the M. tuberculosis SK130-132, but little functional data 
exist. The M. jannaschii SK enzyme previously utilized has very low sequence 
homology compared to other SK enzymes (optimal global alignment: 11% identity 
and 21% similarity to aroL from E. coli; 4% identity and 5% similarity to aroK of M. 
tuberculosis) (three-way alignment, Fig. 9.3). While M. jannaschii is not a pathogen, 
the SK enzymes are, in general, considered promising drug targets27, 101, 133. In order 
to improve the S3P synthesis, effect the phosphorylation of the shikimate analogs,  
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Fig. 9.3: Three-way alignment of SK enzymes. Three sources: E. coli SK II, M. 
tuberculosis SK I, and M. jannaschii SK 
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and probe the activity of diverse SK enzymes, the E. coli aroL (SK II) gene and the 
M. tuberculosis aroK (SK I) gene were obtained, a SK activity assay was developed, 
and the phosphorylation and product purification procedures were optimized. 
Experimental Procedures: 
Materials- All materials were purchased from Sigma except as otherwise stated. 
Shikimate analogs were provided by Dr. Apurba Dutta. Synthetic genes encoding E. 
coli SK II (aroL) and M. tuberculosis SK I (aroK), with codon usage optimized for 
high-level overexpression in bacteria, were purchased from GeneArt (Frankfurt, 
Germany).  
Molecular biology- The GeneArt-produced construct was subjected to restriction 
digest using NdeI and XhoI restriction endonucleases in NEBuffer 2 + BSA (New 
England BioLabs), according to the manufacturer’s instructions. The products of the 
digest were separated by size using agarose gel electrophoresis and the aroL and 
aroK genes were isolated using the QIAquick Gel Extraction Kit (Qiagen), according 
to the manufacturer’s instructions. Empty pET-24c vector (Novagen) was linearized 
and purified by the same restriction digest and gel extraction process, and the aroL 
and aroK genes were ligated into this pre-digested vector using T4 DNA ligase from 
the Quick Ligation kit (New England BioLab), again according to the manufacture’s 
instructions. The product of this cohesive-end ligation was utilized directly to 
transform chemically competent E. coli DH5-α. These cells were plated on LB-Agar 
plates containing 30 µg/ml kanamycin and incubated overnight. The resulting 
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bacterial colonies with kanamycin-resistance were picked and grown in LB media 
overnight, and the plasmids were isolated using the QIAprep Spin Miniprep kit 
(Qiagen) according the manufacturer’s instructions. Samples of the isolated plasmids 
were subjected again to restriction digest by NdeI and XhoI and analyzed by DNA 
agarose gel electrophoresis. Several of the restriction digest analysis displayed 
properly-sized genes; these were submitted for sequence analysis at the Idaho State 
University Molecular Research Core Facility.  
Protein production- The sequences obtained utilizing the T7 primer confirmed the 
presence of the open reading frame of the aroL  and aroK genes, and the aroK-pET-
24c and aroL-pET-24c constructs were transformed into E. coli BL21(DE3)Star cells 
(Invitrogen). Small-scale studies showed that soluble expression of both enzymes 
could by induced, at 37 °C, by addition of 0.5 mM IPTG. Large scale cultures were 
grown to log stage (OD600 = 0.4 to 0.6) at 37 °C in LB media in the presence of 30 
µg/ml kanamycin, induced with 0.5 mM IPTG, and harvested by centrifugation 4-6 
hours post-induction. 
E. coli SK purification- E. coli SK II purification was performed first. As the 
(NH4)2SO4 effects were unknown, the ammonium sulfate precipitation step was 
avoided. Instead, (much as in initial purifications of S. aureus or CP4 EPSPS) cells 
were lysed in extraction buffer and the clarified lysate was loaded directly onto the Q-
sepharose column and eluted along a linear gradient from 100% - 0% buffer A, over 
10 CV. The SK II enzyme was found in the flow through, likely due to the salt 
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content of the extraction buffer (0.1 M NaCl).  The flow through was collecteted and 
concentrated by Amicon apparatus overnight using a 10 kDa Millipore filter. Q-
sepharose Buffer A was added to dilute the salt content of the solution, and a 
precipitate was observed to form. SDS-PAGE indicated that this precipitate was (in 
fact nearly pure) E. coli SK II. Re-addition of NaCl did not re-solubilize the enzyme. 
Prior to performing a new overexpression and purification procedure, the gene 
sequence was checked again. This time, four extraneous residues, two methionines 
and two alanines, were noted at the N-terminus of the protein, an artifact of the 
restriction/ligation process (the gene product is thus N-term-MetAlaMetAla-aroL-C-
term).  Mutation of the methionine codons to something other than “ATG” will 
correct this defect, but this work has not been performed. Due to difficulties in 
purification and gene sequence, this project was set aside.  
M. tuberculosis SK purification- M. tuberculosis SK I was purified by essentially the 
same process. Again, the enzyme was found in the flow through of the first anion-
exchange column, again likely due to the NaCl content of the extraction buffer used 
for resuspension and lysis of the cell pellet. However, the flow-thru showed 
significant enrichment of the SK I enzyme. The flow through was concentrated by 
Amicon apparatus overnight using a 10 kDa Millipore filter. Q-sepharose Buffer A 
was added repeatedly to dilute the salt content of the solution, with no precipitation 
observed. The desalted and partially purified SK I preparation was applied to the 
Resource-Q anion exchange column and eluted over a 20 CV, 100 - 0 % Buffer A 
gradient. This time, the enzyme was found in the collected fractions. The M. 
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tuberculosis SK I enzyme was pooled analyzed by SDS-PAGE, and determined to be 
approximately 90% homogenous; a high molecular-weight contaminant was 
observed. The total yield was about 12 mgs of purified SK I from a 7 g cell pellet.  
SK activity assay- To compare this M. tuberculosis SK to the M. jannaschii SK, and 
to monitor the phosphorylation of the shikimate analogs, an SK couple-enzyme 
activity assay was developed based on that used by Miller et al (1986)134. SK activity 
is coupled to the formation of NAD+ from NADH, resulting in a change in 
absorbance at 340 nm (Fig. 9.4) using the enzymes pyruvate kinase and lactic 
dehydrogenase (from rabbit muscle; ammonium sulfate suspensions from Sigma). 
The total assay volume was 250 µL to facilitate 96-well microtiter plate-based kinetic 
experiments. For maximal activity SK activity, the ingredients in each assay sample 
were: 4 mM shikimate, 5 mM ATP, 2.5 mM PEP, 2.5 mM MgCl2, 0.25 mM NADH, 
2.5 U Pyruvate Kinase, and 2.5 U Lactic Dehydrogenase in a buffer of 100 mM Tris-
HCl pH 8.5, 50 mM KCl, and 2 mM DTT. Typically, 0.0002 mg SK were added to 
start each reaction, and the ΔAbs340 was monitored as a function of time. In this 
reaction, oxidation of NADH is stoichiometrically equivalent to the production of 
ADP (and S3P) by SK; from linear portions of the graphs showing absorbance versus 
time (not shown), the ΔAbs340 per minute was calculated. Based on the extinction 
coefficient of NADH, the SK enzyme activity is equivalent to 0.089 micromoles 
product formed per unit of absorbance change at 340 nm, per minute of reaction, per 
milligram of enzyme. Put another way, SK activity = 0.089 µmol product * ΔAbs340 / 
min / mg.  
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Fig. 9.4: Coupled enzyme assay for monitoring reaction progress. S3P (or S3P 
analog) formation is stoichimetric with NADH consumption. 
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Substrate saturation experiments- To test these SK enzymes and this assay, enzyme 
activity was determined as a function of shikimate concentration and the data were fit 
to Equation 1: v = Vmax * [S] / (Km + [S]) 
to determine the Km and Vmax for each enzyme. The same procedure was utilized to 
study the phosphoryl transfer reaction with each shikimate analog; these data were 
also fit to Equation 1. The results of these assays were used to optimize the 
preparative phosphorylation of shikimate and shikmate-analogs. 
Purification of S3P and S3P analogs- The purification of S3P and S3P analogs was 
simplified. At the suggestion of Dr. Andreas Becker, activated carbon was utilized to 
remove excess nucleotides from the synthesis reaction. Following preparative 
reactions, activated carbon (10% w/v) was stirred into the reaction solutions, and then 
removed by filtration. This step resulted in removal of approximately 90% of the ATP 
and ADP from the sample. The crude mixture was then diluted with H2O to achieve a 
conductivity reading of < 5 mS per cm2, and applied to a 6-ml Resource-Q anion 
exchange column, pre-equilibrated with H2O. This phosphorylated compound was 
then eluted by a TEAB gradient (0 to 0.5 M over 20 CV) and detected by EPSPS 
activity tests, UV absorbance (λ = 215), or simply by time of elution. TEAB is 
volatile and was removed from the sample by rotary evaporation, with methanol 
added repeatedly, as necessary, to increase the rate of evaporation and replace the 
TEAB as solvent. The product was evaporated until dry, massed, and resuspended in 
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H2O. Concentration was determined using the EPSPS phosphate release assay in the 
case of S3P, or based on mass or UV extinction in the case of the S3P-analogs.  
Preaparative synthesis of shikimate analogs- For the preparative synthesis of the 
shikimate analogs described in the results, all reactions were carried out in 100 mM 
Na-HEPES, 50 mM KCl, 10 mM MgCl2 and 2 mM DTT. The ATP and AMP were 
removed using activated carbon, as described, prior to anion-exchange purification. 
Results and Discussion:  
Shikimate-utilizing SK activity assays- Considering the very low sequence homology 
of the SK enzymes from M. jannaschii and M. tuberculosis (Fig. 9.3), the activity of 
these enzymes is remarkably similar.  For maximum activity, both enzymes prefer 
similar reaction conditions. The Km shikimate determinations (see Fig. 9.5) showed 
that these enzymes have comparable affinities for shikimate, and similar reaction 
velocities. The M. tuberculosis SK shows somewhat greater activity, but the M. 
jannaschii organism is thermophilic, so it may be expected that the M. jannaschii SK 
is more stable, and this may be particularly significant with longer reaction times.  
Both of these enzymes have been utilized for preparative S3P syntheses (typically 
allowed to run overnight); in both cases, the reactions ran to near-completion. 
Helpfully, the ADP-production assay allows one to verify that the reaction has been 
started, and also to determine the initial rate of the reaction and to estimate how much 
time is required to reach completion. Regarding preparative syntheses, it should be 
noted that substantial substrate inhibition was observed when using 10 mM ATP.  
 221 
Fig. 9.5: SK utilization of Shikimate 
(○) M. tuberculosis SK: Vmax = 7.2 U/mg; Km = 0.56 mM 
(●) M. jannaschii SK: Vmax = 4.7 U/mg; Km = 0.50 mM 
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This suggests that to scale the enzymatic reactions, one should typically adjust the 
reaction volume, rather than the substrate concentration. 
Shikimate analog phosphorylation trials- The assay described was used to probe the 
ability of these enzymes to phosphorylate analogs of shikimate. Only small amounts 
of the analog were available, precluding extensive testing, but the results were 
enlightening. Our hypothesis was that the divergent SK sequences were indicative of 
differences in the active-site structures; these in turn could result in differential 
affinity for the substrate analogs. While the E. coli aroL gene product, SK II, was not 
obtained, the results of our studies with the other two SK enzymes bear out this 
hypothesis.  
Phosphorylation of the saturated analog of shikimate - Fig. 9.6 shows utilization of 
the saturated analog of shikimate by M. tuberculosis and M. jannaschii SK (see also 
Fig. 9.2). While the Vmax of the enzymes is similar (ca. 1 U/mg), the Km indicates that 
M. jannaschii binds this analog better (Km = 1.4 mM, versus 3.5 mM for the M. 
tuberculosis SK). Based on this data, the M. jannaschii SK was utilized to 
phosphorylate the saturated shikimate analog.  
For the preparative synthesis, an 11 ml overnight synthesis reaction was set up, 
containing 9 mM of the saturated shikimate, 12 mM ATP, and 0.1 mgs of M. 
jannaschii SK. The yield was estimated the following day using an endpoint assay to 
determine total ADP formation; the estimated yield was 56%, or 55.4 micromoles. 
This estimated yield is quite high considering the racemic character of the shikimate  
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Fig. 9.6: SK utilization of Saturated shikimate 
(○)M. tuberculosis SK: Vmax = 0.98 U/mg; Km = 3.4 mM 
(●) M. jannaschii SK: Vmax = 1.1 U/mg; Km = 1.4 mM 
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analogs. The saturated-S3P-analog was purified by anion exchange, as described. 
Since this compound has essentially no absorbance, the fractions where S3P normally 
elutes were collected. 
Phosphorylation of the 5-Fluoro analog of shikimate- Fig. 9.7 shows utilization of the 
5-fluoro analog of shikimate. In this case, the activity of the M. tuberculosis enzyme 
is 5-fold higher, and the Km is halved compared to that exhibited by M. jannaschii 
SK. For the preperative synthesis of this analog, an 11 ml overnight synthesis reaction 
was set up, containing 9 mM of the 5-Fluoro shikimate, 12 mM ATP, and 0.1 mgs of 
M. tuberculosis SK. An additional 0.1 mgs of enzyme was added the following 
morning. The yield was estimated the following day using an endpoint assay to 
determine total ADP formation; the estimated yield was 41%, or 40.6 micromoles. 
Again, the analog was racemic, so this yield is very good. The 5-Fluoro-S3P-analog 
was purified by anion exchange, as described, and detected by UV scanning of the 
fractions. 
Phosphorylation of the 5-deoxy analog of shikimate- Fig. 9.8 shows utilization of the 
5-deoxy analog of shikimate. In this case, the activity of both enzymes is very low, 
but M. tuberculosis shows greater ability to utilized this substrate. The Km values are 
indicate that this compound binds 10-fold better to these enzymes than does 
shikimate. It may be that the low signal-to-noise ratio produced aberrant data. 
Another possibility is that a synthetic contaminant was present and reduced enzyme 
activity at high concentrations. Further experiments would be helpful in determining  
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Fig. 9.7: SK utilization of 5-Fluoro-Shikimate 
(○)M. tuberculosis SK: Vmax = 1.2 U/mg; Km = 0.53 mM 
(●) M. jannaschii SK: Vmax = 0.23 U/mg; Km = 1.26 mM 
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Fig. 9.8: SK utilization of 5-deoxy Shikimate 
(○)M. tuberculosis SK: Vmax = 0.22 U/mg; Km = 0.041 mM 
(●) M. jannaschii SK: Vmax = 0.13 U/mg; Km = 0.021 mM  
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the basis for these unusual data. For the preparative synthesis of this analog, a 33 ml 
overnight synthesis reaction was set up, containing 3 mM of the 5-deoxy-shikimate 
analog, 6 mM ATP, and 0.2 mgs each of M. tuberculosis SK and M. jannaschii SK. 
An additional 0.1 mgs of each enzyme was added the following morning. The 
rationale for the large amount of enzyme was the low specific activity observed. The 
yield was estimated the following day using an endpoint assay to determine total 
ADP formation; the estimated yield was 24%, or 23.8 micromoles. This was better 
than expected based on the peculiar kinetic data. The 5-deoxy-S3P-analog was 
purified by anion exchange, as described, and detected by UV scanning of the 
fractions. 
Phosphorylation of the 5-amino and the 4,5-deoxy analogs of shikimate- Not shown 
are the data concerning the utilization of the 5-amino analog of shikimate and the 4,5-
deoxy analog of shikimate. Both of these showed no activity at concentrations of up 
to 20 mM. Preparative phosphorylation was not performed using the 5-amino 
shikimate analog. A single, possibly erroneous data point suggested that the 4,5-
deoxy analog of shikimate could be phosphorylated by M. jannaschii SK if the analog 
were very concentrated (ca. 40 mM). A 7 ml overnight preparative synthesis reaction 
was set up, containing 30 mM 4,5-deoxy shikimate, 40 mM ATP, and 0.2 mgs of M. 
jannaschii SK. A precipitate formed, and no product was observed the following day. 
On the hypothesis that the precipitate was interfering with assay for detecting product 
formation, purification was attempted by anion exchange. The sample did not bind to 
the column, likely indicating the absence of the phosphate moiety. Additionally, the 
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ADP peak was not observed, suggesting that no ADP, and hence no S3P analog, were 
produced. The flow through was collected and frozen for later use. It is possible that 
another SK enzyme (such as E. coli SK II) could phosphorylate these compounds. 
More testing remains to be done. 
Phosphorylation of Shikimate- As a control for these shikimate analog 
phosphorylation experiments, a 40 ml overnight reaction was set up containing 9 mM 
shikimate, 12 mM ATP, and 0.1 mgs M. jannaschii SK. The yield was estimated at 
109%. This result is likely due to ATP auto-hydrolysis and variance resulting from 
single data points obtained after serial dilution. The yield of this 40 ml S3P synthesis 
reaction was 360 micromoles, nearly 90 mgs of S3P, demonstrating the utility of this 
enzymatic synthesis for the production of S3P.  
Conclusions: 
The production of the E. coli SK requires further analysis and troubleshooting, and 
the purification procedure for the M. tuberculosis SK should be modified to improve 
reproducibility. The production and purification procedures described here for S3P do 
work well and offer significant advantages in comparison to those utilized previously. 
This optimized procedure allows monitoring of the phosphoryl transfer reaction, 
requires only a one-column purification, uses significantly less TEAB, and achieves 
yields of over 90% with respect to shikimate. Further, the SK activity assay 
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developed here can be used to study SK enzymes from diverse species, and should 
aid investigation of these drug targets. Finally, three of the five shikimate analogs 
tested were successfully phosphorylated and purified. Testing and co-crystallization 
experiments will be conducted to examine the interaction of these S3P-analogs with 
EPSPS.   
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Chpt. 10: Summary and Conclusions 
 
 
The results presented here summarize our work toward understanding the structure, 
function, and inhibition of EPSPS enzymes, toward an overall goal of the 
development of novel inhibitors with antimicrobial and herbicidal properties.   
Prior to this work, very little information was available concerning the structure, 
function, or inhibition of class II EPSPS enzymes. We biochemically characterized 
two class II enzymes, EPSPS from the pathogen S. aureus and the economically 
important EPSPS from Agrobacterium sp. strain CP4. We succeeded in determining 
the structure of CP4 EPSPS, revealing the structural basis of glyphosate insensitivity 
exhibited by this enzyme. It is believed that this enzyme can be a useful model, 
facilitating comparative analyses with respect to other EPSPS enzymes. Significant 
structural and functional differences must be accounted for in attempts to develop 
broad-spectrum EPSPS inhibitors, as indicated by the differential inhibition observed 
with respect to the TI analogs studied in chapter 8. 
Our analysis of mutation-induced glyphosate resistance shows that glyphosate 
tolerance can be induced without decreasing substrate affinity, but reduced catalytic 
activity is observed. Such mutations were studied previously in efforts to develop 
glyphosate-resistant crops, and will likely continue to be examined due to the 
emergence of glyphosate-tolerant weeds. Our studies suggest that more global 
coverage of the active site may delay the development of resistance; this should be 
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considered for the design of durable second-generation EPSPS. Until suitable 
glyphosate replacements are available, strategies should be implemented to slow the 
development and reduce the spread of glyphosate resistant weeds. 
The use of alternate (non-substrate) ligands can be useful for exploration of substrate 
recognition and induced fit mechanisms. This approach was utilized using a precursor 
(shikimate), TI analogs (SP-TI, RP-TI, and 2F-TI), using and extrinsic fluorophore 
(ANS), and using a variety of drug-like compounds (HTS experiment). This course of 
study should be further expanded by the utilization of the S3P analogs produced in 
Chapter 9 to probe EPSPS, and our hope is that these results will provide a theoretical 
framework to facilitate structure-based drug design. 
These studies have greatly improved our understanding of the structure, function, and 
inhibition of EPSPS. It is our belief that further efforts toward the development of 
novel EPSPS inhibitors will be crucial to the on-going struggle against agricultural 
pests and human pathogens. 
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